Amedeo Smart

Free Medical Literature Service


 

Amedeo

Influenza

  Free Subscription

Articles published in
J Infect
    September 2022
  1. ZOU P, Li G, Ge X, Wang J, et al
    Lymphocyte subset changes in neonates with respiratory syncytial virus pneumonia.
    J Infect. 2022;85:334-363.
    >> Share

    July 2022
  2. LUO Q, Li M, Li A, Gong C, et al
    Genetic diversity and epidemiological features of respiratory syncytial virus, Beijing, 2015-2019: A multicenter and all-age groups study.
    J Infect. 2022;85:75-85.
    >> Share

  3. YUAN W, Hou Y, Lin Q, Chen L, et al
    How China responds to Omicron.
    J Infect. 2022;85:90-122.
    >> Share

  4. WEN F, Zhang X, Guo J, Liang Z, et al
    Emergence of H3N8 avian influenza viruses possessing tri-basic hemagglutinin cleavage sites in China.
    J Infect. 2022 Jul 1. pii: S0163-4453(22)00383.
    >> Share

    June 2022
  5. RICHARDS A, Muddassir M, Sampson F, MacLachlan L, et al
    Evaluation of pre-hospital COVID-19 rapid antigen tests by paramedics and their use in a direct admission pathway: Pre-Hospital COVID-19 rapid antigen tests.
    J Infect. 2022 Jun 18. pii: S0163-4453(22)00371.
    >> Share

  6. PENG H, Wu X, Xiong S, Li C, et al
    Gout and susceptibility and severity of COVID-19: a bidirectional Mendelian randomization analysis.
    J Infect. 2022 Jun 17. pii: S0163-4453(22)00366.
    >> Share

  7. HATCHER J, Gil E, Storey N, Brown JR, et al
    Reactivation/relapse of SARS-CoV-2 in a child following haematopoietic stem cell transplantation, confirmed by whole genome sequencing, following apparent viral clearance.
    J Infect. 2022 Jun 17. pii: S0163-4453(22)00367.
    >> Share

  8. COCHINO AV, Farkas OM, Ioan A
    Pediatric Patients with Immune-Mediated Diseases on Immunosuppressants Have Low Risk of Severe COVID-19 and No Increase in Flare Rate after SARS CoV-2 Exposure.
    J Infect. 2022 Jun 17. pii: S0163-4453(22)00365.
    >> Share

  9. LAZARUS R, Taucher C, Brown C, Corbic I, et al
    Safety and immunogenicity of the inactivated whole-virus adjuvanted vaccine VLA2001: a randomized, dose escalation, double-blind phase 1/2 clinical trial in healthy adults.
    J Infect. 2022 Jun 16. pii: S0163-4453(22)00361.
    >> Share

  10. WORSLEY CM, van der Mescht MA, Hoffman D, Meyer PWA, et al
    Decline in antibody responses to SARS-CoV-2 post-vaccination poses a risk to health care workers.
    J Infect. 2022 Jun 12. pii: S0163-4453(22)00360.
    >> Share

  11. KANG SW, Kim JY, Park H, Lim SY, et al
    Comparison of outward transmission potential between vaccinated and partially vaccinated or unvaccinated individuals with the SARS-CoV-2 delta variant infection.
    J Infect. 2022 Jun 12. pii: S0163-4453(22)00355.
    >> Share

  12. GABBI C, Renieri A, Strandvik B
    Geographical distribution of cystic fibrosis carriers as population genetic determinant of COVID-19 spread and fatality in 37 countries.
    J Infect. 2022 Jun 11. pii: S0163-4453(22)00359.
    >> Share

  13. SANG L, Cheng B, Yu Y, Xi Y, et al
    The efficacy and safety of IBI314 on Delta and Omicron variant of SARS-CoV-2: first-in-human evidence.
    J Infect. 2022 Jun 9. pii: S0163-4453(22)00354.
    >> Share

  14. XU QY, Li QL, Jia ZJ, Wu MJ, et al
    Is the fourth COVID-19 vaccine dose urgently needed? Revelation from a prospective cohort study.
    J Infect. 2022 Jun 9. pii: S0163-4453(22)00356.
    >> Share

  15. IJAZ S, Dicks S, Jegatheesan K, Parker E, et al
    Mapping of SARS-CoV-2 IgM and IgG in gingival crevicular fluid: antibody dynamics and linkage to severity of COVID-19 in hospital inpatients.
    J Infect. 2022 Jun 3. pii: S0163-4453(22)00339.
    >> Share

  16. LV P, Hu B, Hua R, Zhang J, et al
    A novelly designed protein antagonist confers potent neutralization against SARS-COV-2 variants of concern.
    J Infect. 2022 Jun 3. pii: S0163-4453(22)00350.
    >> Share

  17. ABDI B, Ndoadoumgue AL, Djebara S, Zafilaza K, et al
    High SARS-CoV-2 seroprevalence in HIV patients originating from sub-Saharan Africa in the Ile-de-France area: Seroprevalence of SARS-CoV-2 in HIV patients.
    J Infect. 2022 Jun 2. pii: S0163-4453(22)00346.
    >> Share

  18. MELLON G, Rouquette A, Fac C, Carton B, et al
    SARS-CoV-2 seroprevalence in the adult detainees of the Paris area in 2021: A multicenter cross-sectional study.
    J Infect. 2022 Jun 2. pii: S0163-4453(22)00345.
    >> Share

  19. ZHANG Y, Li J, Jiang L, Chen Q, et al
    Comparison of SARS-CoV-2 aerosol emission from patients with Omicron BA.1 or BA.2 subvariant infection.
    J Infect. 2022 Jun 1. pii: S0163-4453(22)00342.
    >> Share

  20. GUO Z, Zhao S, Ryu S, Mok CKP, et al
    Superspreading potential of infection seeded by the SARS-CoV-2 Omicron BA.1 variant in South Korea.
    J Infect. 2022 Jun 1. pii: S0163-4453(22)00344.
    >> Share

  21. STANKUNAS M, Dziugys A, Skarbalius G, Misiulis E, et al
    EVALUATING THE POTENTIAL IMPACT OF COVID-19 PASSPORTS IN LITHUANIA.
    J Infect. 2022 Jun 1. pii: S0163-4453(22)00340.
    >> Share

  22. LI Y, Guo Y, Duan Y
    Changes in Streptococcus pneumoniae infection in children before and after the COVID-19 pandemic in Zhengzhou, China.
    J Infect. 2022 Jun 1. pii: S0163-4453(22)00348.
    >> Share

    May 2022
  23. WANG B, Fu J, Lu A, Yang J, et al
    Suitability assessment of CD24 targeted-therapy in the cancer patients with COVID-19: Preliminary results from pan-cancer.
    J Infect. 2022 May 31. pii: S0163-4453(22)00337.
    >> Share

  24. GIANNONE D, Vecchione MB, Czernikier A, Polo ML, et al
    SARS-CoV-2 humoral and cellular immune responses in COVID-19 convalescent individuals with HIV.
    J Infect. 2022 May 27. pii: S0163-4453(22)00315.
    >> Share

  25. KAMALI Z, Vonk JM, Thio CHL, Vaez A, et al
    A Mendelian randomization cytokine screen reveals IL-13 as causal factor in risk of severe COVID-19.
    J Infect. 2022 May 23. pii: S0163-4453(22)00313.
    >> Share

  26. SA R, Isidro J, Borges V, Duarte S, et al
    Unravelling the hurdles of a large COVID-19 epidemiological investigation by viral genomics.
    J Infect. 2022 May 21. pii: S0163-4453(22)00302.
    >> Share

  27. SOVIK S, Barrat-Due A, Kasine T, Olasveengen T, et al
    Corticosteroids and superinfections in COVID-19 patients on invasive mechanical ventilation.
    J Infect. 2022 May 20. pii: S0163-4453(22)00305.
    >> Share

  28. NISHIKIMI A, Watanabe K, Watanabe A, Yasuoka M, et al
    Immune responses to COVID-19 vaccine BNT162b2 in workers at a research institute in Japan: 6-month follow-up survey.
    J Infect. 2022 May 20. pii: S0163-4453(22)00307.
    >> Share

  29. CHENG D, Dong Y, Wen S, Shi C, et al
    A child with acute respiratory distress syndrome caused by avian influenza H3N8 virus.
    J Infect. 2022 May 13. pii: S0163-4453(22)00288.
    >> Share

  30. LIU L, Fan X, Guan Q, Yu C, et al
    Bioavailable testosterone level is associated with COVID-19 severity in female: A sex-stratified Mendelian randomization study.
    J Infect. 2022 May 13. pii: S0163-4453(22)00287.
    >> Share

  31. WU X, Peng H, Xiong S, Li C, et al
    Novel evidence revealed genetic association between COVID-19 infection, severity and endometrial cancer: COVID-19 infection, severity and risk of endometrial cancer.
    J Infect. 2022 May 10. pii: S0163-4453(22)00261.
    >> Share

  32. VAN GRONINGEN KM, Dao BL, Gounder P
    Declines in invasive pneumococcal disease (IPD) during the COVID-19 pandemic in Los Angeles county.
    J Infect. 2022 May 9. pii: S0163-4453(22)00259.
    >> Share

  33. ZHANG YM, Liu XZ, Lin MM, Zan JC, et al
    Immunosuppression impaired the immunogenicity of inactivated SARS-CoV-2 vaccine in non-dialysis kidney disease patients.
    J Infect. 2022 May 9. pii: S0163-4453(22)00260.
    >> Share

  34. LUCIJANIC M, Cikara T, Bistrovic P, Papic I, et al
    Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysis.
    J Infect. 2022 May 2. pii: S0163-4453(22)00251.
    >> Share

  35. FERNANDEZ-DE-LAS-PENAS C, Martin-Guerrero JD, Cancela-Cilleruelo I, Moro-Lopez-Menchero P, et al
    Exploring the recovery curves for long-term post-COVID functional limitations on daily living activities: The LONG-COVID-EXP-CM multicenter study.
    J Infect. 2022;84:722-746.
    >> Share

  36. MARIANI C, Borgonovo F, Capetti AF, Oreni L, et al
    Persistence of Long-COVID symptoms in a heterogenous prospective cohort.
    J Infect. 2022;84:722-746.
    >> Share

  37. WAN Z, Lu R, Zhao Y, Zhang C, et al
    Diagnostic strategy of SARS-CoV-2 for containment under China's zero-COVID-19 policy.
    J Infect. 2022 May 1. pii: S0163-4453(22)00250.
    >> Share

    April 2022
  38. JIMENEZ D, Martinez-Sanz J, Sainz T, Calvo C, et al
    Differences in saliva ACE2 activity among infected and non-infected adult and pediatric population exposed to SARS-CoV-2.
    J Infect. 2022 Apr 28. pii: S0163-4453(22)00248.
    >> Share

  39. HIROTSU Y, Maejima M, Shibusawa M, Natori Y, et al
    SARS-CoV-2 Omicron sublineage BA.2 replaces BA.1.1: genomic surveillance in Japan from September 2021 to March 2022.
    J Infect. 2022 Apr 28. pii: S0163-4453(22)00247.
    >> Share

  40. GIANNITRAPANI L, Augello G, Mirarchi L, Amodeo S, et al
    Outcome predictors in SARS-CoV-2 disease (COVID-19): the prominent role of IL-6 levels and an IL-6 gene polymorphism in a western Sicilian population.
    J Infect. 2022 Apr 28. pii: S0163-4453(22)00245.
    >> Share

  41. LI A, Zhang L
    Reduced incidence of acute pharyngitis and increased incidence of chornic pharyngitis under COVID-19 control strategy in Beijing.
    J Infect. 2022 Apr 28. pii: S0163-4453(22)00249.
    >> Share

  42. RANA MS, Usman MM, Ikram A, Salman M, et al
    The negative impact of the COVID-19 Pandemic on immunization and the positive impact on Polio eradication in Pakistan and Afghanistan. A dismal scenario.
    J Infect. 2022 Apr 28. pii: S0163-4453(22)00246.
    >> Share

  43. YUAN S, Jiang SC, Zhang ZW, Fu YF, et al
    Surface electrostatic shift on spike protein decreased antibody activities against SARS-CoV-2 Omicron variant.
    J Infect. 2022 Apr 23. pii: S0163-4453(22)00215.
    >> Share

  44. NGUYEN NN, Houhamdi L, Hoang VT, Stoupan D, et al
    High rate of reinfection with the SARS-CoV-2 Omicron variant.
    J Infect. 2022 Apr 23. pii: S0163-4453(22)00216.
    >> Share

  45. LI Y, Wei L, He L, Sun J, et al
    Interferon-induced transmembrane protein 3 gene polymorphisms are associated with COVID-19 susceptibility and severity: A meta-analysis.
    J Infect. 2022 Apr 21. pii: S0163-4453(22)00208.
    >> Share

  46. HE L, Zeng C, Xu W, Li Y, et al
    Dynamic changes of serum SARS-CoV-2 antibody levels in COVID-19 patients.
    J Infect. 2022 Apr 21. pii: S0163-4453(22)00214.
    >> Share

  47. AO G, Li A, Wang Y, Tran C, et al
    Lack of efficacy for sotrovimab use in patients with COVID-19: A meta-analysis.
    J Infect. 2022 Apr 21. pii: S0163-4453(22)00210.
    >> Share

  48. CIUFFREDA L, Alcoba-Florez J, Lorenzo-Salazar JM, Gil-Campesino H, et al
    Association of the Delta SARS-CoV-2 variant with 28-day hospital mortality between December 2020 and September 2021.
    J Infect. 2022 Apr 21. pii: S0163-4453(22)00212.
    >> Share

  49. PANDIT P, Bhatt P, Sahay RR, Joshi Y, et al
    A case of breakthrough infection with SARS-CoV-2 Delta derivative and reinfection with Omicron variant in a fully vaccinated health care professional.
    J Infect. 2022 Apr 18. pii: S0163-4453(22)00205.
    >> Share

  50. CAI J, Hu S, Lin Q, Ren T, et al
    China's 'dynamic zero COVID-19 strategy' will face greater challenges in the future.
    J Infect. 2022 Apr 18. pii: S0163-4453(22)00209.
    >> Share

  51. DAVIES J, Gibani MM, Portone G, McGregor A, et al
    Cohorting inpatients with Omicron and Delta variants of Sars-CoV-2 does not increase rates of mixed infection.
    J Infect. 2022 Apr 12. pii: S0163-4453(22)00202.
    >> Share

  52. REN Y, Lv L, Li P, Zhang L, et al
    Inhibition of endocytic recycling of ACE2 by SARS-CoV-2 S protein partially explains multiple COVID-19 related diseases caused by ACE2 reduction.
    J Infect. 2022 Apr 11. pii: S0163-4453(22)00201.
    >> Share

  53. ZSIGMOND B, Breathnach AS, Mensah A, Ladhani SN, et al
    Very low rates of severe COVID-19 in children hospitalised with confirmed SARS-CoV-2 infection in London, England".
    J Infect. 2022 Apr 10. pii: S0163-4453(22)00203.
    >> Share

  54. WHITAKER H, Tsang RS, Button E, Andrews N, et al
    Sociodemographic disparities in COVID-19 seroprevalence across England in the Oxford RCGP primary care sentinel network.
    J Infect. 2022 Apr 8. pii: S0163-4453(22)00198.
    >> Share

  55. LIU X, Munro APS, Feng S, Janani L, et al
    Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: three month analyses of the COV-BOOST trial.
    J Infect. 2022 Apr 8. pii: S0163-4453(22)00200.
    >> Share

  56. MARTIN-BLONDEL G, Marcelin AG, Soulie C, Kaisaridi S, et al
    Outcome of very high-risk patients treated by Sotrovimab for mild-to-moderate COVID-19 Omicron, a prospective cohort study (the ANRS 0003S CoCoPrev study).
    J Infect. 2022 Apr 7. pii: S0163-4453(22)00196.
    >> Share

  57. BADDAL B, Bostanci A
    The impact of COVID-19 on the molecular epidemiology of seasonal viral respiratory infections, Cyprus.
    J Infect. 2022 Apr 7. pii: S0163-4453(22)00192.
    >> Share

  58. CHENG CY, Hsiao SH, Fang TC, Lin YC, et al
    SARS-CoV2 Antibody Response After a Third Dose of Heterologous ChAdOx1 nCoV-19 and Moderna Vaccine in Chronic Dialysis Patients.
    J Infect. 2022 Apr 7. pii: S0163-4453(22)00190.
    >> Share

  59. YADAV PD, Sahay RR, Agrawal S, Shete A, et al
    Clinical, immunological and genomic analysis of the post vaccinated SARS-CoV-2 infected cases with Delta derivatives from Maharashtra, India, 2021.
    J Infect. 2022 Apr 7. pii: S0163-4453(22)00193.
    >> Share

  60. LIU Y, Li P, Yang L, Li P, et al
    High vaccination coverage slows down genetic diversity of SARS-CoV-2.
    J Infect. 2022 Apr 7. pii: S0163-4453(22)00191.
    >> Share

  61. AKBAR S, Pan D, Ehdode A, Islam R, et al
    Prognostic value of maximum NEWS-2 scores in addition to ISARIC 4C scores for patients admitted to hospital with COVID-19.
    J Infect. 2022 Apr 7. pii: S0163-4453(22)00195.
    >> Share

  62. ONG JY, Wang CH, Ms YT, Chen FL, et al
    Nosocomial septicemia in COVID-19 Nosocomial K. pneumoniae, A. baumannii, and Elizabethkingia meningoseptica Septicemia in a Patient of COVID-19.
    J Infect. 2022 Apr 5. pii: S0163-4453(22)00188.
    >> Share

  63. SONG W, Yang Y, Huang Y, Chen L, et al
    Acute respiratory infections in children, before and after the COVID-19 pandemic, a sentinel study.
    J Infect. 2022 Apr 5. pii: S0163-4453(22)00183.
    >> Share

  64. GAGNAIRE J, Bonjean P, Verot E, Boulamail B, et al
    SARS-CoV-2 rapid test versus RT-qPCR on noninvasive respiratory self-samples during a city mass testing campaign.
    J Infect. 2022 Apr 5. pii: S0163-4453(22)00184.
    >> Share

  65. BAEK YJ, Lee YJ, Kim JI, Lee S, et al
    Prolonged viral shedding in severely ill patients infected with SARS-CoV-2 Delta variants: a retrospective cohort study.
    J Infect. 2022 Apr 5. pii: S0163-4453(22)00186.
    >> Share

  66. DUVERGER C, Monteil C, Souyri V, Md SF, et al
    Decrease of carbapenemase-producing Enterobacteriaceae incidence during the first year of the COVID-19 pandemic.
    J Infect. 2022 Apr 1. pii: S0163-4453(22)00179.
    >> Share

    March 2022
  67. YOON JG, Yoo JS, Lee J, Hyun HJ, et al
    Viable SARS-CoV-2 Shedding Under Remdesivir and Dexamethasone Treatment.
    J Infect. 2022 Mar 26. pii: S0163-4453(22)00177.
    >> Share

  68. MENG J, Ge Q, Li J, Lu X, et al
    Protective trend of anti-androgen therapy during the COVID-19 pandemic: a meta-analysis.
    J Infect. 2022 Mar 24. pii: S0163-4453(22)00175.
    >> Share

  69. SCHILDGEN V, Lusebrink J, Schildgen O
    Compulsary SARS-CoV-2 (booster-) vaccination in healthcare facilities can not replace personal protection measures while dealing with vulnarable individuals.
    J Infect. 2022 Mar 23. pii: S0163-4453(22)00173.
    >> Share

  70. YADAV PD, Sapkal GN, Sahay RR, Patil DY, et al
    Elevated neutralization of Omicron with sera of COVID-19 recovered and breakthrough cases vaccinated with Covaxin than two dose naive vaccinees.
    J Infect. 2022 Mar 19. pii: S0163-4453(22)00170.
    >> Share

  71. YANG G, Ren Z, Zou Y, Xu Q, et al
    Antimicrobial stewardship in non-COVID-19 patients with fever and respiratory symptoms in outpatient settings: lessons from the "dynamic zero-COVID policy" in mainland China.
    J Infect. 2022 Mar 18. pii: S0163-4453(22)00141.
    >> Share

  72. MURGIA F, Fiamma M, Serra S, Olla S, et al
    The impact of secondary infections in COVID-19 critically ill patients.
    J Infect. 2022 Mar 18. pii: S0163-4453(22)00171.
    >> Share

  73. DIMEGLIO C, Loubes JM, Migueres M, Saune K, et al
    Influence of vaccination and prior immunity on the dynamics of Omicron BA.1 and BA.2 sub-variants.
    J Infect. 2022 Mar 17. pii: S0163-4453(22)00140.
    >> Share

  74. RYAN P, Perez-Garcia F, Torres-Macho J, Bibiano C, et al
    Misdiagnosis rate of among negative COVID-19 patients in real-life with Panbio COVID-19 Antigen Rapid Test during 2021.
    J Infect. 2022 Mar 16. pii: S0163-4453(22)00139.
    >> Share

  75. AO G, Wang Y, Li A, Tran C, et al
    The effect of canakinumab on clinical outcomes in patients with COVID-19: a meta-analysis.
    J Infect. 2022 Mar 14. pii: S0163-4453(22)00137.
    >> Share

  76. CHEN C, Tang J, Wang C, Wen W, et al
    Meta-Analysis of Post-traumatic Stress Disorder and COVID-19 in Patients Discharged.
    J Infect. 2022 Mar 10. pii: S0163-4453(22)00134.
    >> Share

  77. XIANG B, Yang L, Ye Z, Ren T, et al
    Vaccination of Susceptible Animals Against SARS-CoV-2.
    J Infect. 2022 Mar 9. pii: S0163-4453(22)00131.
    >> Share

  78. BONNET B, Chabrolles H, Archimbaud C, Brebion A, et al
    Comparative T and B immune responses of four different anti-COVID-19 vaccine strategies 6 months after vaccination.
    J Infect. 2022 Mar 9. pii: S0163-4453(22)00132.
    >> Share

  79. FERRE VM, Lebourgeois S, Chenane HR, Menidjel R, et al
    Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assays.
    J Infect. 2022 Mar 9. pii: S0163-4453(22)00126.
    >> Share

  80. FANTINI J, Devaux CA, Yahi N, Frutos R, et al
    The novel hamster-adapted SARS-CoV-2 Delta variant may be selectively advantaged in humans.
    J Infect. 2022 Mar 6. pii: S0163-4453(22)00129.
    >> Share

  81. SUN R, Jiang W, Liu S, Peng C, et al
    Emergence of Novel Reassortant H5N6 Influenza Viruses in Poultry and Humans in Sichuan Province, China, 2021.
    J Infect. 2022 Mar 5. pii: S0163-4453(22)00128.
    >> Share

  82. AU WY, Ye C, Briner SL, Suarez GD, et al
    Systematic comparison between BNT162b2 and CoronaVac in the seroprotection against SARS-CoV-2 Alpha, Beta, Gamma, and Delta variants.
    J Infect. 2022 Mar 1. pii: S0163-4453(22)00123.
    >> Share

  83. GIMENEZ E, Albert E, Burgos JS, Peiro S, et al
    SARS-CoV-2 adaptive immunity in nursing home residents up to eight months after two doses of the Comirnaty(R) COVID-19 vaccine.
    J Infect. 2022 Mar 1. pii: S0163-4453(22)00124.
    >> Share

  84. BONGIOVANNI M, Spada E, De Angelis C, Liuzzi G, et al
    SARS-CoV-2: about reinfection, vaccination and neutralizing antibodies.
    J Infect. 2022 Mar 1. pii: S0163-4453(22)00125.
    >> Share

  85. SYED MA DR, A/Qotba HA Dr, Al Nuaimi AS Dr
    Effectiveness of COVID-19 vaccines in Qatar.
    J Infect. 2022 Mar 1. pii: S0163-4453(22)00121.
    >> Share

    February 2022
  86. HAYASHI JY, Simizo A, Miyamoto JG, Costa LVS, et al
    Humoral and Cellular Responses to Vaccination with Homologous CoronaVac or ChAdOx1 and Heterologous Third Dose with BNT162b2.
    J Infect. 2022 Feb 27. pii: S0163-4453(22)00115.
    >> Share

  87. KONIG S, Hohenstein S, Leiner J, Hindricks G, et al
    National mortality data for Germany before and throughout the pandemic: there is an excess mortality exceeding COVID-19-attributed fatalities.
    J Infect. 2022 Feb 26. pii: S0163-4453(22)00113.
    >> Share

  88. SALVAGNO GL, Henry BM, Pighi L, De Nitto S, et al
    SARS-CoV-2 Omicron infection is associated with high nasopharyngeal viral load.
    J Infect. 2022 Feb 26. pii: S0163-4453(22)00114.
    >> Share

  89. PASCARELLA S, Ciccozzi M, Bianchi M, Benvenuto D, et al
    The value of electrostatic potentials of the Spike Receptor binding and N-terminal domains in addressing transmissibility and infectivity of SARS-CoV-2 Variants. of Concern.
    J Infect. 2022 Feb 23. pii: S0163-4453(22)00112.
    >> Share

  90. DE MICHELENA P, Torres I, Ramos-Garcia A, Gozalbes V, et al
    Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant.
    J Infect. 2022 Feb 22. pii: S0163-4453(22)00110.
    >> Share

  91. SAHAY RR, Patil DY, Sapkal GN, Deshpande GR, et al
    SARS-CoV-2 Delta and delta derivatives impact on neutralization of Covishield recipient sera.
    J Infect. 2022 Feb 19. pii: S0163-4453(22)00082.
    >> Share

  92. TANG K, Wu X, Luo Y, Wei Z, et al
    Meta-analysis of Immunologic response after COVID-19 mRNA vaccination in solid organ transplant recipients.
    J Infect. 2022 Feb 19. pii: S0163-4453(22)00081.
    >> Share

  93. LIPPI G, Nocini R, Henry BM
    Is SARS-CoV-2 Omicron (B.1.1.529) variant causing different symptoms?
    J Infect. 2022 Feb 17. pii: S0163-4453(22)00077.
    >> Share

  94. SAEED A, Ahmad B, Majaz S, Nouroz F, et al
    Targeting Omicron and other reported SARS-CoV-2 lineages by Potent inhibitors of Main Protease 3CL Mpro: Molecular Simulation Analysis.
    J Infect. 2022 Feb 17. pii: S0163-4453(22)00079.
    >> Share

  95. ZHENG J, Wang Z, Li J, Zhang Y, et al
    High amounts of SARS-CoV-2 in aerosols exhaled by patients with Omicron variant infection.
    J Infect. 2022 Feb 17. pii: S0163-4453(22)00075.
    >> Share

  96. KWOK KO, Wei WI, Ma BHM, Ip M, et al
    Antibiotic use among COVID-19 patients in Hong Kong, January 2018 to March 2021.
    J Infect. 2022 Feb 17. pii: S0163-4453(22)00078.
    >> Share

  97. TRE-HARDY M, Cupaiolo R, Wilmet A, Antoine-Moussiaux T, et al
    Assessment 2 months after the administration of a 3rd dose mRNA: A new variant-adapted vaccine is expected.
    J Infect. 2022 Feb 15. pii: S0163-4453(22)00073.
    >> Share

  98. BLANCO I, Violan C, Suner C, Garcia-Prieto J, et al
    Comparison between mid-nasal swabs and buccal swabs for SARS-CoV-2 detection in mild COVID-19 patients.
    J Infect. 2022 Feb 13. pii: S0163-4453(22)00072.
    >> Share

  99. YADAV PD, Sapkal GN, Sahay RR, Potdar VA, et al
    Substantial immune response in Omicron infected breakthrough and unvaccinated individuals against SARS-CoV-2 variants of concerns.
    J Infect. 2022 Feb 11. pii: S0163-4453(22)00070.
    >> Share

  100. RIGHI E, Mirandola M, Mazzaferri F, Dossi G, et al
    Determinants of Persistence of Symptoms and Impact on Physical and Mental Wellbeing in Long COVID: A Prospective Cohort Study.
    J Infect. 2022 Feb 9. pii: S0163-4453(22)00065.
    >> Share

  101. MIGUERES M, Dimeglio C, Tremeaux P, Abravanel F, et al
    Influence of immune escape and nasopharyngeal virus load on the spread of SARS-CoV-2 Omicron variant.
    J Infect. 2022 Feb 7. pii: S0163-4453(22)00054.
    >> Share

  102. ZHOU W, Zhong L, Tang X, Huang T, et al
    The early warning and monitoring of COVID-19 by using Baidu Search Index in China.
    J Infect. 2022 Feb 6. pii: S0163-4453(22)00063.
    >> Share

  103. LAZOR-BLANCHET C, Zygoura P, Dafni U, Lamoth F, et al
    Low neutralizing antibody titers after asymptomatic or non-severe SARS-CoV-2 infection over a 6-month assessment period.
    J Infect. 2022 Feb 5. pii: S0163-4453(22)00062.
    >> Share

  104. WESTROP SJ, Whitaker HJ, Powell AA, Power L, et al
    Real-world data on immune responses following heterologous prime-boost COVID-19 vaccination schedule with Pfizer and AstraZeneca vaccines in England.
    J Infect. 2022 Feb 4. pii: S0163-4453(22)00055.
    >> Share

  105. WU Z, Liu J, Zhang H, Chang YF, et al
    The emergence of the novel avian influenza virus (H10N3) in China, 2020-a cause for concern?
    J Infect. 2022 Feb 3. pii: S0163-4453(22)00061.
    >> Share

  106. CUI H, Liu J, Zhang L
    The high expression of key components of inflammasome and pyroptosis might lead to severe COVID-19 infection in cancer patients.
    J Infect. 2022 Feb 3. pii: S0163-4453(22)00057.
    >> Share

  107. DIMEGLIO C, Migueres M, Mansuy JM, Saivin S, et al
    Antibody titers and breakthrough infections with Omicron SARS-CoV-2.
    J Infect. 2022 Feb 3. pii: S0163-4453(22)00060.
    >> Share

  108. KIVIT C, Groen K, Jongbloed M, Linssen C, et al
    An off-season outbreak of human metapneumovirus infections after ending of a COVID-19 lockdown.
    J Infect. 2022 Feb 3. pii: S0163-4453(22)00058.
    >> Share

  109. ESTOFOLETE CF, Fares GF, Banho CA, Sacchetto L, et al
    Predictors of death in COVID-19 vaccine breakthrough infections in Brazil.
    J Infect. 2022 Feb 2. pii: S0163-4453(22)00059.
    >> Share

  110. HAVDAL LB, Boas H, Bekkevold T, Kran AB, et al
    The burden of respiratory syncytial virus in children under 5 years of age in Norway.
    J Infect. 2022;84:205-215.
    >> Share

  111. LI Z, Tao B, Hu Z, Yi Y, et al
    Effects of short-term ambient particulate matter exposure on the risk of severe COVID-19.
    J Infect. 2022 Feb 1. pii: S0163-4453(22)00052.
    >> Share

    January 2022
  112. LIVINGSTONE R, Lin H, Brendish NJ, Poole S, et al
    Routine molecular point-of-care testing for SARS-CoV-2 reduces hospital-acquired COVID-19.
    J Infect. 2022 Jan 30. pii: S0163-4453(22)00049.
    >> Share

  113. XU W, Tang J, Chen C, Wang C, et al
    Safety and Efficacy of the Covid-19 Vaccine in children andor adolescents: A meta-analysis.
    J Infect. 2022 Jan 30. pii: S0163-4453(22)00050.
    >> Share

  114. MATTIUZZI C, Lippi G
    COVID-19 vaccines efficacy in preventing or limiting SARS-CoV-2 infections.
    J Infect. 2022 Jan 30. pii: S0163-4453(22)00051.
    >> Share

  115. JI G, Chen C, Zhou M, Wen W, et al
    Post-COVID-19 Fatigue among COVID-19 in patients discharged from hospital: A meta-analysis.
    J Infect. 2022 Jan 28. pii: S0163-4453(22)00031.
    >> Share

  116. MENSAH AA, Lacy J, Stowe J, Seghezzo G, et al
    Evaluation of disease severity during SARS-COV-2 reinfection, January 2020 to April 2021, England: an observational study.
    J Infect. 2022 Jan 24. pii: S0163-4453(22)00010.
    >> Share

  117. SCHEPERS M, Zanger P, Jahn K, Konig J, et al
    Multi-household social gatherings contribute to the second SARS-CoV-2 wave in Rhineland-Palatinate.
    J Infect. 2022 Jan 23. pii: S0163-4453(22)00028.
    >> Share

  118. RANA MS, Usman MM, Alam MM, Ikram A, et al
    Impact of previous SARS-CoV-2 infection on the rate of mortality in dengue. A preliminary report from Pakistan.
    J Infect. 2022 Jan 23. pii: S0163-4453(22)00027.
    >> Share

  119. GAO R, Xu Y, Zhu G, Zhou S, et al
    Genetic variation associated with COVID-19 is also associated with endometrial cancer.
    J Infect. 2022 Jan 22. pii: S0163-4453(22)00026.
    >> Share

  120. DUCLOUX D, Bamoulid J, Chabannes M, Colladant M, et al
    Current vaccine strategies against SARS_CoV-2 only poorly protect kidney transplant recipients.
    J Infect. 2022 Jan 21. pii: S0163-4453(22)00020.
    >> Share

  121. MAO Q, Wang C, Zhou M, Wen W, et al
    A meta-analysis of the association between calprotectin and the severity of COVID-19.
    J Infect. 2022 Jan 21. pii: S0163-4453(22)00023.
    >> Share

  122. FAVRESSE J, Bayart JL, David C, Dogne JM, et al
    Nucleocapsid Serum Antigen Determination in SARS-CoV-2 Infected Patients Using the Single Molecule Array Technology and Prediction of Disease Severity.
    J Infect. 2022 Jan 21. pii: S0163-4453(22)00022.
    >> Share

  123. ELFIKY AA, Ibrahim IM
    Host-cell recognition through Cs-GRP78 is enhanced in the new Omicron variant of SARS-CoV-2, in silico structural point of view.
    J Infect. 2022 Jan 18. pii: S0163-4453(22)00015.
    >> Share

  124. ZHANG Y, Jiang N, Qi W, Li T, et al
    Intra-host SARS-CoV-2 Single-Nucleotide Variants Emerged During the Early Stage of COVID-19 Pandemic Forecast Population Fixing Mutations.
    J Infect. 2022 Jan 15. pii: S0163-4453(22)00017.
    >> Share

  125. PILECKY M, Harm S, Bauer C, Zottl J, et al
    Performance of lateral flow assays for SARS-CoV-2 compared to RT-qPCR.
    J Infect. 2022 Jan 14. pii: S0163-4453(22)00011.
    >> Share

  126. XU Y, Gao R, Zhu G, Zhou S, et al
    Genetic variation of allergic disease is associated with the susceptibility to COVID-19.
    J Infect. 2022 Jan 14. pii: S0163-4453(22)00016.
    >> Share

  127. THANH TT, Nhan NTT, Anh NT, Chung LT, et al
    SARS-CoV-2 RNA loads in Vietnamese children.
    J Infect. 2022 Jan 13. pii: S0163-4453(22)00012.
    >> Share

  128. LIN M, Chen H, Wang Y, Qiu S, et al
    A Model Study on Predicting New COVID-19 Cases in China Based on Social and News Media.
    J Infect. 2022 Jan 9. pii: S0163-4453(22)00009.
    >> Share

  129. CHEN JM, Chen YQ, Sun YX
    Control of COVID-19 in China likely reduced the burden of multiple other infectious diseases.
    J Infect. 2022 Jan 8. pii: S0163-4453(22)00001.
    >> Share

  130. HAN X, Xu P, Wang H, Mao J, et al
    Incident changes in the prevalence of respiratory virus among children during COVID-19 pandemic in Hangzhou, China.
    J Infect. 2022 Jan 8. pii: S0163-4453(22)00006.
    >> Share

  131. FAUSTINI S, Shields A, Banham G, Wall N, et al
    Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose in healthy and immunocompromised individuals.
    J Infect. 2022 Jan 8. pii: S0163-4453(22)00002.
    >> Share

  132. DE MICHELENA P, Torres I, Albert E, Bracho A, et al
    Impact of time elapsed since full vaccination on SARS-CoV-2 RNA load in Delta-variant breakthrough COVID-19.
    J Infect. 2022 Jan 8. pii: S0163-4453(22)00007.
    >> Share

  133. BORMAN AM, Fountain H, Guy R, Casale E, et al
    Increased mortality in COVID-19 patients with fungal co- and secondary infections admitted to intensive care or high dependency units in NHS hospitals in England.
    J Infect. 2022 Jan 4. pii: S0163-4453(21)00665.
    >> Share

  134. WHITAKER HJ, Tsang RS, Byford R, Andrews NJ, et al
    Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response among individuals in clinical risk groups.
    J Infect. 2022 Jan 3. pii: S0163-4453(21)00664.
    >> Share

  135. MARRAMS ARM, Kobayashi T, Suzuki H, Alsuhaibani M, et al
    Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: a systematic literature review and meta-analysis.
    J Infect. 2022 Jan 1. pii: S0163-4453(21)00658.
    >> Share

    December 2021
  136. SIMIONATTO VZ, Evaristo M, Santos EV, Mello R, et al
    SARS-CoV-2 SEROLOGICAL CROSS-REACTIVITY TESTING IN BRAZILIAN BLOOD DONORS, OCTOBER-DECEMBER, 2019.
    J Infect. 2021 Dec 31. pii: S0163-4453(21)00660.
    >> Share

  137. FINCH LS, Harris A, Lester C, Veal D, et al
    Implementation study of SARS-CoV-2 antigen lateral flow tests in men's professional (Premiership) rugby union sports squads in England during the COVID-19 pandemic.
    J Infect. 2021 Dec 30. pii: S0163-4453(21)00657.
    >> Share

  138. KAWAHARA T, Ueki Y, Nawa N, Miyamae S, et al
    Who is a super-spreader? Determinants of people with higher PCR copy number of SARS-CoV-2 during Mar 2020 to June 2021 in Japan.
    J Infect. 2021 Dec 30. pii: S0163-4453(21)00656.
    >> Share

  139. ARORA U, Priyadarshi M, Katiyar V, Soneja M, et al
    Novel risk factors for Coronavirus disease-associated mucormycosis(CAM): a case-control study during the outbreak in India.
    J Infect. 2021 Dec 30. pii: S0163-4453(21)00654.
    >> Share

  140. ZENG C, Ye Z, Fu L, Ye Y, et al
    Prediction analysis of porcine AXL protein as a potential receptor for SARS-CoV-2.
    J Infect. 2021 Dec 30. pii: S0163-4453(21)00655.
    >> Share

  141. XU B, Ma FQ, He C, Wu ZQ, et al
    Incidence and affecting factors of pulmonary diffusing capacity impairment with COVID-19 survivors 18 months after discharge in Wuhan, China.
    J Infect. 2021 Dec 25. pii: S0163-4453(21)00642.
    >> Share

  142. VENTERO MP, Moreno-Perez O, Molina-Pardines C, Paytuvi-Gallart A, et al
    Nasopharyngeal Microbiota as an early severity biomarker in COVID-19 hospitalised patients: a retrospective cohort study in a Mediterranean area.
    J Infect. 2021 Dec 25. pii: S0163-4453(21)00647.
    >> Share

  143. LAI X, Wang J, Duan J, Gong Y, et al
    Apoptosis inhibitor of macrophage differentiates bacteria from influenza or COVID-19 in hospitalized adults with community-acquired pneumonia.
    J Infect. 2021 Dec 23. pii: S0163-4453(21)00640.
    >> Share

  144. LI Y, Li P, Xi J, Yang J, et al
    Wild bird-origin H3N8 avian influenza virus exhibit well adaptation in mammalian host.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00637.
    >> Share

  145. DAVIS W, Duque J, Huang QS, Olson N, et al
    Sensitivity and specificity of surveillance case definitions in detection of influenza and respiratory syncytial virus among hospitalized patients, New Zealand, 2012-2016.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00635.
    >> Share

  146. GENG Y, Zhang L
    The impact of non-pharmaceutical interventions during COVID-19 pandemic on three children infectious diseases in China.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00645.
    >> Share

  147. MAANI AA, Wahaibi AA, Nazer W, Al-Zadjali N, et al
    The utilization of HCWs surveillance as an early warning of COVID-19 epidemic activity in the community.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00629.
    >> Share

  148. QIN G, Yang J, Zhao C, Ren J, et al
    The COVID-19 susceptibility of cancer patients might due to the high expression of SARS-CoV-2 required host factors.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00634.
    >> Share

  149. VINER R, Waddington C, Mytton O, Booy R, et al
    Transmission of SARS-CoV-2 by children and young people in households and schools: a meta-analysis of population-based and contact-tracing studies.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00633.
    >> Share

  150. SYED-ABDUL S, Babu AS, Bellamkonda RS, Itumalla R, et al
    Using Artificial Intelligence-based models to predict the risk of Mucormycosis among COVID-19 Survivors: An Experience from a public hospital in India.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00639.
    >> Share

  151. COLTELLA L, Ranno S, Piccioni L, Linardos G, et al
    Quantitative SARS-CoV-2 antigen test as a tool able to predict the stage of the infection.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00636.
    >> Share

  152. ORENES-PINERO E, Navas-Carrillo D, Moreno-Docon A, Ortega-Garcia JA, et al
    Confirmation of SARS-CoV-2 airborne dissemination indoors using "COVID-19 traps".
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00630.
    >> Share

  153. KHURRAM M, Ali G, Awan UA, Afzal MS, et al
    COVID-19 and alarming dengue co-epidemics in the dilapidated healthcare system in Pakistan: Where to focus!
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00638.
    >> Share

  154. GAO P, Zhang X, Zhang S, Yu Y, et al
    COVID-19 persists: Current risk of a recurrence of the epidemic in China.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00643.
    >> Share

  155. COSTA R, Olea B, Bracho MA, Albert E, et al
    RNA viral loads of SARS-CoV-2 Alpha and Delta variants in nasopharyngeal specimens at diagnosis stratified by age, clinical presentation and vaccination status.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00641.
    >> Share

  156. YAN F, Gao F
    Mutant EK1 with Q1004E/N1006I: a promising fusion inhibitor for the HR1 domain of SARS-CoV-2.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00644.
    >> Share

  157. RUBESHKUMAR P, John A, Narnaware M, M J, et al
    Persistent Post COVID-19 Symptoms and Functional Status after 12-14 weeks of recovery, Tamil Nadu, India, 2021.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00632.
    >> Share

  158. WANG R
    Genetic variation of interleukin-1 receptor type 1 is associated with severity of COVID-19 disease.
    J Infect. 2021 Dec 21. pii: S0163-4453(21)00631.
    >> Share

  159. MANOLACHE NG, Ursachi V, Scohy A, Desmet C, et al
    Attenuated anti-SARS-CoV-2 antibody response to vaccination in patients with rheumatic diseases.
    J Infect. 2021 Dec 14. pii: S0163-4453(21)00597.
    >> Share

  160. OWEN SI, Williams CT, Garrod G, Fraser AJ, et al
    Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies.
    J Infect. 2021 Dec 11. pii: S0163-4453(21)00598.
    >> Share

  161. FANG X, Ming C, Cen Y, Lin H, et al
    Post-sequelae one year after hospital discharge among older COVID-19 patients: a multi-center prospective cohort study.
    J Infect. 2021 Dec 10. pii: S0163-4453(21)00596.
    >> Share

  162. MAK WA, Koeleman JGM, van der Vliet M, Keuren F, et al
    SARS-CoV-2 antibody and T cell responses one year after COVID-19 and the booster effect of vaccination: A prospective cohort study.
    J Infect. 2021 Dec 9. pii: S0163-4453(21)00593.
    >> Share

  163. QUINTAO TSC, Slavov SN, de Oliveira PM, Bezerra RDS, et al
    Viral metagenomics in nasopharyngeal swabs of Brazilian patients negative for SARS-CoV-2 unveils the presence of Chikungunya virus infection.
    J Infect. 2021 Dec 5. pii: S0163-4453(21)00585.
    >> Share

  164. LUI G, Wong CK, Chan M, Chong KC, et al
    Host inflammatory response is the major marker of severe respiratory syncytial virus infection in older adults.
    J Infect. 2021;83:686-692.
    >> Share

    November 2021
  165. TANI N, Kawai N, Chong Y, Bando T, et al
    Susceptibility of epidemic viruses to neuraminidase inhibitors and treatment-emergent resistance in the Japanese 2019-20 influenza season.
    J Infect. 2021 Nov 30. pii: S0163-4453(21)00583.
    >> Share

  166. OESER C, Whitaker H, Linley E, Borrow R, et al
    Large increases in SARS-CoV-2 seropositivity in children in England: Effects of the Delta wave and vaccination.
    J Infect. 2021 Nov 30. pii: S0163-4453(21)00584.
    >> Share

  167. HAN X, Xu J, Hou H, Yang H, et al
    Significant association of pre-existing asthma with an increased risk for ICU admission among COVID-19 patients: Evidence based on a meta-analysis.
    J Infect. 2021 Nov 29. pii: S0163-4453(21)00582.
    >> Share

  168. MENTZER DAJ, James T, Yongya M, Cox S, et al
    Serum calprotectin is not an independent predictor of severe COVID-19 in ambulatory adult patients.
    J Infect. 2021 Nov 26. pii: S0163-4453(21)00580.
    >> Share

  169. ALDERSON MR, Arkwright PD, Bai X, Black S, et al
    Surveillance and control of meningococcal disease in the COVID-19 era: A Global Meningococcal Initiative review.
    J Infect. 2021 Nov 24. pii: S0163-4453(21)00578.
    >> Share

  170. BEHNOOD SA, Shafran R, Bennett SD, Zhang A, et al
    Persistent symptoms following SARS-CoV-2 infection among children and young people: a meta-analysis of controlled and uncontrolled studies.
    J Infect. 2021 Nov 20. pii: S0163-4453(21)00555.
    >> Share

  171. LEBOURGEOIS S, Menidjel R, Chenane HR, Ferre VM, et al
    Alpha (B.1.1.7) and Delta (B.1.617.2 - AY.40) SARS-CoV-2 variants present strong neutralization decay at M4 post-vaccination and a faster replication rates than D614G (B.1) lineage.
    J Infect. 2021 Nov 19. pii: S0163-4453(21)00556.
    >> Share

  172. LUO L, Luo T, Du M, Mei H, et al
    Efficacy and safety of tocilizumab in hospitalized COVID-19 patients: a systematic review and meta-analysis.
    J Infect. 2021 Nov 19. pii: S0163-4453(21)00557.
    >> Share

  173. PAN D, Kim JW, Nazareth J, Assadi S, et al
    Quantification and prognostic significance of interferon-gamma secreting SARS-CoV-2 responsive T cells in hospitalised patients with acute COVID-19.
    J Infect. 2021 Nov 18. pii: S0163-4453(21)00554.
    >> Share

  174. TSAI SC, Chang WW, Lee WS
    Analysis of an outbreak of COVID-19(alpha-variant) with rapid progression to mortality in Taipei, Taiwan.
    J Infect. 2021 Nov 17. pii: S0163-4453(21)00553.
    >> Share

  175. TILLARD C, Chazard E, Faure K, Bartolo S, et al
    Burden of influenza disease in children under 2 years of age hospitalized between 2011 and 2020 in France.
    J Infect. 2021 Nov 13. pii: S0163-4453(21)00549.
    >> Share

  176. CHAPPELL H, Patel R, Driessens C, Tarr AW, et al
    Immunocompromised children and young people are at no increased risk of severe COVID-19.
    J Infect. 2021 Nov 13. pii: S0163-4453(21)00548.
    >> Share

  177. YAN X, Zhu S, Jin Z, Chen G, et al
    Persistence of anti-SARS-CoV-2 IgM in convalescent COVID-19 patients.
    J Infect. 2021 Nov 13. pii: S0163-4453(21)00550.
    >> Share

  178. BEN S, Xin J, Chen S, Jiang Y, et al
    Global internet search trends related to gastrointestinal symptoms predict regional COVID-19 outbreaks.
    J Infect. 2021 Nov 9. pii: S0163-4453(21)00546.
    >> Share

  179. MARTIN-VICENTE M, Berenguer J, Munoz-Gomez MJ, Diez C, et al
    Similar humoral immune responses against the SARS-CoV-2 spike protein in HIV and non-HIV individuals after COVID-19: Anti-SARS-CoV-2 S antibodies in PWH.
    J Infect. 2021 Nov 6. pii: S0163-4453(21)00545.
    >> Share

  180. BURGI JJ, Rosslein M, Hornung H, Jentsch J, et al
    Divergent humoral responses in mild to moderate SARS-CoV-2 infection over time - indication of persistence of the virus?: Indication of persistence of SARS-CoV-2?
    J Infect. 2021 Nov 5. pii: S0163-4453(21)00544.
    >> Share

  181. GIMENEZ E, Alberola J, Torres I, Albert E, et al
    Evolution of SARS-CoV-2 immune responses in nursing home residents following full dose of the Comirnaty(R) COVID-19 vaccine.
    J Infect. 2021 Nov 2. pii: S0163-4453(21)00542.
    >> Share

  182. HESKIN J, Pallett SJC, Mughal N, Jones R, et al
    Healthcare worker perceptions of routine asymptomatic SARS-CoV-2 screening using lateral flow assays: a qualitative analysis across two London hospitals.
    J Infect. 2021 Nov 1. pii: S0163-4453(21)00537.
    >> Share

    October 2021
  183. NISHIKIMI A, Watanabe K, Watanabe A, Yasuoka M, et al
    Prevalence of SARS-CoV-2 antibodies after one-year follow up among workers in a research institute in Japan.
    J Infect. 2021 Oct 30. pii: S0163-4453(21)00538.
    >> Share

  184. WANG J, Zou H, Corpe C
    An observed association between angiotensin-converting enzyme 2 polymorphisms and COVID-19 severity in China.
    J Infect. 2021 Oct 30. pii: S0163-4453(21)00536.
    >> Share

  185. YE Q, Liu H, Shang S
    Non-pharmaceutical interventions reduced the incidence and exacerbation of allergic diseases in children during the COVID-19 pandemic.
    J Infect. 2021 Oct 30. pii: S0163-4453(21)00541.
    >> Share

  186. LUMLEY SF, Richens N, Lees E, Cregan J, et al
    Changes in paediatric respiratory infections at a UK teaching hospital 2016-2021; impact of the SARS-CoV-2 pandemic.
    J Infect. 2021 Oct 29. pii: S0163-4453(21)00540.
    >> Share

  187. LI X, Chen H, Lu L, Chen LL, et al
    High compliance to infection control measures prevented guest-to-staff transmission in COVID-19 quarantine hotels.
    J Infect. 2021 Oct 26. pii: S0163-4453(21)00533.
    >> Share

  188. CHONG Y, Tani N, Goto T, Yonekawa A, et al
    Contrasting specific antibody response to BNT162b2 mRNA vaccination in SARS-CoV-2-naive and previously infected nursing home residents.
    J Infect. 2021 Oct 20. pii: S0163-4453(21)00508.
    >> Share

  189. EPAULARD O, Buisson M, Nemoz B, Marechal ML, et al
    Persistence at one year of neutralising antibodies after SARS-CoV-2 infection: Influence of initial severity and steroid use.
    J Infect. 2021 Oct 20. pii: S0163-4453(21)00507.
    >> Share

  190. GUPTA A, Bhoyar RC, Mirza S, Jolly B, et al
    SARS-CoV-2 vaccine breakthrough infection following a previous infection in a healthcare worker.
    J Infect. 2021 Oct 19. pii: S0163-4453(21)00506.
    >> Share

  191. GUO J, Yu H, Wang C, Yuan S, et al
    Re-emergence of Highly Pathogenic Avian Influenza A(H5N8) Virus In Domestic Goose, China.
    J Infect. 2021 Oct 17. pii: S0163-4453(21)00504.
    >> Share

  192. WANG MH, Lou J, Cao L, Zhao S, et al
    Characterization of key amino acid substitutions and dynamics of the influenza virus H3N2 hemagglutinin.
    J Infect. 2021 Oct 7. pii: S0163-4453(21)00498.
    >> Share

  193. BOSHIER FAT, Venturini C, Stirrup O, Guerra-Assuncao JA, et al
    The Alpha variant was not associated with excess nosocomial SARS-CoV-2 infection in a multi-centre UK hospital study.
    J Infect. 2021 Oct 2. pii: S0163-4453(21)00493.
    >> Share

  194. FERNANDEZ-DE-LAS-PENAS C, Gomez-Mayordomo V, de-la-Llave-Rincon AI, Palacios-Cena M, et al
    Anxiety, depression and poor sleep quality as long-term post-COVID sequelae in previously hospitalized patients: A multicenter study.
    J Infect. 2021;83:496-522.
    >> Share

  195. HUMBERT MV, Opurum PC, Brendish NJ, Poole S, et al
    A SARS-CoV-2 nucleocapsid ELISA represents a low-cost alternative to lateral flow testing for community screening in LMI countries.
    J Infect. 2021 Oct 1. pii: S0163-4453(21)00492.
    >> Share

    September 2021
  196. A A, M F, J CO, Ejm M, et al
    Serological profile of first SARS-CoV-2 reinfection cases detected within the SIREN study.
    J Infect. 2021 Sep 30. pii: S0163-4453(21)00489.
    >> Share

  197. LEMENAND O, Coeffic T, Thibaut S, Colomb-Cotinat M, et al
    Decreasing proportion of extended-spectrum beta-lactamase among E. coli infections during the COVID-19 pandemic in France.
    J Infect. 2021 Sep 29. pii: S0163-4453(21)00486.
    >> Share

  198. FERRE VM, Lebourgeois S, Menidjel R, Collin G, et al
    Decreasing humoral response among healthcare workers up to 4 months after two doses of BNT162b2 vaccine.
    J Infect. 2021 Sep 29. pii: S0163-4453(21)00488.
    >> Share

  199. LECOINTRE L, Venkatasamy A, Wehr M, Koch A, et al
    Multicentric evaluation of a 3D-printed simulator for COVID- 19 nasopharyngeal swab collection in testing centers.
    J Infect. 2021 Sep 24. pii: S0163-4453(21)00485.
    >> Share

  200. DIMEGLIO C, Herin F, Martin-Blondel G, Miedouge M, et al
    Antibody titers and protection against a SARS-CoV-2 infection.
    J Infect. 2021 Sep 21. pii: S0163-4453(21)00483.
    >> Share

  201. MCMILLAN T, Jones C, O'Connor CJ, Nolan D, et al
    Risk factors associated with bloodstream infections among critically ill patients with COVID-19.
    J Infect. 2021 Sep 16. pii: S0163-4453(21)00480.
    >> Share

  202. ALEMANY A, Millat-Martinez P, Ouchi D, Corbacho-Monne M, et al
    Self-collected mid-nasal swabs and saliva specimens, compared with nasopharyngeal swabs, for SARS-CoV-2 detection in mild COVID-19 patients.
    J Infect. 2021 Sep 16. pii: S0163-4453(21)00481.
    >> Share

  203. LUNA-MUSCHI A, Borges IC, de Faria E, Barboza AS, et al
    Clinical features of COVID-19 by SARS-CoV-2 Gamma variant: a prospective cohort study of vaccinated and unvaccinated healthcare workers.
    J Infect. 2021 Sep 16. pii: S0163-4453(21)00474.
    >> Share

  204. FANG C, Zhou Z, Li J, Zhou M, et al
    Incident changes of rotavirus enteritis among children during the coronavirus disease-2019 pandemic in Hangzhou, China.
    J Infect. 2021 Sep 15. pii: S0163-4453(21)00478.
    >> Share

  205. AWAN UA, Malik MW, Khan MI, Khattak AA, et al
    Predicting COVID-19 incidence in war-torn Afghanistan: A timely response is required!
    J Infect. 2021 Sep 15. pii: S0163-4453(21)00473.
    >> Share

  206. CHEN H, Zhao X, Li L, Yan S, et al
    Mental health and physical symptoms of people quarantined during the COVID-19 outbreak.
    J Infect. 2021 Sep 15. pii: S0163-4453(21)00479.
    >> Share

  207. ZUO L, Ao G, Wang Y, Gao M, et al
    Bamlanivimab improves hospitalization and mortality rates in patients with COVID-19: A systematic review and meta-analysis.
    J Infect. 2021 Sep 14. pii: S0163-4453(21)00477.
    >> Share

  208. QIU S, Wang D, Zhang Y, Hu Y, et al
    Mendelian randomization reveals potential causal candidates for COVID-19 in 123 blood metabolites.
    J Infect. 2021 Sep 13. pii: S0163-4453(21)00471.
    >> Share

  209. OLEARO F, Norz D, Hoffman A, Grunwald M, et al
    Clinical performance and accuracy of a qPCR-based SARS-CoV-2 mass-screening workflow for healthcare-worker surveillance using pooled self-sampled gargling solutions: a cross-sectional study.
    J Infect. 2021 Sep 6. pii: S0163-4453(21)00451.
    >> Share

  210. QIU S, Zhang Y, Wang D, Hu Y, et al
    The high expression of SARS-CoV-2 cell receptors might lead to higher COVID-19 infection rates in cancer patients.
    J Infect. 2021 Sep 2. pii: S0163-4453(21)00449.
    >> Share

  211. LIANG J, Wang Z, Liu Y, Zeng L, et al
    Epidemiology and co-infection patterns in patients with respiratory tract infections in southern China between 2018 and 2020.
    J Infect. 2021;83:e6-e8.
    >> Share

  212. CHANDRA S, Rawal R
    The surge in Covid related mucormycosis.
    J Infect. 2021;83:381-412.
    >> Share

  213. ALKALAMOUNI H, Hitti E, Zaraket H
    Adopting fresh air ventilation may reduce the risk of airborne transmission of SARS-CoV-2 in COVID-19 unit.
    J Infect. 2021 Sep 1. pii: S0163-4453(21)00450.
    >> Share

    August 2021
  214. BHATTACHARYA A, Collin SM, Stimson J, Thelwall S, et al
    Healthcare-associated COVID-19 in England: a national data linkage study.
    J Infect. 2021 Aug 30. pii: S0163-4453(21)00443.
    >> Share

  215. STRALIN K, Bruce D, Wahlstrom E, Walther S, et al
    Impact of the Alpha VOC on disease severity in SARS-CoV-2-positive adults in Sweden.
    J Infect. 2021 Aug 30. pii: S0163-4453(21)00448.
    >> Share

  216. SNELL LB, Awan AR, Charalampous T, Alcolea-Medina A, et al
    SARS-CoV-2 variants with shortened incubation periods necessitate new definitions for nosocomial acquisition.
    J Infect. 2021 Aug 30. pii: S0163-4453(21)00445.
    >> Share

  217. QIU S, Hu Y, Cheng L
    A genome-wide cross-trait analysis highlights the shared genetic structure between COVID-19 and Alzheimer's disease.
    J Infect. 2021 Aug 26. pii: S0163-4453(21)00442.
    >> Share

  218. TRE-HARDY M, Cupaiolo R, Wilmet A, Antoine-Moussiaux T, et al
    Six-month interim analysis of ongoing immunogenicity surveillance of the mRNA-1273 vaccine in healthcare workers: A third dose is expected.
    J Infect. 2021 Aug 23. pii: S0163-4453(21)00433.
    >> Share

  219. QIU S, Hu Y
    Are COVID-19 susceptibility genes related to lung cancer?
    J Infect. 2021 Aug 23. pii: S0163-4453(21)00434.
    >> Share

  220. MORALES-ORTEGA A, Farfan-Sedano AI, Izquierdo-Martinez A, Llarena-Barroso C, et al
    Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients.
    J Infect. 2021 Aug 23. pii: S0163-4453(21)00436.
    >> Share

  221. GUIGON A, Faure E, Lemaire C, Chopin MC, et al
    Emergence of Q493R mutation in SARS-CoV-2 spike protein during bamlanivimab/etesevimab treatment and resistance to viral clearance.
    J Infect. 2021 Aug 23. pii: S0163-4453(21)00435.
    >> Share

  222. KRAL S, Banfi C, Niedrist T, Sareban N, et al
    Long-lasting immune response to a mild course of PCR-confirmed SARS-CoV-2 infection: A cohort study.
    J Infect. 2021 Aug 22. pii: S0163-4453(21)00419.
    >> Share

  223. WEISSMAN YL, Cooper L, Sternbach N, Ashkenazi-Hoffnung L, et al
    Clinical efficacy and safety of high dose trivalent influenza vaccine in adults and immunosuppressed populations -a systematic review and meta-analysis.
    J Infect. 2021 Aug 20. pii: S0163-4453(21)00417.
    >> Share

  224. TEYSSOU E, Delagreverie H, Visseaux B, Lambert-Niclot S, et al
    The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19.
    J Infect. 2021 Aug 19. pii: S0163-4453(21)00416.
    >> Share

  225. BRAMLEY A, Crocker-Buque T, Breuer J, Mahungu TW, et al
    Evidence of the reduction of acute circulating communicable viruses during the SARS-CoV-2 pandemic in London.
    J Infect. 2021 Aug 19. pii: S0163-4453(21)00418.
    >> Share

  226. WANG C, Kang K, Lan X, Fei D, et al
    Cytokinelevels in sputum, not serum, may be more helpful 1 for indicating the damage in the lung and the prognosis of severe COVID-19 - A Case Series.
    J Infect. 2021 Aug 19. pii: S0163-4453(21)00415.
    >> Share

  227. YOU YS, Kim JS
    Influenza and Anosmia: important prediction factors for severity and death of COVID-19.
    J Infect. 2021 Aug 18. pii: S0163-4453(21)00413.
    >> Share

  228. GAO R, Zheng H, Liu K, Ji Z, et al
    Genesis, Evolution and Host Species Distribution of influenza A (H10N3) Virus in China.
    J Infect. 2021 Aug 17. pii: S0163-4453(21)00403.
    >> Share

  229. KRETSCHMER A, Kossow A, Grune B, Schildgen O, et al
    False positive rapid antigen tests for SARS-CoV-2 in the real-world and their economic burden.
    J Infect. 2021 Aug 17. pii: S0163-4453(21)00402.
    >> Share

  230. DOUXFILS J, Gillot C, Mullier F, Favresse J, et al
    Post-SARS-CoV-2 vaccination specific antibody decrease - Thresholds for determining seroprevalence and seroneutralization differ.
    J Infect. 2021 Aug 15. pii: S0163-4453(21)00405.
    >> Share

  231. ARANDA J, Oriol I, Martin M, Feria L, et al
    Long-term impact of COVID-19 associated acute respiratory distress syndrome.
    J Infect. 2021 Aug 13. pii: S0163-4453(21)00396.
    >> Share

  232. WEY EQ, Bristow C, Nandani A, O'Farrell B, et al
    Preserved C-reactive protein responses to blood stream infections following tocilizumab treatment for COVID-19.
    J Infect. 2021 Aug 13. pii: S0163-4453(21)00400.
    >> Share

  233. LADHANI SN, Ireland G, Baawuah F, Beckmann J, et al
    Emergence of SARS-CoV-2 Alpha (B.1.1.7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: active prospective surveillance, December 2020 to March 2021, England.
    J Infect. 2021 Aug 13. pii: S0163-4453(21)00401.
    >> Share

  234. MOSELEY E, Williams P, Muir P, Marlow R, et al
    Influenza A/B and respiratory syncytial virus digital immunoassay evaluation in a paediatric emergency department.
    J Infect. 2021 Aug 11. pii: S0163-4453(21)00397.
    >> Share

  235. COSTA R, Bueno F, Gimenez E, Bracho A, et al
    Initial viral load and decay kinetics of SARS-CoV-2 lineage B.1.1.7 in the upper respiratory tract of adults and children.
    J Infect. 2021 Aug 11. pii: S0163-4453(21)00398.
    >> Share

  236. DONG M, Luo M, Li A, Xie H, et al
    Changes in the pathogenic spectrum of acute respiratory tract infections during the COVID-19 epidemic in Beijing, China: A large-scale active surveillance study.
    J Infect. 2021 Aug 11. pii: S0163-4453(21)00395.
    >> Share

  237. FURUSE Y, Tsnchiya N, Miyahara R, Yasuda D, et al
    COVID-19 case-clusters and transmission chains in the communities in Japan.
    J Infect. 2021 Aug 11. pii: S0163-4453(21)00399.
    >> Share

  238. ALLEN N, Brady M, Martin AIC, Domegan L, et al
    Serological markers of SARS-CoV-2 infection; anti-nucleocapsid antibody positivity may not be the ideal marker of natural infection in vaccinated individuals.
    J Infect. 2021 Aug 9. pii: S0163-4453(21)00394.
    >> Share

  239. YAHI N, Chahinian H, Fantini J
    Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination ?
    J Infect. 2021 Aug 9. pii: S0163-4453(21)00392.
    >> Share

  240. KHAN MI, Qureshi H, Khattak AA, Awan UA, et al
    Predicting COVID-19 incidence in Pakistan: It's time to act now!
    J Infect. 2021 Aug 9. pii: S0163-4453(21)00393.
    >> Share

  241. FERNANDEZ-DE-LAS-PENAS C
    Post-COVID Functional Limitations on Daily Living Activities are Associated with Symptoms Experienced at the Acute Phase of SARS-CoV-2 Infection and Internal Care Unit Admission: A Multicenter Study.
    J Infect. 2021 Aug 7. pii: S0163-4453(21)00391.
    >> Share

  242. ZHANG J, Huang L, Chen Y, Wang X, et al
    Avian influenza H10 subtype viruses continuously pose threat to public health in China.
    J Infect. 2021 Aug 6. pii: S0163-4453(21)00386.
    >> Share


  243. Decreased neutralization of the Eta SARS-CoV-2 variant by sera of previously infected and uninfected vaccinated individuals.
    J Infect. 2021 Aug 6. pii: S0163-4453(21)00388.
    >> Share

  244. GOBBI F, Buonfrate D, Silva R, Martini D, et al
    Antibody response in individuals infected with SARS-CoV-2 early after the first dose of the BNT162b2 mRNA vaccine: SARS-CoV-2 infection early after the first vaccine dose.
    J Infect. 2021 Aug 6. pii: S0163-4453(21)00390.
    >> Share

  245. LAMB G, Heskin J, Randell P, Mughal N, et al
    Real-world evaluation of COVID-19 lateral flow device (LFD) mass-testing in healthcare workers at a London hospital; a prospective cohort analysis.
    J Infect. 2021 Aug 5. pii: S0163-4453(21)00383.
    >> Share


  246. Predominance of Delta variant among the COVID-19 vaccinated and unvaccinated individuals, India, May 2021.
    J Infect. 2021 Aug 5. pii: S0163-4453(21)00387.
    >> Share

  247. TANNER AR, Phan H, Brendish NJ, Borca F, et al
    SARS-CoV-2 Viral load at presentation to hospital is independently associated with the risk of death.
    J Infect. 2021 Aug 4. pii: S0163-4453(21)00384.
    >> Share

  248. CHEN J, Li X, Xu L, Xie S, et al
    Health threats from increased antigenicity changes in H5N6-dominant subtypes, 2020 China.
    J Infect. 2021;83:e9-e11.
    >> Share

  249. FERNANDEZ-DE-LAS-PENAS C, Palacios-Cena D, Gomez-Mayordomo V, Rodriuez-Jimenez J, et al
    Long-term post-COVID symptoms and associated risk factors in previously hospitalized patients: A multicenter study.
    J Infect. 2021;83:237-279.
    >> Share

  250. FERNANDEZ-DE-LAS-PENAS C, Torres-Macho J, Velasco-Arribas M, Arias-Navalon JA, et al
    Similar prevalence of long-term post-COVID symptoms in patients with asthma: A case-control study.
    J Infect. 2021;83:237-279.
    >> Share

  251. MILLER E, Waight PA, Andrews NJ, McOwat K, et al
    Transmission of SARS-CoV-2 in the household setting: a prospective cohort study in children and adults in England.
    J Infect. 2021 Aug 1. pii: S0163-4453(21)00380.
    >> Share

    July 2021
  252. LUMLEY SF, Constantinides B, Sanderson N, Rodger G, et al
    Epidemiological data and genome sequencing reveals that nosocomial transmission of SARS-CoV-2 is underestimated and mostly mediated by a small number of highly infectious individuals.
    J Infect. 2021 Jul 28. pii: S0163-4453(21)00377.
    >> Share

  253. BENE MC, Bittencourt MC, Chevallier P
    Post-SARS-CoV-2 vaccination specific antibody decrease : let's get the half-full glass perspective.
    J Infect. 2021 Jul 28. pii: S0163-4453(21)00370.
    >> Share

  254. LIM SY, Kim JY, Lee JA, Kwon JS, et al
    Immune responses and reactogenicity after ChAdOx1 in individuals with past SARS-CoV-2 infection and those without.
    J Infect. 2021 Jul 28. pii: S0163-4453(21)00375.
    >> Share

  255. RAJAMANICKAM A, Kumar NP, Padmapriyadarsini C, Nancy A, et al
    Latent tuberculosis co-infection is associated with heightened levels of humoral, cytokine and acute phase responses in seropositive SARS-CoV-2 infection.
    J Infect. 2021 Jul 27. pii: S0163-4453(21)00372.
    >> Share

  256. RANA MS, Usman M, Salman M, Alam MM, et al
    Potential impact of COVID-19 Pandemic on escalating antimicrobial resistance in Pakistan.
    J Infect. 2021 Jul 27. pii: S0163-4453(21)00368.
    >> Share

  257. WHITTAKER R, Kristofferson AB, Seppala E, Salamanca BV, et al
    Trajectories of hospitalisation for patients infected with SARS-CoV-2 variant B.1.1.7 in Norway, December 2020 - April 2021.
    J Infect. 2021 Jul 27. pii: S0163-4453(21)00366.
    >> Share

  258. CIUFFREDA L, Salazar JML, Alcoba-Florez J, Rodriguez-Perez H, et al
    Longitudinal study of a SARS-CoV-2 infection in an immunocompromised patient with X-linked agammaglobulinemia.
    J Infect. 2021 Jul 27. pii: S0163-4453(21)00373.
    >> Share

  259. COSENTINO G, Bernard M, Ambroise J, Giannoli JM, et al
    SARS-CoV-2 viral dynamics in infections with Alpha and Beta variants of concern in the French community.
    J Infect. 2021 Jul 27. pii: S0163-4453(21)00374.
    >> Share

  260. EBANKS D, Faustini S, Shields A, Parry H, et al
    Cross reactivity of serological response to SARS-CoV-2 vaccination with viral variants of concern detected by lateral flow immunoassays.
    J Infect. 2021 Jul 26. pii: S0163-4453(21)00363.
    >> Share

  261. ROBERT TANNER A
    Increase in circulation of non-SARS-CoV-2 respiratory viruses following easing of social distancing is associated with increasing hospital attendance.
    J Infect. 2021 Jul 25. pii: S0163-4453(21)00365.
    >> Share

  262. GIDARI A, Sabbatini S, Bastianelli S, Pierucci S, et al
    Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent and P.1 infected.
    J Infect. 2021 Jul 25. pii: S0163-4453(21)00362.
    >> Share

  263. LAI CK, Lui GC, Chen Z, Cheung YY, et al
    Comparison of Self-collected Mouth Gargle with Deep-throat Saliva Samples for the diagnosis of COVID-19: Mouth gargle for diagnosis of COVID-19.
    J Infect. 2021 Jul 25. pii: S0163-4453(21)00354.
    >> Share

  264. BOU-KARROUM L, Khabsa J, Jabbour M, Hilal N, et al
    Public Health Effects of Travel-Related Policies on the COVID-19 Pandemic: A Mixed-Methods Systematic Review.
    J Infect. 2021 Jul 24. pii: S0163-4453(21)00360.
    >> Share

  265. LADHANI SN
    Crossing the Rubicon: a Fine Line between Waiting and Vaccinating Adolescents against COVID-19.
    J Infect. 2021 Jul 21. pii: S0163-4453(21)00357.
    >> Share

  266. GUDIOL C, Dura-Miralles X, Aguilar-Company J, Hernandez-Jimenez P, et al
    Co-infections and superinfections complicating COVID-19 in cancer patients: a multicenter, international study.
    J Infect. 2021 Jul 21. pii: S0163-4453(21)00356.
    >> Share

  267. MOMBELLI M, Hoschler K, Cavassini M, Pascual M, et al
    Seasonal Trivalent Inactivated Influenza Vaccine with Topical Imiquimod in Immunocompromised Patients: a Randomized Controlled Trial.
    J Infect. 2021 Jul 20. pii: S0163-4453(21)00353.
    >> Share

  268. GAO S, Lu Y, Luan J, Zhang L, et al
    Low incidence rate of diarrhoea in COVID-19 patients is due to integrin.
    J Infect. 2021 Jul 15. pii: S0163-4453(21)00348.
    >> Share

  269. MATTIUZZI C, Henry BM, Lippi G
    Is diffusion of SARS-CoV-2 variants of concern associated with different symptoms?: Symptoms of COVID-19.
    J Infect. 2021 Jul 15. pii: S0163-4453(21)00347.
    >> Share

  270. VANCHEESWARAN R, Willcox ML, Stuart B, Knight M, et al
    Accuracy of Rapid Point-of-Care Antibody Test in patients with suspected or confirmed COVID-19.
    J Infect. 2021 Jul 14. pii: S0163-4453(21)00332.
    >> Share

  271. AVDEEV SN, Gaynitdinova VV, Merzhoeva ZM, Berikkhanov ZG, et al
    N-acetylcysteine for the treatment of COVID-19 among hospitalized patients.
    J Infect. 2021 Jul 10. pii: S0163-4453(21)00329.
    >> Share

  272. NIITSU T, Shiroyama T, Hirata H, Noda Y, et al
    Cytomegalovirus infection in critically ill patients with COVID-19.
    J Infect. 2021 Jul 9. pii: S0163-4453(21)00330.
    >> Share

  273. ANGELETTI S, Giovanetti M, Fogolari M, De Florio L, et al
    Detection of a SARS-CoV-2 P.1.1 variant lacking N501Y in a vaccinated Health Care worker in Italy.
    J Infect. 2021 Jul 5. pii: S0163-4453(21)00325.
    >> Share

  274. FAVRESSE J, Douxfils J
    Importance of Sample Dilution in the Evaluation of the Antibody Response after SARS-CoV-2 Vaccination.
    J Infect. 2021 Jul 4. pii: S0163-4453(21)00327.
    >> Share

  275. BARBOSA GR, Moreira LVL, Justo AFO, Perosa AH, et al
    Rapid spread and high impact of the variant of concern P.1 in the largest city of Brazil.
    J Infect. 2021;83:119-145.
    >> Share

  276. ROCHA AS, Meireles M, Vilaca H, Guimaraes TC, et al
    Outcomes of Covid-19 Organizing Pneumonia in Critically Ill Patients: OUTCOMES OF COVID-19 ORGANIZING PNEUMONIA.
    J Infect. 2021 Jul 1. pii: S0163-4453(21)00322.
    >> Share

    June 2021
  277. XIE D, Chu H, Yang D, Ding Q, et al
    A stark difference in the profiles of defective viral transcripts between SARS-CoV-2 and SARS-CoV.
    J Infect. 2021 Jun 30. pii: S0163-4453(21)00315.
    >> Share

  278. SALVAGNO GL, Henry BM, Pighi L, De Nitto S, et al
    Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers.
    J Infect. 2021 Jun 29. pii: S0163-4453(21)00321.
    >> Share

  279. HSU L, Wisplinghoff H, Kossow A, Hurrass J, et al
    Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination.
    J Infect. 2021 Jun 29. pii: S0163-4453(21)00320.
    >> Share

  280. WANG Y, Niu S, Zhang B, Yang C, et al
    The whole genome analysis for the first human infection with H10N3 influenza virus in China.
    J Infect. 2021 Jun 27. pii: S0163-4453(21)00318.
    >> Share

  281. MENDEZ-BRITO A, Bcheraoui CE, Pozo-Martin F
    Systematic review of empirical studies comparing the effectiveness of non-pharmaceutical interventions against COVID-19.
    J Infect. 2021 Jun 20. pii: S0163-4453(21)00316.
    >> Share

  282. TRE-HARDY M, Cupaiolo R, Wilmet A, Beukinga I, et al
    Waning antibodies in SARS-CoV-2 naive vaccinees: results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers.
    J Infect. 2021 Jun 20. pii: S0163-4453(21)00314.
    >> Share

  283. BUSKERMOLEN M, Te Paske K, van Beek J, Kortbeek T, et al
    Relapse in the first 8 weeks after onset of COVID-19 disease in outpatients: viral reactivation or inflammatory rebound?
    J Infect. 2021 Jun 17. pii: S0163-4453(21)00310.
    >> Share

  284. DIMEGLIO C, Herin F, Miedouge M, Da-Silva I, et al
    One year later: SARS-CoV-2 immune response and vaccination of healthcare workers post-infection.
    J Infect. 2021 Jun 17. pii: S0163-4453(21)00312.
    >> Share

  285. HOMMA Y, Katsuta T, Oka H, Inoue K, et al
    The incubation period of the SARS-CoV-2 B.1.1.7 variant is shorter than that of other strains.
    J Infect. 2021 Jun 16. pii: S0163-4453(21)00306.
    >> Share

  286. ANDERSEN MP, Ostergaard L, Phelps M, Butt JH, et al
    Risk of Coronavirus Disease 2019 (Covid-19) Contraction and Severe Infection in Home- or Healthcare Professionals.
    J Infect. 2021 Jun 15. pii: S0163-4453(21)00305.
    >> Share

  287. CENDEJAS-BUENO E, Romero-Gomez MP, Escosa L, Jimenez-Rodriguez S, et al
    Lower nasopharyngeal viral loads in pediatric population. The missing piece to understand SARS-CoV-2 infection in children?
    J Infect. 2021 Jun 13. pii: S0163-4453(21)00289.
    >> Share

  288. LOFFREDO L, Oliva A, Paraninfi A, Ceccarelli G, et al
    An observed association between conjunctivitis and severity of COVID-19.
    J Infect. 2021 Jun 9. pii: S0163-4453(21)00286.
    >> Share

  289. KWOK KO, McNeil EB, Tsoi MTF, Wei VWI, et al
    Will achieving herd immunity be a road to success to end the COVID-19 pandemic?
    J Infect. 2021 Jun 9. pii: S0163-4453(21)00287.
    >> Share

  290. NOH JY, Song JY, Hyun HJ, Yoon JG, et al
    Risk factors for SARS-CoV-2 transmission in non-household clusters.
    J Infect. 2021 Jun 8. pii: S0163-4453(21)00284.
    >> Share

  291. RISTIC S, Pavlic SD, Nadalin S, Cizmarevic NS, et al
    ACE I/D polymorphism and epidemiological findings for COVID-19: one year after the pandemic outbreak in Europe.
    J Infect. 2021 Jun 4. pii: S0163-4453(21)00282.
    >> Share

  292. LORENZO VB, Nascimento-Carvalho C
    Differences between children with severe acute lower respiratory infection with or without SARS-Cov-2 infection.
    J Infect. 2021 Jun 3. pii: S0163-4453(21)00280.
    >> Share

  293. FANTINI J, Yahi N, Azzaz F, Chahinian H, et al
    Structural dynamics of SARS-CoV-2 variants: a health monitoring strategy for anticipating Covid-19 outbreaks.
    J Infect. 2021 Jun 2. pii: S0163-4453(21)00281.
    >> Share

  294. STANG A, Robers J, Schonert B, Jockel KH, et al
    The performance of the SARS-CoV-2 RT-PCR test as a tool for detecting SARS-CoV-2 infection in the population.
    J Infect. 2021 Jun 1. pii: S0163-4453(21)00265.
    >> Share

  295. OLEA B, Albert E, Torres I, Gozalvo-Rovira R, et al
    Lower respiratory tract and plasma SARS-CoV-2 RNA load in critically ill adult COVID-19 patients: relationship with biomarkers of disease severity.
    J Infect. 2021 Jun 1. pii: S0163-4453(21)00279.
    >> Share

    May 2021
  296. KONTOGIANNI K, Cubas-Atienzar AI, Wooding D, Buist K, et al
    Lateral flow antigen tests can sensitively detect live cultured virus of the SARS-CoV-2 B.1.1.7 lineage.
    J Infect. 2021 May 29. pii: S0163-4453(21)00272.
    >> Share

  297. TANG JW, Bird PW, Holmes CW, Nicoara DC, et al
    The UK Leicester COVID-19 'exceedance' May-July 2020: An analysis of hospitalised cases.
    J Infect. 2021 May 29. pii: S0163-4453(21)00270.
    >> Share

  298. ZHANG N, Chen X, Jia W, Jin T, et al
    Evidence for lack of transmission by close contact and surface touch in a restaurant outbreak of COVID-19.
    J Infect. 2021 May 29. pii: S0163-4453(21)00273.
    >> Share

  299. YAN X, Huang H, Wang C, Jin Z, et al
    Follow-up study of pulmonary function among COVID-19 survivors 1 year after recovery.
    J Infect. 2021 May 29. pii: S0163-4453(21)00276.
    >> Share

  300. RAW RK, Kelly C, Rees J, Wroe C, et al
    Previous COVID-19 infection, but not Long-COVID, is associated with increased adverse events following BNT162b2/Pfizer vaccination.
    J Infect. 2021 May 29. pii: S0163-4453(21)00277.
    >> Share

  301. BUTT AA, Khan T, Yan P, Shaikh OS, et al
    Rate and risk factors for breakthrough SARS-CoV-2 infection after vaccination.
    J Infect. 2021 May 28. pii: S0163-4453(21)00263.
    >> Share

  302. PALLOTTO C, Blanc P, Esperti S, Suardi LR, et al
    Remdesivir treatment and transient bradycardia in patients with coronavirus diseases 2019 (COVID-19).
    J Infect. 2021 May 28. pii: S0163-4453(21)00267.
    >> Share

  303. THANGARAJ JWV, Kumar MS, Kumar CG, Kumar VS, et al
    Persistence of humoral immune response to SARS-CoV-2 up to 7 months post-infection: Cross-sectional study, South India, 2020-21.
    J Infect. 2021 May 28. pii: S0163-4453(21)00268.
    >> Share

  304. BREATHNACH AS, Duncan CJA, Bouzidi KE, Hanrath AT, et al
    Prior COVID-19 protects against reinfection, even in the absence of detectable antibodies.
    J Infect. 2021 May 27. pii: S0163-4453(21)00266.
    >> Share

  305. CAPETTI AF, Borgonovo F, Mileto D, Gagliardi G, et al
    One-year durability of anti-spike IgG to SARS-CoV-2: preliminary data from the AntiCROWN prospective observational study One year durability of COVID-19 anti-spike IgG.
    J Infect. 2021 May 27. pii: S0163-4453(21)00264.
    >> Share

  306. VENTURAS J, Zamparini J, Shaddock E, Stacey S, et al
    Comparison of outcomes in HIV-positive and HIV-negative patients with COVID-19.
    J Infect. 2021 May 26. pii: S0163-4453(21)00262.
    >> Share

  307. J BP, Jolly B, John N, Bhoyar RC, et al
    Genomic survey of SARS-CoV-2 vaccine breakthrough infections in healthcare workers from Kerala, India.
    J Infect. 2021 May 24. pii: S0163-4453(21)00260.
    >> Share

  308. YAMAMOTO S, Tanaka A, Oshiro Y, Ishii M, et al
    Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan.
    J Infect. 2021 May 24. pii: S0163-4453(21)00259.
    >> Share

  309. HASAN MJ, Rabbani R, Anam AM, Huq SMR, et al
    Secukinumab in severe COVID-19 pneumonia: does it have a clinical impact?: Secukinumab in severe COVID-19.
    J Infect. 2021 May 21. pii: S0163-4453(21)00253.
    >> Share

  310. SZARPAK L
    Mucormycosis - a serious threat in the COVID-19 pandemic?
    J Infect. 2021 May 21. pii: S0163-4453(21)00257.
    >> Share

  311. FONSECA V, de Jesus R, Adelino T, Reis AB, et al
    Genomic evidence of SARS-CoV-2 reinfection case with the emerging B.1.2 variant in Brazil.
    J Infect. 2021 May 21. pii: S0163-4453(21)00256.
    >> Share

  312. BORDI L, Parisi G, Sberna G, Amendola A, et al
    Effective screening strategy against SARS-CoV-2 on self-collected saliva samples in primary school setting: a pilot project.
    J Infect. 2021 May 20. pii: S0163-4453(21)00254.
    >> Share

  313. CARAMELLO V, Boccuzzi A, Basile V, Ferraro A, et al
    Are antigenic tests useful for detecting SARS-CoV-2 infections in patients accessing to emergency departments? Results from a North-West Italy Hospital.
    J Infect. 2021 May 20. pii: S0163-4453(21)00255.
    >> Share

  314. ZARIF A, Joy M, Sherlock J, Sheppard JP, et al
    The impact of primary care supported shielding on the risk of mortality in people vulnerable to COVID-19: English sentinel network matched cohort study.
    J Infect. 2021 May 15. pii: S0163-4453(21)00220.
    >> Share

  315. CHIRICO F, Nucera G, Szarpak L
    COVID-19 mortality in Italy: The first wave was more severe and deadly, but only in Lombardy region.
    J Infect. 2021 May 13. pii: S0163-4453(21)00248.
    >> Share

  316. KOROMPOKI E, Gavriatopoulou M, Hicklen RS, Ntanasis-Stathopoulos I, et al
    Epidemiology and organ specific sequelae of post-acute COVID19: A Narrative Review.
    J Infect. 2021 May 13. pii: S0163-4453(21)00247.
    >> Share

  317. KOW CS, Merchant HA, Hasan SS
    Mortality risk in patients infected with SARS-CoV-2 of the lineage B.1.1.7 in the UK.
    J Infect. 2021 May 13. pii: S0163-4453(21)00250.
    >> Share

  318. HOTHAM M
    Potential future implications of the COVID-19 pandemic on Norovirus infections in England.
    J Infect. 2021 May 13. pii: S0163-4453(21)00241.
    >> Share

  319. MANN JA, Bird PW, Bandi S, Tang JW, et al
    Asymptomatic SARS-CoV-2-infected children attending hospital with non-COVID-19 diagnoses, March 2020-February 2021.
    J Infect. 2021 May 13. pii: S0163-4453(21)00240.
    >> Share

  320. WINCHESTER S, John S, Jabbar K, John I, et al
    Clinical Efficacy of Nitric Oxide Nasal Spray (NONS) for the Treatment of Mild COVID-19 Infection.
    J Infect. 2021 May 13. pii: S0163-4453(21)00251.
    >> Share

  321. WHITAKER HJ, Elgohari S, Rowe C, Otter AD, et al
    Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021.
    J Infect. 2021 May 11. pii: S0163-4453(21)00224.
    >> Share

  322. FERNANDEZ-VILLA T, Vazquez-Casares A, Rivero-Rodriguez A, Carvajal-Urena A, et al
    Rapid antigen test for SARS-CoV-2 and primary health care.
    J Infect. 2021 May 7. pii: S0163-4453(21)00226.
    >> Share

  323. SANSONE E, Tiraboschi M, Sala E, Albini E, et al
    Effectiveness of BNT162b2 vaccine against the B.1.1.7 variant of SARS-CoV-2 among healthcare workers in Brescia, Italy.
    J Infect. 2021 May 6. pii: S0163-4453(21)00225.
    >> Share

  324. MACLOT F, Bontems S, Meex C, Artesi M, et al
    Development of a multiplex RT-qPCR using the drop out strategy to screen the SARS-CoV-2 South African 501Y.V2 variant.
    J Infect. 2021 May 3. pii: S0163-4453(21)00221.
    >> Share

  325. MATAKI N, Ohmura H, Kodama T, Nakamura S, et al
    Myxovirus resistance protein A in peripheral blood predicts supplemental oxygen need in COVID-19.
    J Infect. 2021;82:186-230.
    >> Share

  326. RICCO M, Ranzieri S, Marchesi F
    Rapid antigen tests for large-scale diagnostic campaigns: A case study from North-Eastern Italy.
    J Infect. 2021;82:e39-e40.
    >> Share

    April 2021
  327. DE PAULA CSY, Palandri GG, Fonseca TS, Vendramini TCA, et al
    Gastrointestinal manifestations are associated with severe pediatric COVID-19: a study in tertiary hospital.
    J Infect. 2021 Apr 30. pii: S0163-4453(21)00217.
    >> Share

  328. GARVEY MI, Wilkinson MAC, Holden E, Shields A, et al
    Early observations on the impact of a healthcare worker COVID-19 vaccination programme at a major UK tertiary centre.
    J Infect. 2021 Apr 29. pii: S0163-4453(21)00214.
    >> Share

  329. CHUDASAMA DY, Flannagan J, Collin SM, Charlett A, et al
    Household clustering of SARS-CoV-2 variant of concern B.1.1.7 (VOC-202012-01) in England.
    J Infect. 2021 Apr 29. pii: S0163-4453(21)00216.
    >> Share

  330. VUSIRIKALA A, Whitaker H, Jones S, Tessier E, et al
    Seroprevalence of SARS-CoV-2 Antibodies in University Students: cross-sectional study, December 2020, England.
    J Infect. 2021 Apr 29. pii: S0163-4453(21)00215.
    >> Share

  331. TEYSSOU E, Soulie C, Visseaux B, Lambert-Niclot S, et al
    The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients.
    J Infect. 2021 Apr 28. pii: S0163-4453(21)00211.
    >> Share

  332. BAEK YJ, Lee YJ, Yoon JS, Sohn Y, et al
    Duration of culturable SARS-CoV-2 within different specimens among mild and severe COVID-19 patients: a longitudinal study.
    J Infect. 2021 Apr 28. pii: S0163-4453(21)00212.
    >> Share

  333. BONGIOVANNI M, Arienti R, Bini F, Bodini BD, et al
    Differences between the waves in Northern Italy: how the characteristics and the outcome of COVID-19 infected patients admitted to the emergency room have changed.
    J Infect. 2021 Apr 28. pii: S0163-4453(21)00210.
    >> Share

  334. GARVEY MI, McMurray C, Casey AL, Ratcliffe L, et al
    Observations of SARS-CoV-2 variant of concern B.1.1.7 at the UK's largest hospital Trust.
    J Infect. 2021 Apr 28. pii: S0163-4453(21)00213.
    >> Share

  335. GALOW L, Haag L, Kahre E, Blankenburg J, et al
    Lower household transmission rates of SARS-CoV-2 from children compared to adults.
    J Infect. 2021 Apr 27. pii: S0163-4453(21)00209.
    >> Share

  336. MARTIN-SANCHEZ M, Lim WW, Yeung A, Adam DC, et al
    COVID-19 transmission in Hong Kong despite universal masking.
    J Infect. 2021 Apr 22. pii: S0163-4453(21)00205.
    >> Share

  337. LI KK, Woo YM, Stirrup O, Hughes J, et al
    Genetic epidemiology of SARS-CoV-2 transmission in renal dialysis units - a high risk community-hospital interface.
    J Infect. 2021 Apr 22. pii: S0163-4453(21)00206.
    >> Share

  338. CHEN S, Zhang X, Zhou Y, Yang K, et al
    COVID-19 protective measures prevent the spread of respiratory and intestinal infectious diseases but not sexually transmitted and bloodborne diseases.
    J Infect. 2021 Apr 22. pii: S0163-4453(21)00204.
    >> Share

  339. STOCKDALE AJ, Fyles F, Farrell C, Lewis J, et al
    Sensitivity of SARS-CoV-2 RNA polymerase chain reaction using a clinical and radiological reference standard: Clinical sensitivity of SARS-CoV-2 PCR.
    J Infect. 2021 Apr 20. pii: S0163-4453(21)00198.
    >> Share

  340. FAROOQ HZ, Davies E, Brown B, Whitfield T, et al
    Real-world SARS CoV-2 Testing in Northern England during the first wave of the COVID-19 Pandemic.
    J Infect. 2021 Apr 20. pii: S0163-4453(21)00199.
    >> Share

  341. FU H, Zhang N, Zheng Y, Jiang N, et al
    Risk stratification of cardiac sequelae detected using cardiac magnetic resonance in late convalescence at the six-month follow-up of recovered COVID-19 patients.
    J Infect. 2021 Apr 19. pii: S0163-4453(21)00202.
    >> Share

  342. BARO B, Rodo P, Ouchi D, Bordoy AE, et al
    Performance characteristics of five antigen-detecting rapid diagnostic test (Ag-RDT) for SARS-CoV-2 asymptomatic infection: a head-to-head benchmark comparison.
    J Infect. 2021 Apr 18. pii: S0163-4453(21)00191.
    >> Share

  343. KODANA M, Kitagawa Y, Takahashi R, Matsuoka M, et al
    Concerns about the clinical usefulness of saliva specimens 1 for the diagnosis of COVID-19.
    J Infect. 2021 Apr 16. pii: S0163-4453(21)00194.
    >> Share

  344. ALCOBA-FLOREZ J, Lorenzo-Salazar JM, Gil-Campesino H, Inigo-Campos A, et al
    Monitoring the rise of the SARS-CoV-2 lineage B.1.1.7 in Tenerife (Spain) since mid-December 2020.
    J Infect. 2021 Apr 12. pii: S0163-4453(21)00168.
    >> Share

  345. DONADIO C, Rainone A, Gouronnec A, Belmin J, et al
    Asymptomatic COVID-19 cases among older patients despite BNT162b2 vaccination: a case series in a geriatric rehabilitation ward during an outbreak.
    J Infect. 2021 Apr 11. pii: S0163-4453(21)00167.
    >> Share

  346. BONGIOVANNI M, Marra AM, Bini F, Bodini BD, et al
    COVID-19 reinfection in healthcare workers: a case series.
    J Infect. 2021 Apr 8. pii: S0163-4453(21)00165.
    >> Share

  347. LIU Y, Chen H, Tan W, Kuang Y, et al
    Clinical characteristics and outcome of SARS-CoV-2 infection during pregnancy.
    J Infect. 2021 Apr 5. pii: S0163-4453(21)00163.
    >> Share

  348. TABOADA M, Gonzalez M, Alvarez A, Eiras M, et al
    First, second and third wave of COVID-19. What have we changed in the ICU management of these patients?
    J Infect. 2021 Apr 4. pii: S0163-4453(21)00160.
    >> Share

  349. NAYAGAM JS, Jeyaraj R, Mitchell T, Walder DP, et al
    Persistent cholestasis in survivors of SARS-CoV-2.
    J Infect. 2021 Apr 4. pii: S0163-4453(21)00162.
    >> Share

  350. OGURI S, Fujisawa S, Kamada K, Nakakubo S, et al
    Effect of varying storage conditions on diagnostic test outcomes of SARS-CoV-2.
    J Infect. 2021 Apr 3. pii: S0163-4453(21)00159.
    >> Share

  351. GARCIA-PACHON E, Grau-Delgado J, Soler-Sempere MJ, Zamora-Molina L, et al
    Low prevalence of post-COVID-19 syndrome in patients with asthma.
    J Infect. 2021 Apr 2. pii: S0163-4453(21)00156.
    >> Share

    March 2021
  352. MASIA M, Padilla S, Galiana A, Fernandez-Gonzalez M, et al
    Incidence of delayed asymptomatic COVID-19 recurrences in a 6-month longitudinal study.
    J Infect. 2021 Mar 29. pii: S0163-4453(21)00152.
    >> Share

  353. PILLAI A, Koduri K, Gokhale Y, Venkatesh M, et al
    Covid-19 Letter to the Editor.
    J Infect. 2021 Mar 28. pii: S0163-4453(21)00154.
    >> Share

  354. MULCHANDANI R, Taylor-Philips S, Jones HE, Ades AE, et al
    Association between self-reported signs and symptoms and SARS-CoV-2 antibody detection in UK key workers.
    J Infect. 2021 Mar 25. pii: S0163-4453(21)00151.
    >> Share

  355. WILLIAMS CM, Pan D, Decker J, Wisniewska A, et al
    Exhaled SARS-CoV-2 quantified by face-mask sampling in hospitalised patients with covid-19.
    J Infect. 2021 Mar 24. pii: S0163-4453(21)00135.
    >> Share

  356. CHAU DNVV
    Rapid whole-genome sequencing to inform COVID-19 outbreak response in Vietnam.
    J Infect. 2021 Mar 24. pii: S0163-4453(21)00133.
    >> Share

  357. HARRIS RJ, Whitaker HJ, Andrews NJ, Aiano F, et al
    Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers.
    J Infect. 2021 Mar 22. pii: S0163-4453(21)00132.
    >> Share

  358. HIROTSU Y, Omata M
    Discovery of a SARS-CoV-2 variant 1 from the P.1 lineage harboring K417T/E484K/N501Y mutations in Kofu, Japan.
    J Infect. 2021 Mar 22. pii: S0163-4453(21)00130.
    >> Share

  359. MURRAY MJ, McIntosh M, Atkinson C, Mahungu T, et al
    Validation of a commercially available indirect assay for SARS-CoV-2 neutralising antibodies using a pseudotyped virus assay.
    J Infect. 2021 Mar 19. pii: S0163-4453(21)00127.
    >> Share

  360. THARMARAJAH E, Buazon A, Patel V, Hannah JR, et al
    IL-6 inhibition in the treatment of COVID-19: a meta-analysis and meta-regression.
    J Infect. 2021 Mar 18. pii: S0163-4453(21)00125.
    >> Share

  361. WILLIAMS P, McWilliams C, Soomro K, Harding I, et al
    The dynamics of procalcitonin in COVID-19 patients admitted to Intensive Care Unit - A multi-centre cohort study in the South West of England, UK.
    J Infect. 2021 Mar 18. pii: S0163-4453(21)00128.
    >> Share

  362. GARVEY MI, Casey AL, Wilkinson MAC, Ratcliffe L, et al
    Details of SARS-CoV-2 reinfections at a major UK tertiary centre.
    J Infect. 2021 Mar 17. pii: S0163-4453(21)00122.
    >> Share

  363. BIRD PW, Holmes C, Fletcher O, Badhwar V, et al
    Retrospective serosurveillance for anti-SARS-CoV-2 immunoglobulin during a time of low prevalence: A cautionary tale.
    J Infect. 2021 Mar 17. pii: S0163-4453(21)00124.
    >> Share

  364. SHAN FZ, Zhu LL, Zhang Y, Tang YH, et al
    Comparison of the role of neutrophil extracellular traps between patients admitted to the intensive care unit with influenza A and B virus infection.
    J Infect. 2021 Mar 15. pii: S0163-4453(21)00121.
    >> Share

  365. REBOIRO MLL, Fuentetaja RS, Lopez RG, Castro-Conde BA, et al
    Role of lupus anticoagulant and von Willebrand factor in chronic reactive endotheliitis in COVID-19.
    J Infect. 2021 Mar 15. pii: S0163-4453(21)00123.
    >> Share

  366. CHAUDHRY Z, Shawe-Taylor M, Rampling T, Cutfield T, et al
    Short durations of corticosteroids for hospitalised COVID-19 patients are associated with a high readmission rate.
    J Infect. 2021 Mar 11. pii: S0163-4453(21)00115.
    >> Share

  367. YANG H, Hou H, Liang X, Xu J, et al
    Lack of significant association between dyslipidemia and COVID-19 mortality.
    J Infect. 2021 Mar 5. pii: S0163-4453(21)00114.
    >> Share

  368. MARTYN EM, Whitaker H, Gil E, Ighomereho P, et al
    Disproportionate impact of SARS-CoV-2 on ethnic minority and frontline healthcare workers: A cross-sectional seroprevalence survey at a North London hospital.
    J Infect. 2021 Mar 4. pii: S0163-4453(21)00098.
    >> Share

  369. YOUNG BC, Eyre DW, Jeffery K
    Use of lateral flow devices allows rapid triage of patients with SARS-CoV-2 on admission to hospital.
    J Infect. 2021 Mar 1. pii: S0163-4453(21)00096.
    >> Share

  370. BADDAL B, Bostanci A, Suer K, Sanlidag T, et al
    SARS-CoV-2 was already in circulation in Northern Cyprus in the prepandemic period.
    J Infect. 2021 Mar 1. pii: S0163-4453(21)00097.
    >> Share

    February 2021
  371. PETRONE L, Petruccioli E, Alonzi T, Vanini V, et al
    In-vitro evaluation of the immunomodulatory effects of baricitinib: implication for COVID-19 therapy.
    J Infect. 2021 Feb 24. pii: S0163-4453(21)00094.
    >> Share

  372. MENSAH AA, Sinnathamby M, Zaidi A, Coughlan L, et al
    SARS-CoV-2 infections in children following the full re-opening of schools and the impact of national lockdown: prospective, national observational cohort surveillance, July-December 2020, England.
    J Infect. 2021 Feb 24. pii: S0163-4453(21)00093.
    >> Share

  373. DENNY S, Abdolrasouli A, Elamin T, Gonzalo X, et al
    A retrospective multicenter analysis of candidaemia among COVID-19 patients during the first UK pandemic wave.
    J Infect. 2021 Feb 18. pii: S0163-4453(21)00090.
    >> Share

  374. SCIMECA M, Mauriello S, Servadei F, Caggiano B, et al
    Persistence of SARS-CoV-2 viral RNA in nasopharyngeal swabs after death.
    J Infect. 2021 Feb 17. pii: S0163-4453(21)00083.
    >> Share

  375. ANTONELLI M, Capdevila J, Chaudhari A, Granerod J, et al
    Optimal symptom combinations to aid COVID-19 case identification: analysis from a community-based, prospective, observational cohort.
    J Infect. 2021 Feb 13. pii: S0163-4453(21)00079.
    >> Share

  376. BULILETE O, Lorente P, Leiva A, Carandell E, et al
    Panbio rapid antigen test for SARS-CoV-2 has acceptable accuracy in symptomatic patients in primary health care.
    J Infect. 2021 Feb 13. pii: S0163-4453(21)00080.
    >> Share

  377. TORRES I, Poujois S, Albert E, Alvarez G, et al
    Point-of-care evaluation of a rapid antigen test (CLINITEST() Rapid COVID-19 Antigen Test) for diagnosis of SARS-CoV-2 infection in symptomatic and asymptomatic individuals.
    J Infect. 2021 Feb 12. pii: S0163-4453(21)00075.
    >> Share

  378. YANG H, Liang X, Hou H, Xu J, et al
    The association of dementia with COVID-19 mortality: Evidence based on adjusted effect estimates.
    J Infect. 2021 Feb 11. pii: S0163-4453(21)00078.
    >> Share

  379. LORA-TAMAYO J, Maestro G, Lalueza A, Rubio-Rivas M, et al
    Early Lopinavir/ritonavir does not reduce mortality in COVID-19 patients: Results of a large multicenter study.
    J Infect. 2021 Feb 11. pii: S0163-4453(21)00077.
    >> Share

  380. NADAL M, Lassel L, Denis M, Gibelin A, et al
    ROLE OF SUPER-SPREADER PHENOMENON IN A COVID-19 CLUSTER AMONG HEALTHCARE WORKERS IN A PRIMARY CARE HOSPITAL.
    J Infect. 2021 Feb 10. pii: S0163-4453(21)00074.
    >> Share

  381. SCUTT DG, Overall DA
    Single nucleotide polymorphisms in key aging pathways, and phenotypic markers of frailty are associated with increased odds of hospital admission with COVID-19.
    J Infect. 2021 Feb 10. pii: S0163-4453(21)00056.
    >> Share

  382. EIGNER U, Verstraeten T, Weil J
    Decrease in Norovirus infections in Germany following COVID-19 containment measures.
    J Infect. 2021 Feb 10. pii: S0163-4453(21)00076.
    >> Share

  383. ADRIELLE DOS SANTOS L, Filho PGG, Silva AMF, Santos JVG, et al
    Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers.
    J Infect. 2021 Feb 9. pii: S0163-4453(21)00043.
    >> Share

  384. KEVORKIAN JP, Lopes A, Sene D, Riveline JP, et al
    Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study.
    J Infect. 2021 Feb 9. pii: S0163-4453(21)00058.
    >> Share

  385. LI G, Niu J, Fan X, Chen T, et al
    The chilly climate may increase the chance of infecting COVID-19.
    J Infect. 2021 Feb 8. pii: S0163-4453(21)00057.
    >> Share

  386. DE MONTMOLLIN E, Faille D, Andrieu V, Ajzenberg N, et al
    Intensified thromboprophylaxis in COVID-19 critically ill patients: Is it enough?
    J Infect. 2021 Feb 5. pii: S0163-4453(21)00054.
    >> Share

  387. BELSKY JA, Tullius BP, Lamb MG, Sayegh R, et al
    COVID-19 in immunocompromised patients: a systematic review of cancer, hematopoietic cell and solid organ transplant patients.
    J Infect. 2021 Feb 4. pii: S0163-4453(21)00045.
    >> Share

  388. MORALES-ORTEGA A, Rivas-Prado L, Frutos-Perez B, Jaenes-Barrios B, et al
    Early clinical experience with imatinib in COVID-19: searching for a dual effect.
    J Infect. 2021 Feb 4. pii: S0163-4453(21)00051.
    >> Share

  389. TOOVEY OTR, Harvey KN, Bird PW, Tang JWW, et al
    Introduction of Brazilian SARS-CoV-2 484K.V2 related variants into the UK.
    J Infect. 2021 Feb 3. pii: S0163-4453(21)00047.
    >> Share

  390. BORGONOVO F, Passerini M, Piscaglia M, Morena V, et al
    Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study.
    J Infect. 2021 Feb 3. pii: S0163-4453(21)00048.
    >> Share

  391. WILSON-DAVIES ESW, Mahanama AIK, Samaraweera B, Ahmed N, et al
    Concerns regarding the sensitivity of the OptiGene direct SARS-CoV-2 LAMP assay and its suitability for use in at-risk groups and hospital staff.
    J Infect. 2021 Feb 2. pii: S0163-4453(21)00036.
    >> Share

  392. ALMHAWISH N, Karah N, Elferruh Y, Aksh A, et al
    Protecting healthcare workers in conflict zones during the COVID-19 pandemic: northwest Syria.
    J Infect. 2021 Feb 2. pii: S0163-4453(21)00046.
    >> Share

  393. TUBIANA S, Burdet C, Houhou N, Thy M, et al
    High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in in-hospital workers - the CoV-CONTACT cohort.
    J Infect. 2021 Feb 2. pii: S0163-4453(21)00049.
    >> Share

  394. FOWLER DV, Douglas DA, Godfrey PK, Williams PA, et al
    Critical evaluation of the methodology used by Wilson-Davies et al., (2020) entitled "Concerning the Optigene Direct LAMP assay, and it`s use in at-risk groups and hospital staff".
    J Infect. 2021;82:282-327.
    >> Share

    January 2021
  395. DIMEGLIO C, Miedouge M, Loubes JM, Mansuy JM, et al
    Side effect of a 6 p.m curfew for preventing the spread of SARS-CoV-2: a modelling study from Toulouse, France.
    J Infect. 2021 Jan 31. pii: S0163-4453(21)00044.
    >> Share

  396. TANAKA A, Yamamoto S, Miyo K, Mizoue T, et al
    Seroprevalence of antibodies against SARS-CoV-2 in a large national hospital and affiliated facility in Tokyo, Japan.
    J Infect. 2021 Jan 29. pii: S0163-4453(21)00032.
    >> Share

  397. RANA MS, Usman M, Alam MM, Ikram A, et al
    Impact of COVID-19 preventive measures on other infectious and non-infectious respiratory diseases in Pakistan.
    J Infect. 2021 Jan 29. pii: S0163-4453(21)00041.
    >> Share

  398. T U, Am DR, Bm W, Ar H, et al
    Increased inflammatory markers reflecting fibrogenesis are independently associated with cardiac involvement in hospitalized COVID-19 patients.
    J Infect. 2021 Jan 28. pii: S0163-4453(21)00040.
    >> Share

  399. DOWNS LO, Eyre DW, O'Donnell D, Jeffery K, et al
    Home-based SARS-CoV-2 lateral flow antigen testing in hospital workers.
    J Infect. 2021 Jan 25. pii: S0163-4453(21)00033.
    >> Share

  400. ADACHI Y, Shiroyama T, Yamaguchi Y, Murakami T, et al
    Predicting recurrence of respiratory failure in critically ill patients with COVID-19: A preliminary study: Running head: Factors predicting respiratory failure in COVID-19.
    J Infect. 2021 Jan 24. pii: S0163-4453(21)00039.
    >> Share

  401. ELFIKY AA, Ibrahim IM
    Host-cell recognition through GRP78 is enhanced in the new UK variant of SARS-CoV-2, in silico.
    J Infect. 2021 Jan 22. pii: S0163-4453(21)00038.
    >> Share

  402. XU Y, Liang H, Wen H
    Frequent reassortment and potential recombination shape the genetic diversity of influenza D viruses.
    J Infect. 2021 Jan 21. pii: S0163-4453(21)00037.
    >> Share

  403. DE FRANCESCO MA, Poiesi C, Gargiulo F, Bonfanti C, et al
    Co-infection of Chlamydia pneumoniae and Mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features.
    J Infect. 2021 Jan 19. pii: S0163-4453(21)00031.
    >> Share

  404. TANG JW, Toovey OTR, Harvey KN, Hui DDS, et al
    Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK.
    J Infect. 2021 Jan 17. pii: S0163-4453(21)00030.
    >> Share

  405. MORENO-PEREZ O, Merino E, Leon-Ramirez JM, Andres M, et al
    Post-acute COVID-19 Syndrome. Incidence and risk factors: a Mediterranean cohort study.
    J Infect. 2021 Jan 12. pii: S0163-4453(21)00009.
    >> Share

  406. BREATHNACH DAS, Riley PA, Cotter MP, Houston AC, et al
    Prior COVID-19 significantly reduces the risk of subsequent infection, but reinfections are seen after eight months.
    J Infect. 2021 Jan 12. pii: S0163-4453(21)00010.
    >> Share

  407. GARCIA-ORTEGA A, Oscullo G, Calvillo P, Lopez-Reyes R, et al
    INCIDENCE, RISK FACTORS, AND THROMBOTIC LOAD OF PULMONARY EMBOLISM IN PATIENTS HOSPITALIZED FOR COVID-19 INFECTION.
    J Infect. 2021 Jan 10. pii: S0163-4453(21)00007.
    >> Share

  408. GARRATT AM, Ghanima W, Einvik G, Stavem K, et al
    Quality of life after COVID-19 without hospitalisation: good overall, but reduced in some dimensions.
    J Infect. 2021 Jan 9. pii: S0163-4453(21)00006.
    >> Share

  409. ALEMANY A, Baro B, Ouchi D, Rodo P, et al
    Analytical and Clinical Performance of the Panbio COVID-19 Antigen-Detecting Rapid Diagnostic Test.
    J Infect. 2021 Jan 6. pii: S0163-4453(21)00004.
    >> Share

  410. BONGIOVANNI M, Bini F, Giuliani G, Gianturco L, et al
    Insight into the reason of prolonged viral RNA shedding in patients with COVID-19 infection.
    J Infect. 2021 Jan 3. pii: S0163-4453(21)00002.
    >> Share

  411. NISHI A, Lee LF, Tsuji H, Takasaki Y, et al
    Letter to the Editor: Revisiting the County/city-level Event Risk Assessment during the COVID-19 Pandemic.
    J Infect. 2021 Jan 3. pii: S0163-4453(21)00003.
    >> Share

    December 2020
  412. LIU Y, Li M, Liu D, Luo JF, et al
    Developing a multivariable risk prediction model to predict prolonged viral clearance in patients with COVID-19.
    J Infect. 2020 Dec 30. pii: S0163-4453(20)30787.
    >> Share

  413. GUO J, Yu H, Yang J, Li Y, et al
    Weighted gene co-expression network analysis revealed host transcriptional response to H1N1 influenza A virus infection.
    J Infect. 2020 Dec 29. pii: S0163-4453(20)30779.
    >> Share

  414. TANG JW, Tambyah PA, Hui DS
    Emergence of a new SARS-CoV-2 variant in the UK.
    J Infect. 2020 Dec 28. pii: S0163-4453(20)30786.
    >> Share

  415. YANG H, Xu J, Liang X, Shi L, et al
    Autoimmune diseases are independently associated with COVID-19 severity: Evidence based on adjusted effect estimates.
    J Infect. 2020 Dec 28. pii: S0163-4453(20)30785.
    >> Share

  416. HANRATH AT, Payne BAI, Duncan CJA, van der Loeff IS, et al
    Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection.
    J Infect. 2020 Dec 26. pii: S0163-4453(20)30781.
    >> Share

  417. CHAN HT, Chao CM, Lai CC
    Sofosbuvir/daclatasvir in the treatment of COVID-19 infection: a meta-analysis.
    J Infect. 2020 Dec 26. pii: S0163-4453(20)30783.
    >> Share

  418. TABOADA M, Carinena A, Moreno E, Rodriguez N, et al
    Post-COVID-19 functional status six-months after Hospitalization.: Functional status after COVID-19.
    J Infect. 2020 Dec 26. pii: S0163-4453(20)30784.
    >> Share

  419. KONIG S, Hohenstein S, Ueberham L, Hindricks G, et al
    Regional and temporal disparities of excess all-cause mortality for Germany in 2020: Is there more than just COVID-19?
    J Infect. 2020 Dec 23. pii: S0163-4453(20)30777.
    >> Share

  420. GANDINI O, Lubrano C
    Use of rapid ferritin test to predict clinical deterioration in at home COVID-19 patients.
    J Infect. 2020 Dec 20. pii: S0163-4453(20)30775.
    >> Share

  421. TURCATO G, Zaboli A, Pfeifer N, Ciccariello L, et al
    Clinical application of a rapid antigen test for the detection of SARS-CoV-2 infection in symptomatic and asymptomatic patients evaluated in the emergency department: a preliminary report.
    J Infect. 2020 Dec 18. pii: S0163-4453(20)30773.
    >> Share

  422. BELLANTI F, Buglio AL, Custodero G, Barbera L, et al
    Fatal relapse of COVID-19 after recovery? A case report of an older Italian patient.
    J Infect. 2020 Dec 16. pii: S0163-4453(20)30770.
    >> Share

  423. AGULLO V, Fernandez-Gonzalez M, Ortiz de la Tabla V, Gonzalo-Jimenez N, et al
    Evaluation of the rapid antigen test Panbio COVID-19 in saliva and nasal swabs in a population-based point-of-care study.
    J Infect. 2020 Dec 9. pii: S0163-4453(20)30768.
    >> Share

  424. ZHOU H, Li C, Hu T, Liu T, et al
    Total Infectomes of 162 SARS-CoV-2 Cases Using Meta-Transcriptomic Sequencing.
    J Infect. 2020 Dec 8. pii: S0163-4453(20)30765.
    >> Share

  425. CHEN PJ, Chao CM, Lai CC
    Clinical efficacy and safety of favipiravir in the treatment of COVID-19 patients.
    J Infect. 2020 Dec 7. pii: S0163-4453(20)30766.
    >> Share

  426. SALMON D, Slama D, De Broucker T, Karmochkine M, et al
    Clinical, virological and imaging profile in patients with Persistent or Resurgent forms of COVID-19: a cross-sectional study.
    J Infect. 2020 Dec 4. pii: S0163-4453(20)30762.
    >> Share

  427. BARRASA H, Martin A, Maynar J, Rello J, et al
    High rate of infections during ICU admission of patients with severe SARS-CoV-2 pneumonia: a matter of time?
    J Infect. 2020 Dec 4. pii: S0163-4453(20)30761.
    >> Share

  428. FRICKE LM, Glockner S, Dreier M, Lange B, et al
    Impact of non-pharmaceutical interventions targeted at COVID-19 pandemic on influenza burden - a systematic review.
    J Infect. 2020 Dec 2. pii: S0163-4453(20)30756.
    >> Share

  429. PIOVANI D, Christodoulou MN, Hadjidemetriou A, Pantavou K, et al
    Effect of early application of social distancing interventions on Covid-19 mortality over the first pandemic wave: an analysis of longitudinal data from 37 countries.
    J Infect. 2020 Dec 1. pii: S0163-4453(20)30751.
    >> Share

  430. PANDEY M, Sisodia S, Bandi S, Roland D, et al
    Incidence of spread of clinically relevant SARS-CoV2 infection between children in a tertiary emergency department: An evaluation.
    J Infect. 2020;81:979-997.
    >> Share

  431. FALCINELLI E, Petito E, Becattini C, De Robertis E, et al
    Role of endothelial dysfunction in the thrombotic complications of COVID-19 patients.
    J Infect. 2020 Dec 1. pii: S0163-4453(20)30760.
    >> Share

    November 2020
  432. FOWLER VL, Armson B, Gonzales JL, Wise EL, et al
    A highly effective reverse-transcription loop-mediated isothermal amplification (RT-LAMP) assay for the rapid detection of SARS-CoV-2 infection.
    J Infect. 2020 Nov 30. pii: S0163-4453(20)30731.
    >> Share

  433. FURUSE Y
    Risk at mass-gathering events and the usefulness of complementary events during COVID-19 pandemic.
    J Infect. 2020 Nov 30. pii: S0163-4453(20)30759.
    >> Share

  434. MAANI AA, Al-Jardani A, Karrar H, Petersen E, et al
    COVID-19 in a case previously infected with MERS-CoV: no cross immunity.
    J Infect. 2020 Nov 30. pii: S0163-4453(20)30754.
    >> Share

  435. DUBOUCHER C
    SARS-CoV-2 and superimposed infection by trichomonads.
    J Infect. 2020 Nov 30. pii: S0163-4453(20)30757.
    >> Share

  436. JONES CR, Hamilton FW, Thompson A, Morris TT, et al
    SARS-CoV-2 IgG seroprevalence in healthcare workers and other staff at North Bristol NHS Trust: a sociodemographic analysis.
    J Infect. 2020 Nov 30. pii: S0163-4453(20)30755.
    >> Share

  437. MOREIRA LVL, de Souza Luna LK, Barbosa GR, Perosa AH, et al
    Test on stool samples improves the diagnosis of hospitalized patients: detection of SARS-CoV-2 genomic and subgenomic RNA.
    J Infect. 2020 Nov 30. pii: S0163-4453(20)30753.
    >> Share

  438. GURGEL RQ, de Sa LC, Souza DRV, Martins AF, et al
    SARS-CoV-2 has been circulating in northeastern Brazil since February 2019: evidence for antibody detection in asymptomatic patients.
    J Infect. 2020 Nov 30. pii: S0163-4453(20)30752.
    >> Share

  439. LIU D, Yang J, Feng B, Lu W, et al
    Mendelian randomization analysis identified genes pleiotropically associated with the risk and prognosis of COVID-19.
    J Infect. 2020 Nov 28. pii: S0163-4453(20)30726.
    >> Share

  440. LAI CC, Chen SY, Yen MY, Lee PI, et al
    The impact of COVID-19 preventative measures on airborne/droplet-transmitted infectious diseases in Taiwan.
    J Infect. 2020 Nov 26. pii: S0163-4453(20)30724.
    >> Share

  441. LEVI M, Miglietta A, Romeo G, Bartolacci S, et al
    Letter in response to article in Journal of Infection: Impact of Routine Infant BCG Vaccination on COVID-19.
    J Infect. 2020 Nov 25. pii: S0163-4453(20)30718.
    >> Share

  442. SUI Z, Zhang Y, Tu J, Xie J, et al
    Evaluation of saliva as an alternative diagnostic specimen source for SARS-CoV-2 detection by RT-dPCR.
    J Infect. 2020 Nov 25. pii: S0163-4453(20)30716.
    >> Share

  443. BERASTEGUI-CABRERA J, Salto-Alejandre S, Valerio M, Perez-Palacios P, et al
    SARS-CoV-2 RNAemia is associated with severe chronic underlying diseases but not with nasopharyngeal viral load.
    J Infect. 2020 Nov 25. pii: S0163-4453(20)30719.
    >> Share

  444. ROMERO-GOMEZ MP, Gomez-Sebastian S, Cendejas-Bueno E, Montero-Vega MD, et al
    Ct value is not enough to discriminate patients harbouring infective virus.
    J Infect. 2020 Nov 25. pii: S0163-4453(20)30720.
    >> Share

  445. MAJRA D, Benson J, Pitts J, Stebbing J, et al
    SARS-CoV-2 (COVID-19) Superspreader Events.
    J Infect. 2020 Nov 24. pii: S0163-4453(20)30717.
    >> Share

  446. KOWALL B, Nonnemacher M, Brune B, Brinkmann M, et al
    A model to identify individuals with a high probability of a SARS-CoV-2 infection.
    J Infect. 2020 Nov 24. pii: S0163-4453(20)30721.
    >> Share

  447. VOICU S, Chousterman BG, Bonnin P, Deye N, et al
    Increased anticoagulation reduces proximal deep vein thrombosis in mechanically ventilated COVID-19 patients: Venous thrombosis prevention & COVID-19.
    J Infect. 2020 Nov 20. pii: S0163-4453(20)30714.
    >> Share

  448. CHAU NVV, Toan LM, Man DNH, Thao HP, et al
    Absence of SARS-CoV-2 antibodies in health care workers of a tertiary referral hospital for COVID-19 in southern Vietnam.
    J Infect. 2020 Nov 19. pii: S0163-4453(20)30713.
    >> Share

  449. XIONG X, Jiao X, Li H, Zeng S, et al
    Glucocorticoid benefits the ventilatory function of sever/critical COVID-19 patients.
    J Infect. 2020 Nov 18. pii: S0163-4453(20)30712.
    >> Share

  450. BAUER W, Diehl-Wiesenecker E, Ulke J, Galtung N, et al
    Outcome prediction by serum calprotectin in patients with COVID-19 in the emergency department.
    J Infect. 2020 Nov 17. pii: S0163-4453(20)30711.
    >> Share

  451. TORRES M, Collins K, Corbit M, Ramirez M, et al
    Comparison of Saliva and Nasopharyngeal Swab SARS-CoV-2 RT-qPCR Testing in a Community Setting.
    J Infect. 2020 Nov 17. pii: S0163-4453(20)30710.
    >> Share

  452. POOLE S, Brendish NJ, Clark TW
    SARS-CoV-2 has displaced other seasonal respiratory viruses: results from a prospective cohort study.
    J Infect. 2020 Nov 15. pii: S0163-4453(20)30707.
    >> Share

  453. COLSON P, Finaud M, Levy N, Lagier JC, et al
    Evidence of SARS-CoV-2 re-infection with a different genotype.
    J Infect. 2020 Nov 15. pii: S0163-4453(20)30706.
    >> Share

  454. AUNG AK, Aitken T, Teh BM, Yu C, et al
    Angiotensin converting enzyme genotypes and mortality from COVID-19: An ecological study.
    J Infect. 2020 Nov 14. pii: S0163-4453(20)30708.
    >> Share

  455. HAMED E, Alnuaimi AS, Syed MA, Elhamid MA, et al
    Clinical characteristics of 51815 patients presenting with positive and negative SARS-CoV-2 swab results in primary health care settings.
    J Infect. 2020 Nov 13. pii: S0163-4453(20)30709.
    >> Share

  456. RANA MS
    Clinical and laboratory characteristics of recovered versus deceased COVID-19 patients in Islamabad, Pakistan.
    J Infect. 2020 Nov 13. pii: S0163-4453(20)30705.
    >> Share

  457. GARDINER T, Cooke G, Fidler S, Cooper N, et al
    The under-representation of BAME patients in the COVID-19 Recovery trial at a major London NHS Trust.
    J Infect. 2020 Nov 12. pii: S0163-4453(20)30699.
    >> Share

  458. CHAN RWY, Chan KC, Chan KYY, Lui GCY, et al
    SARS-CoV-2 detection by nasal strips: a superior tool for surveillance of pediatric population.
    J Infect. 2020 Nov 12. pii: S0163-4453(20)30704.
    >> Share

  459. YAN Y, Jiang X, Fu J, Huang J, et al
    Immune responses and residual SARS-CoV-2 in two critically ill COVID-19 patients before and after lung transplantation.
    J Infect. 2020 Nov 12. pii: S0163-4453(20)30701.
    >> Share

  460. CHARLTON M, Dashey S, Stubbs A, Lai FY, et al
    Comparing SARS-CoV-2 and influenza A(H1N1)pdm09-infected patients requiring ECMO - a single-centre, retrospective observational cohort experience.
    J Infect. 2020 Nov 9. pii: S0163-4453(20)30698.
    >> Share

  461. JI J, Wu M, Zhong L, Liu Z, et al
    Early, low-dose, short-term methylprednisolone decreased the mortality in critical COVID-19 patients: a multicenter retrospective cohort study.
    J Infect. 2020 Nov 8. pii: S0163-4453(20)30696.
    >> Share

  462. ROWLAND TAJ, Whitaker H, Jeffery-Smith A, Lang N, et al
    Seropositivity and risk factors for SARS-CoV-2 infection in staff working in care homes during the COVID-19 pandemic.
    J Infect. 2020 Nov 4. pii: S0163-4453(20)30695.
    >> Share

  463. ALANIO A, Delliere S, Voicu S, Bretagne S, et al
    The presence of Pneumocystis jirovecii in critically ill patients with COVID-19.
    J Infect. 2020 Nov 4. pii: S0163-4453(20)30694.
    >> Share

  464. SAITO S, Asai Y, Matsunaga N, Hayakawa K, et al
    First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics: Comparison of the two COVID-19 waves in Japan.
    J Infect. 2020 Nov 2. pii: S0163-4453(20)30693.
    >> Share

  465. SCAGNOLARI C, Bitossi C, Frasca F, Viscido A, et al
    Differential toll like receptor expression in cystic fibrosis patients' airways during rhinovirus infection.
    J Infect. 2020;81:726-735.
    >> Share

  466. SCHIRINZI A, Pesce F, Laterza R, D'Alise MG, et al
    Pentraxin 3: potential prognostic role in SARS-CoV-2 patients admitted to the emergency department.
    J Infect. 2020 Nov 1. pii: S0163-4453(20)30687.
    >> Share

    October 2020
  467. WANG X, Lin L, Xuan Z, Xu J, et al
    Risk communication on behavioral responses during COVID-19 among general population in China: a rapid national study.
    J Infect. 2020 Oct 31. pii: S0163-4453(20)30689.
    >> Share

  468. HAMED E
    Rates of recurrent positive SARS-CoV-2 swab results among patients attending primary care in Qatar.
    J Infect. 2020 Oct 31. pii: S0163-4453(20)30691.
    >> Share

  469. DIMEGLIO C, Loubes JM, Mansuy JM, Izopet J, et al
    Quantifying the impact of public health protection measures on the spread of SARS-CoV-2.
    J Infect. 2020 Oct 28. pii: S0163-4453(20)30686.
    >> Share

  470. ARAN D, Beachler DC, Lanes S, Overhage JM, et al
    Prior Presumed Coronavirus Infection Reduces COVID-19 Risk: A Cohort Study.
    J Infect. 2020 Oct 27. pii: S0163-4453(20)30683.
    >> Share

  471. MERLI M, Pasulo L, Perricone G, Travi G, et al
    Impact of immunosuppressive therapy on the severity of COVID-19 in solid organ transplant recipients.
    J Infect. 2020 Oct 27. pii: S0163-4453(20)30685.
    >> Share

  472. GUETL K, Moazedi-Fuerst F, Rosskopf K, Brodmann M, et al
    SARS-CoV-2 positive virus culture 7 weeks after onset of COVID-19 in an immunocompromised patient suffering from X chromosome-linked agammaglobulinemia.
    J Infect. 2020 Oct 26. pii: S0163-4453(20)30684.
    >> Share

  473. CHEN CH, Lai CC, Chao CM, Tang HJ, et al
    Zero measles after COVID-19 pandemic in Taiwan Running title: measles and COVID-19.
    J Infect. 2020 Oct 26. pii: S0163-4453(20)30679.
    >> Share

  474. ALFEHAIDI A, Ahmed SA, Hamed E
    A case of SARS-CoV-2 re-infection.
    J Infect. 2020 Oct 25. pii: S0163-4453(20)30677.
    >> Share

  475. MASIA M, Fernandez-Gonzalez M, Garcia JA, Padilla S, et al
    Lack of detrimental effect of corticosteroids on antibody responses to SARS-CoV-2 and viral clearance in patients hospitalized with COVID-19.
    J Infect. 2020 Oct 25. pii: S0163-4453(20)30676.
    >> Share

  476. MORFELD P, Timmermann B, Gross JV, DeMatteis S, et al
    COVID-19: Spatial resolution of excess mortality in Germany and Italy.
    J Infect. 2020 Oct 25. pii: S0163-4453(20)30678.
    >> Share

  477. WELLBELOVE Z, Walsh C, Perinpanathan T, Lillie P, et al
    Comparing the 4C mortality score for COVID-19 to established scores (CURB65, CRB65, qSOFA, NEWS) for respiratory infection patients.
    J Infect. 2020 Oct 25. pii: S0163-4453(20)30673.
    >> Share

  478. DAHDOUH E, Lazaro-Perona F, Romero-Gomez MP, Mingorance J, et al
    Ct values from SARS-CoV-2 diagnostic PCR assays should not be used as direct estimates of viral load.
    J Infect. 2020 Oct 24. pii: S0163-4453(20)30675.
    >> Share

  479. GANDINI O, Criniti A, Gagliardi MC, Ballesio L, et al
    Sex-disaggregated data confirm serum ferritin as an independent predictor of disease severity both in male and female COVID-19 patients.
    J Infect. 2020 Oct 22. pii: S0163-4453(20)30654.
    >> Share

  480. YANG J, Li Y, Guo J, Luo K, et al
    Genetic characterization of an H5N6 avian influenza virus from chickens in Guangdong, China.
    J Infect. 2020 Oct 21. pii: S0163-4453(20)30656.
    >> Share

  481. MELE M, Henares D, Pino R, Asenjo S, et al
    Low impact of SARS-CoV-2 infection among paediatric acute respiratory disease hospitalizations.
    J Infect. 2020 Oct 21. pii: S0163-4453(20)30655.
    >> Share

  482. WELLS PM, Doores KJ, Couvreur S, Nunez RM, et al
    Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE England.
    J Infect. 2020 Oct 14. pii: S0163-4453(20)30653.
    >> Share

  483. WALSH KA, Spillane S, Comber L, Cardwell K, et al
    The duration of infectiousness of individuals infected with SARS-CoV-2.
    J Infect. 2020 Oct 10. pii: S0163-4453(20)30651.
    >> Share

  484. RANA MS, Usman M, Alam MM, Ikram A, et al
    Impact of COVID-19 pandemic on Measles surveillance in Pakistan.
    J Infect. 2020 Oct 8. pii: S0163-4453(20)30650.
    >> Share

  485. SONG W, Jia X, Zhang X, Ling Y, et al
    Co-infection in COVID-19, a cohort study.
    J Infect. 2020 Oct 8. pii: S0163-4453(20)30648.
    >> Share

  486. JIA X, Xiao L, Liu Y
    False negative RT-PCR and false positive antibody tests-Concern and solutions in the diagnosis of COVID-19.
    J Infect. 2020 Oct 8. pii: S0163-4453(20)30649.
    >> Share

  487. BI J, Wang S, Wang Y, Yang D, et al
    Effect of Administering Subsequent Immune Checkpoint Inhibition in Cancer Patients with Prior COVID-19 Infection.
    J Infect. 2020 Oct 8. pii: S0163-4453(20)30647.
    >> Share

  488. MAO MH, Guo JJ, Qin LZ, Han ZX, et al
    Serial semiquantitative detection of SARS-CoV-2 in saliva samples.
    J Infect. 2020 Oct 5. pii: S0163-4453(20)30644.
    >> Share

  489. TANG JW, Kalliomaki P, Varila TM, Waris M, et al
    Nebulisers as a potential source of airborne virus.
    J Infect. 2020;81:647-679.
    >> Share

  490. GREEN ST, Cladi L
    High time for an efficient and effective internationally-supported Zoonosis Surveillance System?
    J Infect. 2020;81:647-679.
    >> Share

    September 2020
  491. DIMEGLIO C, Herin F, Miedouge M, Cambus JP, et al
    Screening for SARS-CoV-2 antibodies among healthcare workers in a University Hospital in Southern France.
    J Infect. 2020 Sep 30. pii: S0163-4453(20)30640.
    >> Share

  492. KUNDI H, Cetin EHO, Canpolat U, Aras S, et al
    The role of Frailty on Adverse Outcomes Among Older Patients with COVID-19.
    J Infect. 2020 Sep 28. pii: S0163-4453(20)30636.
    >> Share

  493. BRENDISH NJ, Poole S, Naidu VV, Mansbridge CT, et al
    Clinical characteristics, symptoms and outcomes of 1054 adults presenting to hospital with suspected COVID-19: a comparison of patients with and without SARS-CoV-2 infection.
    J Infect. 2020 Sep 27. pii: S0163-4453(20)30638.
    >> Share

  494. SIXT T, Moretto F, Devilliers H, Abdallahoui M, et al
    The usefulness of NEWS2 at day 7 of hospitalization in predicting COVID-19 evolution and as an early endpoint in therapeutic trials.
    J Infect. 2020 Sep 27. pii: S0163-4453(20)30639.
    >> Share

  495. MOISEEV S, Brovko M, Tao E, Bulanov N, et al
    Sex differences in mortality in the intensive care unit patients with severe COVID-19.
    J Infect. 2020 Sep 27. pii: S0163-4453(20)30635.
    >> Share

  496. HUANG W, Wu Q, Chen Z, Xiong Z, et al
    The potential indicators for pulmonary fibrosis in survivors of severe COVID-19.
    J Infect. 2020 Sep 27. pii: S0163-4453(20)30632.
    >> Share

  497. MIYAZAWA DD
    Letter in response to article in journal of infection: "Clinical characteristics of 345 patients with coronavirus disease 2019 in Japan: A multicenter retrospective study".
    J Infect. 2020 Sep 27. pii: S0163-4453(20)30637.
    >> Share

  498. SEATON RA, Gibbons CL, Cooper L, Malcolm W, et al
    Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals.
    J Infect. 2020 Sep 25. pii: S0163-4453(20)30616.
    >> Share

  499. SALTO-ALEJANDRE S, Roca-Oporto C, Martin-Gutierrez G, Aviles MD, et al
    A quick prediction tool for unfavourable outcome in COVID-19 inpatients:development and internal validation.
    J Infect. 2020 Sep 25. pii: S0163-4453(20)30619.
    >> Share

  500. WANG S, Fu L, Huang K, Han J, et al
    Neutrophil-to-lymphocyte ratio at admission is an independent risk factors for the severity and mortality in patients with coronavirus disease 2019.
    J Infect. 2020 Sep 23. pii: S0163-4453(20)30630.
    >> Share

  501. LIU K, Wang X, Jiang D, Xu N, et al
    Pathogenicity and transmissibility of an H9N2 avian influenza virus that naturally harbors the mammalian-adaptive molecular factors in the hemagglutinin and PB2 proteins.
    J Infect. 2020 Sep 19. pii: S0163-4453(20)30589.
    >> Share

  502. LI C, Zhang X, Zhu Y, Lin Q, et al
    Excess pneumonia and influenza death as herald wave of COVID-19 in England and Wales, United Kingdom.
    J Infect. 2020 Sep 19. pii: S0163-4453(20)30591.
    >> Share

  503. STANG A, Standl F, Kowall B, Brune B, et al
    Excess mortality due to COVID-19 in Germany.
    J Infect. 2020 Sep 19. pii: S0163-4453(20)30596.
    >> Share

  504. PAGANI G, Conti F, Giacomelli A, Bernacchia D, et al
    Seroprevalence of SARS-CoV-2 significantly varies with age: preliminary results from a mass population screening.
    J Infect. 2020 Sep 19. pii: S0163-4453(20)30629.
    >> Share

  505. PAN D, Sze S, Rogers B, Bron J, et al
    Serial simultaneously self-swabbed samples from multiple sites show similarly decreasing SARS-CoV-2 loads in COVID-19 cases of differing clinical severity.
    J Infect. 2020 Sep 19. pii: S0163-4453(20)30623.
    >> Share

  506. JUAN HC, Chao CM, Lai CC, Tang HJ, et al
    Decline in invasive pneumococcal disease during COVID-19 pandemic in Taiwan.
    J Infect. 2020 Sep 19. pii: S0163-4453(20)30624.
    >> Share

  507. KOW CS, Hasan SS
    The use of antimotility drugs in COVID-19 associated diarrhea.
    J Infect. 2020 Sep 19. pii: S0163-4453(20)30592.
    >> Share

  508. ORTH-HOLLER D, Eigentler A, Stiasny K, Weseslindtner L, et al
    Kinetics of SARS-CoV-2 specific antibodies (IgM, IgA, IgG) in non-hospitalized patients four months following infection.
    J Infect. 2020 Sep 19. pii: S0163-4453(20)30593.
    >> Share

  509. WEN F, Li W, Guo J, Yang J, et al
    Genetic characterization of a novel genotype H9N2 avian influenza virus from chicken in south China.
    J Infect. 2020 Sep 18. pii: S0163-4453(20)30588.
    >> Share

  510. SORIANO MC, Vaquero C, Ortiz-Fernandez A, Caballero A, et al
    Low incidence of co-infection, but high incidence of ICU-acquired infections in critically ill patients with COVID-19.
    J Infect. 2020 Sep 18. pii: S0163-4453(20)30594.
    >> Share

  511. LADHANI SN, Chow JY, Atkin S, Brown KE, et al
    REGULAR MASS SCREENING FOR SARS-CoV-2 INFECTION IN CARE HOMES ALREADY AFFECTED BY COVID-19 OUTBREAKS: implications of false positive test results.
    J Infect. 2020 Sep 16. pii: S0163-4453(20)30621.
    >> Share

  512. GANDINI O, Criniti A, Ballesio L, Giglio S, et al
    Serum ferritin as an independent risk factor for acute respiratory distress syndrome in COVID-19 patients in Rome Italy.
    J Infect. 2020 Sep 15. pii: S0163-4453(20)30617.
    >> Share

  513. TANG HJ, Lai CC
    The association between corticosteroid uses and mortality among severe COVID-19 patients.
    J Infect. 2020 Sep 12. pii: S0163-4453(20)30599.
    >> Share

  514. ISHII M, Terai H, Kabata H, Masaki K, et al
    Clinical characteristics of 345 patients with coronavirus disease 2019 in Japan: a multicenter retrospective study.
    J Infect. 2020 Sep 10. pii: S0163-4453(20)30590.
    >> Share

  515. ELFIKY AA, Ibrahim IM, Ismail AM, Elshemey WM, et al
    A possible role for GRP78 in cross vaccination against COVID-19.
    J Infect. 2020 Sep 10. pii: S0163-4453(20)30598.
    >> Share

  516. RANA DMS, Usman MM, Alam DMM, Khalid DA, et al
    First trimester miscarriage in a pregnant woman infected with COVID-19 in Pakistan.
    J Infect. 2020 Sep 4. pii: S0163-4453(20)30587.
    >> Share

  517. BONGIOVANNI M, Zago T
    Acute hepatitis caused by asymptomatic COVID-19 infection.
    J Infect. 2020 Sep 3. pii: S0163-4453(20)30586.
    >> Share

  518. CHEN HJ, Lin HJ, Wu MC, Tang HJ, et al
    The implementation of an active surveillance integrating information technology and drive-through coronavirus testing station for suspected COVID-19 cases.
    J Infect. 2020 Sep 2. pii: S0163-4453(20)30585.
    >> Share

  519. BARNETT WR, Radhakrishnan M, Macko J, Hinch BT, et al
    Initial MEWS score to predict ICU admission or transfer of hospitalized patients with COVID-19: A retrospective study.
    J Infect. 2020 Sep 2. pii: S0163-4453(20)30583.
    >> Share

  520. MIRZA FN, Malik AA, Couzens C, Omer SB, et al
    Influenza-Negative Influenza-Like Illness (fnILI) Z-Score as a Proxy for Incidence and Mortality of COVID-19.
    J Infect. 2020 Sep 1. pii: S0163-4453(20)30581.
    >> Share

  521. KEVORKIAN JP, Riveline JP, Vandiedonck C, Girard D, et al
    Early short-course corticosteroids and furosemide combination to treat non-critically ill COVID-19 patients: An observational cohort study.
    J Infect. 2020 Sep 1. pii: S0163-4453(20)30579.
    >> Share

    August 2020
  522. AXELL-HOUSE DB, Lavingia R, Rafferty M, Clark E, et al
    The Estimation of Diagnostic Accuracy of Tests for COVID-19: A Scoping Review.
    J Infect. 2020 Aug 31. pii: S0163-4453(20)30577.
    >> Share

  523. YANYAN, Jiang X, Wang X, Liu B, et al
    CCL28 mucosal expression in SARS-CoV-2-infected patients with diarrhea in relation to disease severity.
    J Infect. 2020 Aug 29. pii: S0163-4453(20)30576.
    >> Share

  524. GRALL I, Alloui CA, Tandjaoui-Lambiotte Y, Deslandes A, et al
    Viral spreading in asymptomatic cases with SARS-CoV-2 infections: a Pilot study.
    J Infect. 2020 Aug 29. pii: S0163-4453(20)30578.
    >> Share

  525. KANAMORI H
    Rethinking environmental contamination and fomite transmission of SARS-CoV-2 in the healthcare.
    J Infect. 2020 Aug 27. pii: S0163-4453(20)30575.
    >> Share

  526. NSN G, C J, R M, P R, et al
    High rates of SARS-CoV-2 seropositivity in nursing home residents.
    J Infect. 2020 Aug 26. pii: S0163-4453(20)30574.
    >> Share

  527. DE LUSIGNAN S, Joy M, Oke J, McGagh D, et al
    Disparities in the excess risk of mortality in the first wave of COVID-19: cross sectional study of the English sentinel network.
    J Infect. 2020 Aug 25. pii: S0163-4453(20)30564.
    >> Share

  528. LEI H, Xu X, Xiao S, Wu X, et al
    Household transmission of COVID-19-a systematic review and meta-analysis.
    J Infect. 2020 Aug 25. pii: S0163-4453(20)30571.
    >> Share

  529. LANDI F, Gremese E, Rota E, Carfi' A, et al
    Positive RT-PCR nasopharyngeal swab in patients recovered from COVID-19 disease: When does quarantine really end?
    J Infect. 2020 Aug 24. pii: S0163-4453(20)30565.
    >> Share

  530. GARRIGUES E, Janvier P, Kherabi Y, Bot AL, et al
    Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19.
    J Infect. 2020 Aug 24. pii: S0163-4453(20)30562.
    >> Share

  531. VALDIVIA A, Torres I, Huntley D, Alcaraz MJ, et al
    Diagnostic significance of SARS-CoV-2 IgM positive/IgG negative antibody profile in symptomatic patients with suspected COVID-19 testing negative by RT-PCR.
    J Infect. 2020 Aug 24. pii: S0163-4453(20)30568.
    >> Share

  532. KORTE W, Buljan M, Rosslein M, Wick P, et al
    SARS-CoV-2 IgG and IgA antibody response is gender dependent; and IgG antibodies rapidly decline early on.
    J Infect. 2020 Aug 24. pii: S0163-4453(20)30567.
    >> Share

  533. ARSHAD Y, Mahmood N, Zaidi SSZ, Sharif S, et al
    Detection of SARS-CoV-2 in ophthalmic secretions in Pakistan: A preliminary report.
    J Infect. 2020 Aug 24. pii: S0163-4453(20)30569.
    >> Share

  534. YAN Y, Liu B, Ding H, Wang X, et al
    Characterizing COVID-19 severity, epidemiology and SARS-CoV-2 genotypes in a regional business hub of China.
    J Infect. 2020 Aug 24. pii: S0163-4453(20)30566.
    >> Share

  535. KROEMER M, Spehner L, Vettoretti L, Bouard A, et al
    COVID-19 patients display distinct SARS-CoV-2 specific T-cell responses according to disease severity.
    J Infect. 2020 Aug 24. pii: S0163-4453(20)30563.
    >> Share

  536. HE L, Zeng Y, Zeng C, Zhou Y, et al
    Positive Rate of Serology and RT-PCR for COVID-19 among Healthcare Workers during Different Periods in Wuhan, China.
    J Infect. 2020 Aug 24. pii: S0163-4453(20)30561.
    >> Share

  537. GROSSI E, Terruzzi V
    Exceptionally high COVID-19 viral load and very long duration of shedding in a young pauci-symptomatic child with autism resident in an Italian nursing home.
    J Infect. 2020 Aug 22. pii: S0163-4453(20)30560.
    >> Share

  538. LI Z, Xu H, Chen J, Pang Z, et al
    Internet-based remote consultation facilitates the medical care of patients with chronic skin diseases during COVID-19 pandemic.
    J Infect. 2020 Aug 21. pii: S0163-4453(20)30559.
    >> Share

  539. GU J, Gu M, Yan Y, Liu K, et al
    Detection of PB2 627K mutation in two highly pathogenic isolates of the H7N9 subtype influenza A virus from chickens in northern China.
    J Infect. 2020 Aug 20. pii: S0163-4453(20)30558.
    >> Share


  540. Clinical characteristics and outcome of COVID-19 pneumonia in elderly subjects.
    J Infect. 2020 Aug 19. pii: S0163-4453(20)30557.
    >> Share

  541. NAKAJIMA K, Abe T, Saji R, Ogawa F, et al
    Serum cholinesterase associated with COVID-19 pneumonia severity and mortality.
    J Infect. 2020 Aug 19. pii: S0163-4453(20)30555.
    >> Share

  542. BONGIOVANNI M, Vignati M, Giuliani G, Manes G, et al
    The dilemma of COVID-19 recurrence after clinical recovery.
    J Infect. 2020 Aug 15. pii: S0163-4453(20)30553.
    >> Share

  543. LIM RH, Chow A, Ho HJ
    Decline in pneumococcal disease incidence in the time of COVID-19 in Singapore.
    J Infect. 2020 Aug 15. pii: S0163-4453(20)30554.
    >> Share

  544. KELLENI MT
    SARS CoV-2 viral load might not be the right predictor of COVID-19 mortality.
    J Infect. 2020 Aug 15. pii: S0163-4453(20)30552.
    >> Share

  545. FAURY H, Courboules C, Payen M, Jary A, et al
    Medical Features of COVID-19 and Influenza Infection: A Comparative Study in Paris, France.
    J Infect. 2020 Aug 13. pii: S0163-4453(20)30551.
    >> Share

  546. JIANG W, Li Z, Liu S, Li J, et al
    Genetic characterization of a highly pathogenic H5N6 avian influenza virus isolated from greylag goose.
    J Infect. 2020 Aug 12. pii: S0163-4453(20)30550.
    >> Share

  547. YUAN Y, Liu D, Zeng S, Wang S, et al
    In-hospital Use of ACEI/ARB is associated with lower Risk of Mortality and Critic Illness in COVID-19 Patients with Hypertension: ACEI/ARB protect COVID-19 patients.
    J Infect. 2020 Aug 12. pii: S0163-4453(20)30548.
    >> Share

  548. SADDIQUE A, Rana MS, Alam MM, Ikram A, et al
    "Emergence of co-infection of COVID-19 and dengue: A serious public health threat ".
    J Infect. 2020 Aug 12. pii: S0163-4453(20)30545.
    >> Share

  549. TOMASSINI S, Kotecha D, Bird PW, Folwell A, et al
    Setting the criteria for SARS-CoV-2 reinfection - six possible cases.
    J Infect. 2020 Aug 12. pii: S0163-4453(20)30546.
    >> Share


  550. Previous cardiovascular surgery significantly increases the risk of developing critical illness in patients with COVID-19.
    J Infect. 2020 Aug 12. pii: S0163-4453(20)30544.
    >> Share

  551. KINOSHITA M, Tanaka M
    Impact of routine infant BCG vaccination in young generation on prevention of local COVID-19 spread in Japan.
    J Infect. 2020 Aug 11. pii: S0163-4453(20)30547.
    >> Share

  552. LUIS GARCIA DE GUADIANAROMUALD, Mulero MDR, Olivo MH, Rojas CR, et al
    Circulating levels of GDF-15 and calprotectin for prediction of in-hospital mortality in COVID-19 patients: a case series.
    J Infect. 2020 Aug 11. pii: S0163-4453(20)30543.
    >> Share

  553. DAI CY, Dai TH, Ho HY, Ho CK, et al
    The strategies for the Coronavirus Disease 2019 (COVID-19) in Taiwan: A different tale.
    J Infect. 2020 Aug 10. pii: S0163-4453(20)30542.
    >> Share

  554. KIM YJ, Jeong YJ, Kim SH, Oh AR, et al
    Preparing for long-term non-face-to-face outpatient care services during the COVID-19 pandemic.
    J Infect. 2020 Aug 7. pii: S0163-4453(20)30540.
    >> Share

  555. AL-HATMI AMS, Mohsin J, Al-Huraizi A, Khamis F, et al
    COVID-19 associated invasive candidiasis.
    J Infect. 2020 Aug 6. pii: S0163-4453(20)30539.
    >> Share

  556. HAN J, Gong H, Fu L, Chen P, et al
    Clinical and CT imaging features of SARS-CoV-2 patients presented with diarrhea.
    J Infect. 2020 Aug 5. pii: S0163-4453(20)30536.
    >> Share

  557. BIRGAND G, Blanckaert K, Deschanvres C, Vaudron A, et al
    Testing strategies for the control of COVID-19 in nursing homes: Universal or targeted screening?
    J Infect. 2020 Aug 5. pii: S0163-4453(20)30535.
    >> Share

  558. BOGLIONE L, Rostagno R, Poletti F, Moglia R, et al
    The proper use of corticosteroids for 2019-nCov pneumonia: towards promising results?
    J Infect. 2020 Aug 4. pii: S0163-4453(20)30534.
    >> Share

  559. LUI G, Ling L, Lai CK, Tso EY, et al
    Viral dynamics of SARS-CoV-2 across a spectrum of disease severity in COVID-19.
    J Infect. 2020;81:318-356.
    >> Share

  560. LUAN J, Lu Y, Gao S, Zhang L, et al
    A potential inhibitory role for integrin in the receptor targeting of SARS-CoV-2.
    J Infect. 2020;81:318-356.
    >> Share

  561. LIU Z, Long W, Tu M, Chen S, et al
    Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19.
    J Infect. 2020;81:318-356.
    >> Share

  562. XIE Y, Cao S, Dong H, Li Q, et al
    Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19.
    J Infect. 2020;81:318-356.
    >> Share

  563. FRONTERA A, Martin C, Vlachos K, Sgubin G, et al
    Regional air pollution persistence links to COVID-19 infection zoning.
    J Infect. 2020;81:318-356.
    >> Share

  564. XING Y, Ni W, Wu Q, Li W, et al
    Dynamics of faecal SARS-CoV-2 in infected children during the convalescent phase.
    J Infect. 2020;81:318-356.
    >> Share

  565. ZHANG Z, Shen Y, Wang H, Zhao L, et al
    High-resolution computed tomographic imaging disclosing COVID-19 pneumonia: A powerful tool in diagnosis.
    J Infect. 2020;81:318-356.
    >> Share

  566. LIU WD, Chang SY, Wang JT, Tsai MJ, et al
    Prolonged virus shedding even after seroconversion in a patient with COVID-19.
    J Infect. 2020;81:318-356.
    >> Share

  567. WANG L, Chen H, Qiu S, Song H, et al
    Evaluation of control measures for COVID-19 in Wuhan, China.
    J Infect. 2020;81:318-356.
    >> Share

  568. XIE H, Ying H
    Is the conclusion available? Letter to the Editor concerning the study of Prof. Jin titled "Clinical features and outcomes of pregnant women suspected of coronavirus disease 2019".
    J Infect. 2020;81:e130-e131.
    >> Share

  569. WANG Y, Chow A
    Dancing with COVID-19 after the Hammer is Lifted: Enhancing Healthcare Worker Surveillance.
    J Infect. 2020 Aug 1. pii: S0163-4453(20)30533.
    >> Share

  570. GLATMAN-FREEDMAN A, Kaufman Z, Applbaum Y, Dichtiar R, et al
    Respiratory Syncytial Virus hospitalization burden: a nation-wide population-based analysis, 2000-2017.
    J Infect. 2020;81:297-303.
    >> Share

  571. ELKINGTON P, Morgan H
    Personal respirators for population level control of the COVID19 pandemic.
    J Infect. 2020;81:318-356.
    >> Share

    July 2020
  572. HUANG L, Zhai T, Hua L, Zhan Q, et al
    Early Identification of Patients with Severe Influenza-Associated Aspergillosis (IAA) in the Intensive Care Unit--An IAA Prediction Score System (Asper-PreSS).
    J Infect. 2020 Jul 30. pii: S0163-4453(20)30516.
    >> Share

  573. DE ABREU MC
    SARS-CoV-2 IgM and IgG rapid serologic test for the diagnosis of COVID-19 in the emergency department.
    J Infect. 2020 Jul 30. pii: S0163-4453(20)30513.
    >> Share

  574. CHETRIT A, Lechien JR, Ammar A, Chekkoury-Idrissi Y, et al
    Magnetic Resonance Imaging of COVID-19 Anosmic Patients Reveals Abnormalities of the Olfactory Bulb: Preliminary Prospective Study.
    J Infect. 2020 Jul 30. pii: S0163-4453(20)30509.
    >> Share

  575. HAMILTON F, Muir P, Attwood M, Vipond ANB, et al
    Kinetics and performance of the Abbott Architect SARS-CoV-2 IgG antibody assay.
    J Infect. 2020 Jul 30. pii: S0163-4453(20)30510.
    >> Share

  576. PALLETT SJC, Jones R, Pallett MA, Rayment M, et al
    Characterising differential antibody response is integral to future SARS-CoV-2 serostudies.
    J Infect. 2020 Jul 30. pii: S0163-4453(20)30511.
    >> Share

  577. BLAIRON L, Mokrane S, Wilmet A, Dessilly G, et al
    Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak.
    J Infect. 2020 Jul 30. pii: S0163-4453(20)30514.
    >> Share

  578. LADHANI SN, Chow JY, Janarthanan R, Fok J, et al
    INCREASED RISK OF SARS-CoV-2 INFECTION IN STAFF WORKING ACROSS DIFFERENT CARE HOMES ENCHANCED CoVID-19 OUTBREAK INVESTIGATIONS IN LONDON CARE HOMES.
    J Infect. 2020 Jul 28. pii: S0163-4453(20)30508.
    >> Share

  579. LU QB, Jiang WL, Zhang X, Li HJ, et al
    Comorbidities for fatal outcome among the COVID-19 patients: a hospital-based case-control study.
    J Infect. 2020 Jul 27. pii: S0163-4453(20)30507.
    >> Share

  580. WU J, Xie X, Yang L, Xu X, et al
    Mobile health technology combats Covid-19 in China.
    J Infect. 2020 Jul 27. pii: S0163-4453(20)30505.
    >> Share

  581. TU D, Shu J, Wu X, Li H, et al
    Immunological detection of serum antibodies in pediatric medical workers exposed to varying levels of SARS-CoV-2.
    J Infect. 2020 Jul 25. pii: S0163-4453(20)30504.
    >> Share

  582. BARNACLE JR, Cairney G, Rainsley J, Mercuri L, et al
    Changes in the hospital admission profile of COVID-19 positive patients at a central London trust.
    J Infect. 2020 Jul 23. pii: S0163-4453(20)30501.
    >> Share

  583. GIL E, Weller S, Rokadiya S, Mirfenderesky M, et al
    Letter in Response to 'Modelling SARS-COV2 Spread in London: Approaches to Lift the Lockdown' Local Experience, National Questions. How Local is Local Enough?
    J Infect. 2020 Jul 23. pii: S0163-4453(20)30492.
    >> Share

  584. NYAZIKA TK, Law A, Swarthout TD, Sibale L, et al
    Influenza-like illness is associated with high pneumococcal carriage density in Malawian children.
    J Infect. 2020 Jul 22. pii: S0163-4453(20)30495.
    >> Share

  585. BI J, Lin Y, Zhong R, Jiang G, et al
    Prevalence and Clinical Characterization of Cancer Patients with Asymptomatic SARS-CoV-2 Infection History.
    J Infect. 2020 Jul 22. pii: S0163-4453(20)30493.
    >> Share

  586. VILLAR LM, da Costa VD, Marques BL, da Silva LL, et al
    USEFULNESS OF SALIVA SAMPLES FOR DETECTING SARS-CoV-2 RNA AMONG LIVER DISEASE PATIENTS.
    J Infect. 2020 Jul 22. pii: S0163-4453(20)30491.
    >> Share

  587. SHUAI H, Chu H, Hou Y, Yang D, et al
    Differential immune activation profile of SARS-CoV-2 and SARS-CoV infection in human lung and intestinal cells: implications for treatment with IFN-beta and IFN inducer.
    J Infect. 2020 Jul 21. pii: S0163-4453(20)30490.
    >> Share

  588. FODJO JNS, Pengpid S, Villela EFM, Van TV, et al
    Mass masking as a way to contain COVID-19 and exit lockdown in low- and middle-income countries.
    J Infect. 2020 Jul 16. pii: S0163-4453(20)30489.
    >> Share

  589. LIU Q, Chen H, Zeng Q
    Clinical characteristics of COVID-19 patients with complication of cardiac arrhythmia.
    J Infect. 2020 Jul 11. pii: S0163-4453(20)30470.
    >> Share


  590. Fasting blood glucose predicts the occurrence of critical illness in COVID-19 patients: a multicenter retrospective cohort study.
    J Infect. 2020 Jul 8. pii: S0163-4453(20)30464.
    >> Share

  591. ROKADIYA S, Gil E, Stubbs C, Bell D, et al
    COVID-19: Outcomes of patients with confirmed COVID-19 re-admitted to hospital.
    J Infect. 2020 Jul 8. pii: S0163-4453(20)30466.
    >> Share

  592. ZHA L, Shen J, Tefsen B, Wang Y, et al
    Clinical features and outcomes of adult COVID-19 patients co-infected with Mycoplasma pneumoniae.
    J Infect. 2020 Jul 8. pii: S0163-4453(20)30468.
    >> Share

  593. GROSSI E, Costantino L, Ferrara F, Terruzzi V, et al
    Oscillation of SARS CoV-2 RNA load in a cohort of children and adolescents with neuro-psychiatric disorders resident in a nursing home of Lombardy Region (Italy).
    J Infect. 2020 Jul 8. pii: S0163-4453(20)30469.
    >> Share

  594. RAN J, Zhao S, Han L, Chen D, et al
    The Ambient Ozone and COVID-19 Transmissibility in China: A Data-Driven Ecological Study of 154 Cities.
    J Infect. 2020 Jul 8. pii: S0163-4453(20)30465.
    >> Share

  595. ROSSOTTI R, Travi G, Ughi N, Corradin M, et al
    SAFETY AND EFFICACY OF ANTI-IL6-RECEPTOR TOCILIZUMAB USE IN SEVERE AND CRITICAL PATIENTS AFFECTED BY CORONAVIRUS DISEASE 2019: A COMPARATIVE ANALYSIS.
    J Infect. 2020 Jul 8. pii: S0163-4453(20)30467.
    >> Share

  596. KOMIYA K, Yamasue M, Takahashi O, Hiramatsu K, et al
    The COVID-19 pandemic and the true incidence of tuberculosis in Japan.
    J Infect. 2020 Jul 7. pii: S0163-4453(20)30462.
    >> Share

  597. SALMON D, Bartier S, Hautefort C, Nguyen Y, et al
    Self-reported loss of smell without nasal obstruction to identify COVID-19. The multicenter CORANOSMIA cohort study.
    J Infect. 2020 Jul 7. pii: S0163-4453(20)30463.
    >> Share

  598. LU L, Zhong W, Bian Z, Li Z, et al
    A Comparison of Mortality-related Risk Factors of COVID-19, SARS, and MERS: A Systematic Review and Meta-analysis.
    J Infect. 2020 Jul 4. pii: S0163-4453(20)30460.
    >> Share

  599. ARRIOLA-VILLALOBOS P, Fernandez-Perez C, Arino-Gutierrez M, Fernandez-Vigo JI, et al
    Letter in Response to Article in Journal of Infection: "High SARS-CoV-2 antibody prevalence among healthcare workers exposed to COVID-19 patients".
    J Infect. 2020 Jul 3. pii: S0163-4453(20)30459.
    >> Share

  600. CHANG CY, Chan KG
    Underestimation of co-infections in COVID-19 due to non-discriminatory use of antibiotics.
    J Infect. 2020 Jul 3. pii: S0163-4453(20)30458.
    >> Share

  601. YIN S, Tong X, Huang A, Shen H, et al
    Longitudinal anti-SARS-CoV-2 antibody profile and neutralization activity of a COVID-19 patient.
    J Infect. 2020 Jul 2. pii: S0163-4453(20)30457.
    >> Share

  602. HUANG W, Lin D, Wang C, Bao C, et al
    The determination of release from isolation of COVID-19 patients requires ultra-high sensitivity nucleic acid test technology.
    J Infect. 2020 Jul 2. pii: S0163-4453(20)30456.
    >> Share

  603. XU B, Fan CY, Wang AL, Zou YL, et al
    Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China.
    J Infect. 2020;81:e51-e60.
    >> Share

  604. TU H, Tu S, Gao S, Shao A, et al
    Current epidemiological and clinical features of COVID-19; a global perspective from China.
    J Infect. 2020;81:1-9.
    >> Share

  605. LIU Y, Du X, Chen J, Jin Y, et al
    Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19.
    J Infect. 2020;81:e6-e12.
    >> Share

  606. DU X, Yu X, Li Q, Li X, et al
    Duration for carrying SARS-CoV-2 in COVID-19 patients.
    J Infect. 2020;81:e78-e79.
    >> Share

  607. HE M, Xiong J, Huang S, Bian Y, et al
    Airborne precautions recommended in Wuhan, China for bedside fiberoptic bronchoscopy examination of patients with COVID-19.
    J Infect. 2020;81:e75-e77.
    >> Share

  608. ZUIN M, Rigatelli G, Zuliani G, Rigatelli A, et al
    Arterial hypertension and risk of death in patients with COVID-19 infection: Systematic review and meta-analysis.
    J Infect. 2020;81:e84-e86.
    >> Share

  609. FANG X, Mei Q, Yang T, Li L, et al
    Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19.
    J Infect. 2020;81:147-178.
    >> Share

  610. BENVENUTO D, Angeletti S, Giovanetti M, Bianchi M, et al
    Evolutionary analysis of SARS-CoV-2: how mutation of Non-Structural Protein 6 (NSP6) could affect viral autophagy.
    J Infect. 2020;81:e24-e27.
    >> Share

  611. YANG Z, Liu J, Zhou Y, Zhao X, et al
    The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis.
    J Infect. 2020;81:e13-e20.
    >> Share

  612. ZHU Z, Lu Z, Xu T, Chen C, et al
    Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19.
    J Infect. 2020;81:e21-e23.
    >> Share

  613. LU Y, Zhang L
    Social media WeChat infers the development trend of COVID-19.
    J Infect. 2020;81:e82-e83.
    >> Share

  614. PAN Y, Li X, Yang G, Fan J, et al
    Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients.
    J Infect. 2020;81:e28-e32.
    >> Share

  615. ZENG Z, Chen L, Pan Y, Deng Q, et al
    Re: Profile of specific antibodies to SARS-CoV-2: The first report.
    J Infect. 2020;81:e80-e81.
    >> Share

  616. WANG Z, Ma W, Zheng X, Wu G, et al
    Household transmission of SARS-CoV-2.
    J Infect. 2020;81:179-182.
    >> Share

  617. LIU L, Quan J, Lv J, Long S, et al
    A cluster of pneumonia associated with the SARS-Cov-2 outside of Wuhan related to a house-warming banquet.
    J Infect. 2020;81:147-178.
    >> Share

  618. SHEN L, Li S, Zhu Y, Zhao J, et al
    Clinical and laboratory-derived parameters of 119 hospitalized patients with coronavirus disease 2019 in Xiangyang, Hubei Province, China.
    J Infect. 2020;81:147-178.
    >> Share

  619. ZHOU J, Tan Y, Li D, He X, et al
    Observation and analysis of 26 cases of asymptomatic SARS-COV2 infection.
    J Infect. 2020;81:e69-e70.
    >> Share

    June 2020
  620. LIM KH, Yang S, Kim SH, Joo JY, et al
    Elevation of ACE2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer's disease.
    J Infect. 2020 Jun 30. pii: S0163-4453(20)30453.
    >> Share

  621. BATISSE D, Benech N, Botelho-Nevers E, Bouiller K, et al
    Clinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound?
    J Infect. 2020 Jun 30. pii: S0163-4453(20)30454.
    >> Share

  622. GIANNIS D, Ziogas IA
    Letter in response to article in journal of infection: "Cardiovascular complications in COVID-19: A systematic review and meta-analysis".
    J Infect. 2020 Jun 30. pii: S0163-4453(20)30455.
    >> Share

  623. VRSALOVIC M, Presecki AV
    Cardiac injury and mortality in COVID-19: a reappraisal.
    J Infect. 2020 Jun 29. pii: S0163-4453(20)30447.
    >> Share

  624. WALSH KA, Jordan K, Clyne B, Rohde D, et al
    SARS-CoV-2 Detection, Viral Load and Infectivity over the Course of an Infection: SARS-CoV-2 Detection, Viral Load and Infectivity.
    J Infect. 2020 Jun 29. pii: S0163-4453(20)30449.
    >> Share

  625. BROWN C, Clare K, Chand M, Andrews J, et al
    Snapshot PCR Surveillance for SARS-CoV-2 in Hospital Staff in England.
    J Infect. 2020 Jun 29. pii: S0163-4453(20)30450.
    >> Share

  626. KUMAR DR, Bhattacharya DB, Meena DV, Soneja DM, et al
    COVID-19 and TB co-infection - 'Finishing touch'' in perfect recipe to 'severity' or 'death'.
    J Infect. 2020 Jun 28. pii: S0163-4453(20)30443.
    >> Share

  627. PIASERICO S, Meneguzzo A, Messina F
    REPLY TO: Interleukin-17: a potential therapeutic target in COVID-19.
    J Infect. 2020 Jun 28. pii: S0163-4453(20)30444.
    >> Share

  628. PRAZUCK T, Giache S, Gubavu C, Colin M, et al
    Investigation of a family outbreak of COVID-19 using systematic rapid diagnostic tests raises new questions about transmission.
    J Infect. 2020 Jun 28. pii: S0163-4453(20)30448.
    >> Share

  629. T U, Jc H, Ar H, Ke M, et al
    Distinct and early increase in circulating MMP-9 in COVID-19 patients with respiratory failure.
    J Infect. 2020 Jun 27. pii: S0163-4453(20)30442.
    >> Share

  630. YOUNGS J, Wyncoll D, Hopkins P, Arnold A, et al
    Improving antibiotic stewardship in COVID-19: bacterial co-infection is less common than with influenza.
    J Infect. 2020 Jun 25. pii: S0163-4453(20)30436.
    >> Share

  631. ZHU J, Guo J, Xu Y, Chen X, et al
    Viral dynamics of SARS-CoV-2 in saliva from infected patients.
    J Infect. 2020 Jun 25. pii: S0163-4453(20)30440.
    >> Share

  632. DE DEYN MLZQ, Ng QX, Loke W, Yeo WS, et al
    A tale of two cities: a comparison of Hong Kong and Singapore's early strategies for the Coronavirus Disease 2019 (COVID-19).
    J Infect. 2020 Jun 25. pii: S0163-4453(20)30439.
    >> Share

  633. MOYNAN D, Cagney M, Dhuthaigh AN, Foley M, et al
    The role of healthcare staff COVID-19 screening in infection prevention & control.
    J Infect. 2020 Jun 25. pii: S0163-4453(20)30438.
    >> Share

  634. LIANG X, Shi L, Wang Y, Xiao W, et al
    The association of hypertension with the severity and mortality of COVID-19 patients: evidence based on adjusted effect estimates.
    J Infect. 2020 Jun 25. pii: S0163-4453(20)30441.
    >> Share

  635. OTTE MS, Klussmann JP, Luers JC
    Persisting olfactory dysfunction in patients after recovering from COVID-19.
    J Infect. 2020 Jun 24. pii: S0163-4453(20)30435.
    >> Share

  636. LIN Z, Long F, Yang Y, Chen X, et al
    Serum ferritin as an independent risk factor for severity in COVID-19 patients.
    J Infect. 2020 Jun 24. pii: S0163-4453(20)30434.
    >> Share

  637. BOUZA E, Perez-Granda MJ, Escribano P, Fernandez-Del Rey R, et al
    OUTBREAK OF COVID-19 IN A NURSING HOME IN MADRID.
    J Infect. 2020 Jun 24. pii: S0163-4453(20)30437.
    >> Share

  638. CANTINI F, Niccoli L, Nannini C, Matarrese D, et al
    Retrospective, multicenter study on the impact of baricitinib in COVID-19 moderate pneumonia.
    J Infect. 2020 Jun 24. pii: S0163-4453(20)30433.
    >> Share

  639. SKEVAKI C, Fragkou PC, Cheng C, Xie M, et al
    Laboratory characteristics of patients infected with the novel SARS-CoV-2 virus.
    J Infect. 2020 Jun 21. pii: S0163-4453(20)30420.
    >> Share

  640. JARY A, Flandre P, Chabouis A, Nguyen S, et al
    Clinical presentation of Covid-19 in health care workers from a French University Hospital.
    J Infect. 2020 Jun 21. pii: S0163-4453(20)30424.
    >> Share

  641. FAN J, Li X, Gao Y, Zhou J, et al
    The Lung Tissue Microbiota Features of 20 Deceased Patients with COVID-19.
    J Infect. 2020 Jun 21. pii: S0163-4453(20)30429.
    >> Share

  642. FIORE A, de Roux Q, Daami N, Clariot S, et al
    Clinical feedback from experience with COVID-19: specific considerations for ExtraCorporeal Membrane Oxygenation.
    J Infect. 2020 Jun 21. pii: S0163-4453(20)30431.
    >> Share

  643. AZZI L, Baj A, Alberio T, Lualdi M, et al
    RAPID SALIVARY TEST SUITABLE FOR A MASS SCREENING PROGRAM TO DETECT SARS-COV-2: A DIAGNOSTIC ACCURACY STUDY.
    J Infect. 2020 Jun 21. pii: S0163-4453(20)30423.
    >> Share

  644. M MB, L B, I A, P D, et al
    Etoposide treatment adjunctive to immunosuppressants for critically ill COVID-19 patients: Etoposide for severe COVID-19 patients.
    J Infect. 2020 Jun 21. pii: S0163-4453(20)30386.
    >> Share

  645. KUNUTSOR SK, Laukkanen JA
    Hepatic manifestations and complications of COVID-19: A systematic review and meta-analysis.
    J Infect. 2020 Jun 21. pii: S0163-4453(20)30425.
    >> Share

  646. CHEN J, Huang C, Zhang Y, Zhang S, et al
    Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibodies in Pets in Wuhan, China.
    J Infect. 2020 Jun 21. pii: S0163-4453(20)30427.
    >> Share

  647. WONG M, Huang J, Teoh J, Wong S, et al
    Evaluation on different non-pharmaceutical interventions during COVID-19 pandemic: an analysis of 139 countries.
    J Infect. 2020 Jun 21. pii: S0163-4453(20)30426.
    >> Share

  648. DAUNT A, Perez-Guzman PN, Liew F, Hauck K, et al
    Validity of the UK Early Access to Medicines Scheme Criteria for Remdesivir use in patients with COVID-19 disease.
    J Infect. 2020 Jun 21. pii: S0163-4453(20)30430.
    >> Share

  649. CLARK TW, Brendish NJ, Poole S, Naidu VV, et al
    Diagnostic accuracy of the FebriDx host response point-of-care test in patients hospitalised with suspected COVID-19.
    J Infect. 2020 Jun 21. pii: S0163-4453(20)30432.
    >> Share

  650. HATTORI T, Amishima M, Morinaga D, Kamada K, et al
    Older age is associated with sustained detection of SARS-CoV-2 in nasopharyngeal swab samples.
    J Infect. 2020 Jun 21. pii: S0163-4453(20)30428.
    >> Share

  651. CENTO V, Colagrossi L, Nava A, Lamberti A, et al
    Persistent positivity and fluctuations of SARS-CoV-2 RNA in clinically-recovered COVID-19 patients.
    J Infect. 2020 Jun 20. pii: S0163-4453(20)30405.
    >> Share

  652. ZHANG H, Wu T
    CD4+T, CD8+T counts and severe COVID-19: A meta-analysis.
    J Infect. 2020 Jun 19. pii: S0163-4453(20)30417.
    >> Share

  653. MCDEVITT KEM, Ganjoo N, Mlangeni D, Pathak S, et al
    Outcome of Universal screening of asymptomatic neonates for COVID-19 from asymptomatic mothers.
    J Infect. 2020 Jun 18. pii: S0163-4453(20)30418.
    >> Share

  654. VAN TAN L, Hong NTT, Ngoc NM, Thanh TT, et al
    SARS-CoV-2 and co-infections detection in nasopharyngeal throat swabs of COVID-19 patients by metagenomics.
    J Infect. 2020 Jun 17. pii: S0163-4453(20)30410.
    >> Share

  655. LIU F, Long X, Ji G, Zhang B, et al
    Clinically significant portal hypertension in cirrhosis patients with COVID-19: clinical characteristics and outcomes.
    J Infect. 2020 Jun 17. pii: S0163-4453(20)30409.
    >> Share

  656. KOLLIAS A, Kyriakoulis KG, Destounis A, Stergiou GS, et al
    Letter to the EditorCARDIAC INJURY AND PROGNOSIS IN COVID-19: METHODOLOGICAL CONSIDERATIONS AND UPDATED META-ANALYSIS.
    J Infect. 2020 Jun 17. pii: S0163-4453(20)30413.
    >> Share

  657. KHALIL K, Agbontaen K, McNally D, Love A, et al
    Clinical Characteristics and 28-Day Mortality of Medical Patients Admitted with COVID-19 to a Central London Teaching Hospital.
    J Infect. 2020 Jun 17. pii: S0163-4453(20)30408.
    >> Share

  658. BIRD P, Badhwar V, Fallon K, Kwok KO, et al
    High SARS-CoV-2 infection rates in respiratory staff nurses and correlation of COVID-19 symptom patterns with PCR positivity and relative viral loads.
    J Infect. 2020 Jun 17. pii: S0163-4453(20)30415.
    >> Share

  659. CHEN F, Fu D, Yang Q, Geng Z, et al
    Low Transmission Risk of 9 Asymptomatic Carriers Tested Positive for both SARS-CoV-2 Nucleic Acid and Serum IgG.
    J Infect. 2020 Jun 17. pii: S0163-4453(20)30416.
    >> Share

  660. KRUPP KF, Madhivanan P, Perez-Velez CM
    Should qualitative RT-PCR be used to determine release from isolation of COVID-19 patients?
    J Infect. 2020 Jun 17. pii: S0163-4453(20)30411.
    >> Share

  661. WU JL, Tseng WP, Lin CH, Lee TF, et al
    Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2.
    J Infect. 2020 Jun 15. pii: S0163-4453(20)30404.
    >> Share

  662. TOMB RM, MacLean DAR, Gunson PRN
    Retrospective screening for SARS-CoV-2 in Greater Glasgow and Clyde ICUs between December 2019 and February 2020.
    J Infect. 2020 Jun 15. pii: S0163-4453(20)30403.
    >> Share

  663. MARKO C, Andro K, Danijela C
    Math and aftermath of COVID-19 pandemic and its interrelationship from the resilience perspective.
    J Infect. 2020 Jun 13. pii: S0163-4453(20)30401.
    >> Share

  664. JUNG J, Kim JY, Bae S, Cha HH, et al
    Contamination of personal protective equipment by SARS-CoV-2 during routine care of patients with mild COVID-19.
    J Infect. 2020 Jun 12. pii: S0163-4453(20)30402.
    >> Share

  665. YU J, Yang Z, Zhou X, Wu D, et al
    Prognostic value of Carcinoembryonic antigen on outcome in patients with Coronavirus disease 2019.
    J Infect. 2020 Jun 12. pii: S0163-4453(20)30399.
    >> Share

  666. DARAEI H, Toolabian K, Kazempour M, Javanbakht M, et al
    The role of the environment and its pollution in the prevalence of COVID-19.
    J Infect. 2020 Jun 12. pii: S0163-4453(20)30400.
    >> Share

  667. THIJSEN S, Heron M, Gremmels H, van der Kieft R, et al
    Elevated nucleoprotein-induced interferon-gamma release in COVID-19 patients detected in a SARS-CoV-2 enzyme-linked immunosorbent spot assay.
    J Infect. 2020 Jun 12. pii: S0163-4453(20)30395.
    >> Share

  668. WONG MC, Huang J, Lai C, Ng R, et al
    Detection of SARS-CoV-2 RNA in fecal specimens of patients with confirmed COVID-19: a meta-analysis.
    J Infect. 2020 Jun 11. pii: S0163-4453(20)30394.
    >> Share

  669. GALLO O, Giovanni LL, Orlando P, Martelli F, et al
    "Is really the cancer population at risk for more severe COVID-19? Some hints from the cytokine profile".
    J Infect. 2020 Jun 10. pii: S0163-4453(20)30392.
    >> Share

  670. ROSAKIS P, Marketou ME
    Rethinking case fatality ratios for covid-19 from a data-driven viewpoint.
    J Infect. 2020 Jun 10. pii: S0163-4453(20)30391.
    >> Share

  671. LAI CC, Yu WL
    The COVID-19 Pandemic and Tuberculosis in Taiwan.
    J Infect. 2020 Jun 10. pii: S0163-4453(20)30397.
    >> Share

  672. GRIFONI E, Valoriani A, Cei F, Lamanna R, et al
    Interleukin-6 as prognosticator in patients with COVID-19: IL-6 and Covid-19.
    J Infect. 2020 Jun 8. pii: S0163-4453(20)30388.
    >> Share

  673. LI G
    Aspartate aminotransferase: a prognostic marker rather than a specific liver injury marker in COVID-19.
    J Infect. 2020 Jun 7. pii: S0163-4453(20)30389.
    >> Share

  674. FURUSE Y, Oshitani H
    Association between Numbers of "Imported Cases" and "Reported Cases in a Source Country" of COVID-19: January to April 2020 in Japan.
    J Infect. 2020 Jun 6. pii: S0163-4453(20)30383.
    >> Share

  675. BUETTI N, Mazzuchelli T, Priore EL, Balmelli C, et al
    Early administered antibiotics do not impact mortality in critically ill patients with COVID-19.
    J Infect. 2020 Jun 5. pii: S0163-4453(20)30381.
    >> Share

  676. YOU J, Zhang L, Ni-Jia-Ti MY, Zhang J, et al
    Anormal pulmonary function and residual CT abnormalities in rehabilitating COVID-19 patients after discharge: a prospective cohort study.
    J Infect. 2020 Jun 5. pii: S0163-4453(20)30382.
    >> Share

  677. IWASAKI S, Fujisawa S, Nakakubo S, Kamada K, et al
    Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva.
    J Infect. 2020 Jun 4. pii: S0163-4453(20)30349.
    >> Share

  678. ZHU C, Liu W, Su H, Li S, et al
    nBreastfeeding Risk from Detectable Severe Acute Respiratory Syndrome Coronavirus 2 in Breastmilk.
    J Infect. 2020 Jun 4. pii: S0163-4453(20)30379.
    >> Share

  679. CHEN Y, Tong X, Wang J, Huang W, et al
    High SARS-CoV-2 antibody prevalence among healthcare workers exposed to COVID-19 patients.
    J Infect. 2020 Jun 4. pii: S0163-4453(20)30344.
    >> Share

  680. ZHAO S, Lou J, Cao L, Chen Z, et al
    Quantifying the importance of the key sites on haemagglutinin in determining the selection advantage of influenza virus: using A/H3N2 as an example.
    J Infect. 2020 Jun 3. pii: S0163-4453(20)30343.
    >> Share

  681. RAZANAMAHERY J, Soumagne T, Humbert S, Brunel AS, et al
    Does type of immunosupression influence the course of Covid-19 infection?
    J Infect. 2020 Jun 3. pii: S0163-4453(20)30351.
    >> Share

  682. MENDOZA VMM
    Interleukin-17: a potential therapeutic target in COVID-19.
    J Infect. 2020 Jun 3. pii: S0163-4453(20)30350.
    >> Share

  683. KUNUTSOR SK, Laukkanen JA
    Cardiovascular complications in COVID-19: A systematic review and meta-analysis.
    J Infect. 2020 Jun 3. pii: S0163-4453(20)30345.
    >> Share

  684. TUAILLON E, Bollore K, Pisoni A, Debiesse S, et al
    Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients.
    J Infect. 2020 Jun 3. pii: S0163-4453(20)30376.
    >> Share

  685. KRATZEL A, Steiner S, Todt D, V'kovski P, et al
    Temperature-dependent surface stability of SARS-CoV-2.
    J Infect. 2020 Jun 3. pii: S0163-4453(20)30352.
    >> Share

  686. GUEMES-VILLAHOZ N, Burgos-Blasco B, Arribi-Vilela A, Arriola-Villalobos P, et al
    SARS-CoV-2 RNA detection in tears and conjunctival secretions of COVID-19 patients with conjunctivitis.
    J Infect. 2020 Jun 3. pii: S0163-4453(20)30346.
    >> Share

  687. GRAHAM N, Junghans C, Downes R, Sendall C, et al
    SARS-CoV-2 infection, clinical features and outcome of COVID-19 in United Kingdom nursing homes.
    J Infect. 2020 Jun 3. pii: S0163-4453(20)30348.
    >> Share

  688. HE B, Zhong A, Wu Q, Liu X, et al
    Tumor biomarkers predict clinical outcome of COVID-19 patients.
    J Infect. 2020 Jun 3. pii: S0163-4453(20)30347.
    >> Share

  689. LIU M, Gao Y, Zhang Y, Shi S, et al
    The association between severe or death COVID-19 and autoimmune disease: a systematic review and meta-analysis.
    J Infect. 2020 Jun 2. pii: S0163-4453(20)30342.
    >> Share

  690. HUANG L, Zhang X, Zhang X, Wei Z, et al
    Rapid asymptomatic transmission of COVID-19 during the incubation period demonstrating strong infectivity in a cluster of youngsters aged 16-23 years outside Wuhan and characteristics of young patients with COVID-19: A prospective contact-tracing stud
    J Infect. 2020;80:e1-e13.
    >> Share

  691. FU L, Wang B, Yuan T, Chen X, et al
    Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis.
    J Infect. 2020;80:656-665.
    >> Share

  692. YE Q, Wang B, Mao J
    The pathogenesis and treatment of the `Cytokine Storm' in COVID-19.
    J Infect. 2020;80:607-613.
    >> Share

  693. YANG P, Liu P, Li D, Zhao D, et al
    Corona Virus Disease 2019, a growing threat to children?
    J Infect. 2020;80:671-693.
    >> Share

  694. SUN H, Lu M, Chen S, Cheng Z, et al
    Nosocomial SARS-CoV-2 infection among nurses in Wuhan at a single centre.
    J Infect. 2020;80:e41-e42.
    >> Share

  695. CHEN L, Cai J, Lin Q, Xiang B, et al
    Imported COVID-19 cases pose new challenges for China.
    J Infect. 2020;80:e43-e44.
    >> Share

  696. ZHANG J, Jia W, Zhu J, Li B, et al
    Insights into the cross-species evolution of 2019 novel coronavirus.
    J Infect. 2020;80:671-693.
    >> Share

  697. HAO W, Li M
    Clinical features of atypical 2019 novel coronavirus pneumonia with an initially negative RT-PCR assay.
    J Infect. 2020;80:671-693.
    >> Share

  698. GAO Y, Shi C, Chen Y, Shi P, et al
    A cluster of the Corona Virus Disease 2019 caused by incubation period transmission in Wuxi, China.
    J Infect. 2020;80:666-670.
    >> Share

    May 2020
  699. GALLOWAY JB, Norton S, Barker RD, Brookes A, et al
    A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: an observational cohort study.
    J Infect. 2020 May 29. pii: S0163-4453(20)30314.
    >> Share

  700. SZE S, Pan D, Williams CML, Wong N, et al
    Letter to the Editor: Variability but not admission or trends in NEWS2 score predicts clinical outcome in elderly hospitalised patients with COVID-19.
    J Infect. 2020 May 29. pii: S0163-4453(20)30341.
    >> Share

  701. ZHENG X, Wang H, Su Z, Li W, et al
    Co-infection of SARS-CoV-2 and Influenza virus in Early Stage of the COVID-19 Epidemic in Wuhan, China.
    J Infect. 2020 May 28. pii: S0163-4453(20)30319.
    >> Share

  702. WU P, Lu W, He L, Meng Y, et al
    COVID-19 Patients with Recent Influenza A/B Infection: A Retrospective Study.
    J Infect. 2020 May 28. pii: S0163-4453(20)30333.
    >> Share

  703. LIU M, Gao Y, Shi S, Chen Y, et al
    Drinking no-links to the severity of COVID-19: a systematic review and meta-analysis.
    J Infect. 2020 May 28. pii: S0163-4453(20)30320.
    >> Share

  704. AFSHAR ZM, Dayani M, Naderi M, Ghabarveisi F, et al
    Fatality rate of COVID-19 in patients with malignancies: a sytematic review and meta-analysis.
    J Infect. 2020 May 28. pii: S0163-4453(20)30340.
    >> Share

  705. MOISEEV S, Avdeev S, Brovko M, Akulkina L, et al
    Cancer in intensive care unit patients with COVID-19.
    J Infect. 2020 May 28. pii: S0163-4453(20)30327.
    >> Share

  706. BETTENCOURT P, Fernandes C, Gil A, Almeida A, et al
    Qualitative serology in patients recovered from SARS CoV 2 infection.
    J Infect. 2020 May 28. pii: S0163-4453(20)30335.
    >> Share

  707. ZHONG Y, Wang K, Zhu Y, Lyu D, et al
    COVID-19: Evidence of the Eye.
    J Infect. 2020 May 28. pii: S0163-4453(20)30331.
    >> Share

  708. PENG HC, Hussin N, Nalliah S, Ooi WT, et al
    Experience of short-term hydroxychloroquine and azithromycin in COVID-19 patients and effect on QTc trend.
    J Infect. 2020 May 28. pii: S0163-4453(20)30336.
    >> Share

  709. PIROLA CJ, Sookoian S
    Estimation of RAAS-Inhibitor effect on the COVID-19 outcome: A Meta-analysis.
    J Infect. 2020 May 28. pii: S0163-4453(20)30329.
    >> Share

  710. NGUYEN Y, Corre F, Honsel V, Curac S, et al
    Applicability of the CURB-65 pneumonia severity score for outpatient treatment of COVID-19.
    J Infect. 2020 May 28. pii: S0163-4453(20)30330.
    >> Share

  711. WONG MC, Teoh JY, Huang J, Wong SH, et al
    The potential impact of vulnerability and coping capacity on the pandemic control of COVID-19.
    J Infect. 2020 May 28. pii: S0163-4453(20)30337.
    >> Share

  712. MEYLAN S, Akrour R, Regina J, Bart PA, et al
    An Early Warning Score to predict ICU admission in COVID-19 positive patients.
    J Infect. 2020 May 28. pii: S0163-4453(20)30324.
    >> Share

  713. SAGNELLI C, Gentile V, Tirri R, Macera M, et al
    Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient.
    J Infect. 2020 May 28. pii: S0163-4453(20)30322.
    >> Share

  714. HU J, Zhang X, Zhang X, Zhao H, et al
    COVID-19 patients with hypertension have more severity condition, and ACEI/ARB treatment have no infulence on the clinical severity and outcome.
    J Infect. 2020 May 28. pii: S0163-4453(20)30334.
    >> Share

  715. COLTON H, Ankcorn M, Yavuz M, Tovey L, et al
    Improved sensitivity using a dual target, E and RdRp assay for the diagnosis of SARS-CoV-2 infection: Experience at a large NHS Foundation Trust in the UK.
    J Infect. 2020 May 28. pii: S0163-4453(20)30339.
    >> Share

  716. KUNUTSOR SK, Laukkanen JA
    Markers of liver injury and clinical outcomes in COVID-19 patients: A systematic review and meta-analysis.
    J Infect. 2020 May 28. pii: S0163-4453(20)30325.
    >> Share

  717. KAKKAR DN, Dunphy DJ, Raza DM
    Ethnicity profiles of COVID-19 admissions and outcomes.
    J Infect. 2020 May 27. pii: S0163-4453(20)30338.
    >> Share

  718. WONG MC, Teoh JY, Huang J, Wong SH, et al
    Strengthening early testing and surveillance of COVID-19 to enhance identification of asymptomatic patients.
    J Infect. 2020 May 27. pii: S0163-4453(20)30328.
    >> Share

  719. LANSBURY L, Lim B, Baskaran V, Lim WS, et al
    Co-infections in people with COVID-19: a systematic review and meta-analysis.
    J Infect. 2020 May 27. pii: S0163-4453(20)30323.
    >> Share

  720. VARIKASUVU SR, Dutt N
    Cardiovascular disease as a risk factor of disease progression in COVID-19: The corrected effect size and forest plot.
    J Infect. 2020 May 27. pii: S0163-4453(20)30316.
    >> Share

  721. BORGHETTI A, Ciccullo A, Paratore M, Rovedi F, et al
    Derivation and validation of a scoring system to assess pre-test probability of being COVID-19 positive.
    J Infect. 2020 May 27. pii: S0163-4453(20)30321.
    >> Share

  722. KLEMENT-FRUTOS E, Burrel S, Peytavin G, Marot S, et al
    Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19.
    J Infect. 2020 May 27. pii: S0163-4453(20)30318.
    >> Share


  723. Follow-up study on pulmonary function and radiological changes in critically ill patients with COVID-19.
    J Infect. 2020 May 27. pii: S0163-4453(20)30317.
    >> Share

  724. GOSCE L, Phillips PA, Spinola P, Gupta DRK, et al
    Modelling SARS-COV2 Spread in London: Approaches to Lift the Lockdown.
    J Infect. 2020 May 24. pii: S0163-4453(20)30315.
    >> Share

  725. DE SOUZA LUNA LK, Perosa DAH, Conte DD, Carvalho JMA, et al
    Different patterns of Influenza A and B detected during early stages of COVID-19 in a university hospital in Sao Paulo, Brazil.
    J Infect. 2020 May 21. pii: S0163-4453(20)30313.
    >> Share

  726. FRONTERA A, Cianfanelli L, Vlachos K, Landoni G, et al
    Severe air pollution links to higher mortality in COVID-19 patients: the "double-hit" hypothesis.
    J Infect. 2020 May 21. pii: S0163-4453(20)30285.
    >> Share

  727. NOH JY, Yoon JG, Seong H, Choi WS, et al
    Asymptomatic infection and atypical manifestations of COVID-19: Comparison of viral shedding duration.
    J Infect. 2020 May 21. pii: S0163-4453(20)30310.
    >> Share

  728. MANZONI P, Milillo C
    Covid-19 mortality in Italian Doctors.
    J Infect. 2020 May 20. pii: S0163-4453(20)30311.
    >> Share

  729. ANIM DO, Ofori-Asenso R
    Water scarcity and COVID-19 in sub-Saharan Africa.
    J Infect. 2020 May 20. pii: S0163-4453(20)30312.
    >> Share

  730. TANG JW, Young S, May S, Bird P, et al
    Comparing hospitalised, community and staff COVID-19 infection rates during the early phase of the evolving COVID-19 epidemic.
    J Infect. 2020 May 19. pii: S0163-4453(20)30308.
    >> Share

  731. CAI C, Ahmed OA, Shen H, Zeng S, et al
    Which cancer type has the highest risk of COVID-19 infection?
    J Infect. 2020 May 19. pii: S0163-4453(20)30307.
    >> Share

  732. VOINSKY I, Baristaite G, Gurwitz D
    Effects of age and sex on recovery from COVID-19: Analysis of 5,769 Israeli patients.
    J Infect. 2020 May 16. pii: S0163-4453(20)30303.
    >> Share

  733. CHEN DX, Shan Y
    Mesenchymal stem cell therapy in severe COVID-19: a retrospective study of short-term treatment efficacy and side effects.
    J Infect. 2020 May 15. pii: S0163-4453(20)30295.
    >> Share

  734. BRUNO G, Perelli S, Fabrizio C, Buccoliero GB, et al
    Short-term outcomes in individuals aged 75 or older with severe coronavirus disease (COVID-19): First observations from an Infectious Diseases Unit in Southern Italy.
    J Infect. 2020 May 14. pii: S0163-4453(20)30301.
    >> Share

  735. GOURSAUD S, Descamps R, Daubin C, du Cheyron D, et al
    Corticosteroid use in selected patients with severe Acute Respiratory Distress Syndrome related to Covid-19.
    J Infect. 2020 May 14. pii: S0163-4453(20)30299.
    >> Share

  736. HUANG W, Zhao Z, He Z, Liu S, et al
    Unfavorable outcomes in pregnant patients with COVID-19 outside Wuhan, China.
    J Infect. 2020 May 14. pii: S0163-4453(20)30292.
    >> Share

  737. JIA Y, Yang C, Zhang M, Yang X, et al
    Characterization of eight novel full-length genomes of SARS-CoV-2 among imported COVID-19 cases from abroad in Yunnan, China.
    J Infect. 2020 May 14. pii: S0163-4453(20)30291.
    >> Share

  738. GAO Y, Chen Y, Liu M, Shi S, et al
    Impacts of immunosuppression and immunodeficiency on COVID-19: a systematic review and meta-analysis.
    J Infect. 2020 May 14. pii: S0163-4453(20)30294.
    >> Share

  739. MARIE TH, Laurent B, Alain W, Ingrid B, et al
    The role of serology for COVID-19 control: Population, kinetics and test performance do matter.
    J Infect. 2020 May 14. pii: S0163-4453(20)30297.
    >> Share

  740. SHI L, Wang Y, Wang Y, Duan G, et al
    Dyspnea rather than fever is a risk factor for predicting mortality in patients with COVID-19.
    J Infect. 2020 May 14. pii: S0163-4453(20)30288.
    >> Share

  741. CHEN L, Zhang B, Ti MN, Yang K, et al
    Clinical course of severe and critically ill patients with coronavirus disease 2019 (COVID-19): a comparative study.
    J Infect. 2020 May 13. pii: S0163-4453(20)30296.
    >> Share

  742. TUNESI S, Bourgarit A
    Prescribing COVID-19 treatments: what we should never forget.
    J Infect. 2020 May 13. pii: S0163-4453(20)30298.
    >> Share

  743. VRSALOVIC M, Vrsalovic Presecki A
    Cardiac troponins predict mortality in patients with COVID-19: A meta-analysis of adjusted risk estimates.
    J Infect. 2020 May 13. pii: S0163-4453(20)30300.
    >> Share

  744. WOODRUFF A
    COVID-19 Follow up Testing.
    J Infect. 2020 May 11. pii: S0163-4453(20)30289.
    >> Share

  745. PIROLA CJ, Sookoian S
    Age but not sex may explain the negative effect of arterial hypertension and diabetes on COVID-19 prognosis.
    J Infect. 2020 May 11. pii: S0163-4453(20)30284.
    >> Share

  746. JAYARAJ R
    Clinical and conceptual comments on "Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis".
    J Infect. 2020 May 11. pii: S0163-4453(20)30287.
    >> Share

  747. LEE J, Lee YH, Chang HH, Choi SH, et al
    Comparison of short-term mortality between mechanically ventilated patients with COVID-19 and influenza in a setting of sustainable healthcare system.
    J Infect. 2020 May 8. pii: S0163-4453(20)30278.
    >> Share

  748. AITKEN T, Chin KL, Liew D, Ofori-Asenso R, et al
    Rethinking pandemic preparation: Global Health Security Index (GHSI) is predictive of COVID-19 burden, but in the opposite direction.
    J Infect. 2020 May 8. pii: S0163-4453(20)30273.
    >> Share

  749. JUNG J, Oh DK, Ahn JH, Hong SB, et al
    Re: Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19.
    J Infect. 2020 May 8. pii: S0163-4453(20)30277.
    >> Share

  750. NG JJ, Luo Y, Phua K, Choong AMTL, et al
    Acute kidney injury in hospitalized patients with coronavirus disease 2019 (COVID-19): A meta-analysis.
    J Infect. 2020 May 8. pii: S0163-4453(20)30280.
    >> Share

  751. DEMEY B, Daher N, Francois C, Lanoix JP, et al
    Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays.
    J Infect. 2020 May 7. pii: S0163-4453(20)30244.
    >> Share

  752. ZHANG B, Liu S, Zhang J, Xiao J, et al
    Children hospitalized for coronavirus disease 2019 (COVID-19): A multicenter retrospective descriptive study.
    J Infect. 2020 May 7. pii: S0163-4453(20)30272.
    >> Share

  753. RAVIOLI S, Ochsner H, Lindner G
    Reactivation of COVID-19 pneumonia: A report of two cases.
    J Infect. 2020 May 7. pii: S0163-4453(20)30279.
    >> Share

  754. SU Y, Tu GW, Ju MJ, Yu SJ, et al
    Comparison of CRB-65 and quick sepsis-related organ failure assessment for predicting the need for intensive respiratory or vasopressor support in patients with COVID-19.
    J Infect. 2020 May 7. pii: S0163-4453(20)30281.
    >> Share

  755. AYLWIN SJ, Patel AS, Post FA
    COVID-19 diagnoses in South East London peaked before the UK suggesting early measures reduced transmission.
    J Infect. 2020 May 3. pii: S0163-4453(20)30269.
    >> Share

  756. CHIN KL, Ofori-Asenso R, Jordan KA, Jones D, et al
    Early signs that COVID-19 is being contained in Australia.
    J Infect. 2020 May 1. pii: S0163-4453(20)30268.
    >> Share

  757. ZHANG Z, Xiao K, Zhang X, Roy A, et al
    Emergence of SARS-like coronavirus in China: An update.
    J Infect. 2020;80:e28-e29.
    >> Share

  758. WANG D, Zhou M, Nie X, Qiu W, et al
    Epidemiological characteristics and transmission model of Corona Virus Disease 2019 in China.
    J Infect. 2020;80:e25-e27.
    >> Share

    April 2020
  759. CHOW A, Hein AA, Kyaw WM
    Unintended Consequence: Influenza plunges with public health response to COVID-19 in Singapore.
    J Infect. 2020 Apr 30. pii: S0163-4453(20)30262.
    >> Share

  760. MENG Y, Guo E, Liu J, Huang X, et al
    Value and Challenges: Nucleic Acid Amplification Tests for SARS-CoV-2 in Hospitalized COVID-19 Patients.
    J Infect. 2020 Apr 30. pii: S0163-4453(20)30261.
    >> Share

  761. YE G, Lin H, Chen L, Wang S, et al
    Environmental Contamination of SARS-CoV-2 in Healthcare Premises.
    J Infect. 2020 Apr 30. pii: S0163-4453(20)30260.
    >> Share

  762. LIU Y, Lam TTY, Lai FYL, Krajden M, et al
    Comparative seasonalities of influenza A, B and 'common cold' coronaviruses - setting the scene for SARS-CoV-2 infections and possible unexpected host immune interactions.
    J Infect. 2020 Apr 29. pii: S0163-4453(20)30243.
    >> Share

  763. DIMEGLIO C, Loubes JM, Deporte B, Dubois M, et al
    The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France.
    J Infect. 2020 Apr 29. pii: S0163-4453(20)30242.
    >> Share

  764. CHU Y, Li T, Fang Q, Wang X, et al
    Clinical features of critically ill patients with confirmed COVID-19.
    J Infect. 2020 Apr 28. pii: S0163-4453(20)30150.
    >> Share

  765. ZHEN-DONG Y, Gao-Jun Z, Run-Ming J, Zhi-Sheng L, et al
    Clinical and transmission dynamics characteristics of 406 children with coronavirus disease 2019 in China: A review.
    J Infect. 2020 Apr 28. pii: S0163-4453(20)30241.
    >> Share

  766. TOMLINS J, Hamilton F, Gunning S, Sheehy C, et al
    Clinical features of 95 sequential hospitalised patients with novel coronavirus 2019 disease (COVID-19), the first UK cohort.
    J Infect. 2020 Apr 27. pii: S0163-4453(20)30232.
    >> Share

  767. WU J, Liang J, Zhou H, Peng F, et al
    Clinical Features and Outcomes of Asymptomatic Cases of SARS-CoV-2 Infection.
    J Infect. 2020 Apr 23. pii: S0163-4453(20)30238.
    >> Share

  768. MINOTTI C, Tirelli F, Barbieri E, Giaquinto C, et al
    How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review.
    J Infect. 2020 Apr 23. pii: S0163-4453(20)30237.
    >> Share

  769. CHENG VCC, Wong SC, Chuang VWM, So SYC, et al
    The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2.
    J Infect. 2020 Apr 23. pii: S0163-4453(20)30235.
    >> Share

  770. PETERS A, Lotfinejad N, Simniceanu A, Pittet D, et al
    The economics of infection prevention: why it is crucial to invest in hand hygiene and nurses during the novel coronavirus pandemic.
    J Infect. 2020 Apr 23. pii: S0163-4453(20)30240.
    >> Share

  771. ZHANG B, Liu S, Dong Y, Zhang L, et al
    Positive rectal swabs in young patients recovered from coronavirus disease 2019 (COVID-19).
    J Infect. 2020 Apr 23. pii: S0163-4453(20)30233.
    >> Share

  772. SONG R, Han B, Song M, Wang L, et al
    Clinical and epidemiological features of COVID-19 family clusters in Beijing, China.
    J Infect. 2020 Apr 23. pii: S0163-4453(20)30229.
    >> Share

  773. JIANG Y, Niu W, Wang Q, Zhao H, et al
    Characteristics of a family cluster of Severe Acute Respiratory Syndrome Coronavirus 2 in Henan, China.
    J Infect. 2020 Apr 23. pii: S0163-4453(20)30239.
    >> Share

  774. ZHENG Z, Peng F, Xu B, Zhao J, et al
    Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis.
    J Infect. 2020 Apr 23. pii: S0163-4453(20)30234.
    >> Share

  775. LEE YL, Liao CH, Liu PY, Cheng CY, et al
    Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients.
    J Infect. 2020 Apr 23. pii: S0163-4453(20)30230.
    >> Share

  776. SPICUZZA L, Montineri A, Manuele R, Crimi C, et al
    Reliability and usefulness of a rapid IgM-IgG antibody test for the diagnosis of SARS-CoV-2 infection: a preliminary report.
    J Infect. 2020 Apr 23. pii: S0163-4453(20)30231.
    >> Share

  777. CANTINI F, Niccoli L, Matarrese D, Nicastri E, et al
    Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact.
    J Infect. 2020 Apr 22. pii: S0163-4453(20)30228.
    >> Share

  778. LI H, Chen K, Liu M, Xu H, et al
    The profile of peripheral blood lymphocyte subsets and serum cytokines in children with 2019 novel coronavirus pneumonia.
    J Infect. 2020 Apr 20. pii: S0163-4453(20)30207.
    >> Share

  779. LI J, Li Z, Cui X, Wu C, et al
    Bayesian phylodynamic inference on the temporal evolution and global transmission of SARS-CoV-2.
    J Infect. 2020 Apr 20. pii: S0163-4453(20)30227.
    >> Share

  780. LIU X, Zhou H, Zhou Y, Wu X, et al
    Risk Factors Associated with Disease Severity and Length of Hospital Stay in COVID-19 Patients.
    J Infect. 2020 Apr 16. pii: S0163-4453(20)30216.
    >> Share

  781. GODAERT L, Proye E, Demoustier-Tampere D, Coulibaly PS, et al
    Clinical characteristics of older patients: The experience of a geriatric short-stay unit dedicated to patients with COVID-19 in France.
    J Infect. 2020 Apr 16. pii: S0163-4453(20)30217.
    >> Share

  782. KENYON C
    Flattening-the-curve associated with reduced COVID-19 case fatality rates- an ecological analysis of 65 countries.
    J Infect. 2020 Apr 16. pii: S0163-4453(20)30215.
    >> Share

  783. WEI YY, Wang RR, Zhang DW, Tu YH, et al
    Risk factors for severe COVID-19: evidence from 167 hospitalized patients in Anhui, China.
    J Infect. 2020 Apr 16. pii: S0163-4453(20)30219.
    >> Share

  784. LV B, Li Z, Chen Y, Long C, et al
    Global COVID-19 fatality analysis reveals Hubei-like countries potentially with severe outbreaks.
    J Infect. 2020 Apr 14. pii: S0163-4453(20)30157.
    >> Share

  785. AZZI L, Carcano G, Gianfagna F, Grossi P, et al
    SALIVA IS A RELIABLE TOOL TO DETECT SARS-CoV-2.
    J Infect. 2020 Apr 13. pii: S0163-4453(20)30213.
    >> Share

  786. MA J, Yin J, Qian Y, Wu Y, et al
    Clinical Characteristics and Prognosis in Cancer Patients with COVID-19: a Single Center's Retrospective Study.
    J Infect. 2020 Apr 13. pii: S0163-4453(20)30214.
    >> Share

  787. MENG H, Xiong R, He R, Lin W, et al
    CT imaging and clinical course of asymptomatic cases with COVID-19 pneumonia at admission in Wuhan, China.
    J Infect. 2020 Apr 12. pii: S0163-4453(20)30211.
    >> Share

  788. YANG H, Sun G, Tang F, Peng M, et al
    Clinical Features and Outcomes of Pregnant Women Suspected of Coronavirus Disease 2019.
    J Infect. 2020 Apr 12. pii: S0163-4453(20)30212.
    >> Share

  789. JIANG DM
    Recurrent PCR positivity after hospital discharge of people with coronavirus disease 2019 (COVID-19).
    J Infect. 2020 Apr 11. pii: S0163-4453(20)30152.
    >> Share

  790. LI H, Xiang X, Ren H, Xu L, et al
    SAA is a biomarker to distinguish the severity and prognosis of Coronavirus Disease 2019 (COVID-19).
    J Infect. 2020 Apr 8. pii: S0163-4453(20)30162.
    >> Share

  791. ZHANG X, Chen X, Zhang Z, Roy A, et al
    Strategies to trace back the origin of COVID-19.
    J Infect. 2020 Apr 8. pii: S0163-4453(20)30160.
    >> Share

  792. WANG JT, Lin YY, Chang SY, Yeh SH, et al
    The Role of Phylogenetic Analysis in Clarifying the Infection Source of a COVID-19 Patient.
    J Infect. 2020 Apr 8. pii: S0163-4453(20)30159.
    >> Share

  793. ZHU Y, Gao ZH, Liu YL, Xu DY, et al
    Clinical and CT imaging features of 2019 novel coronavirus disease (COVID-19).
    J Infect. 2020 Apr 8. pii: S0163-4453(20)30161.
    >> Share

  794. LI W, Zhang J, Xiao S, Sun L, et al
    Characteristics of health worker fatality in China during the outbreak of COVID-19 infection.
    J Infect. 2020 Apr 8. pii: S0163-4453(20)30158.
    >> Share

  795. ZENG J, Peng S, Lei Y, Huang J, et al
    Clinical and Imaging features of COVID-19 Patients: Analysis of Data from High-Altitude Areas.
    J Infect. 2020 Apr 7. pii: S0163-4453(20)30155.
    >> Share

  796. LI DL, Chen MX
    Critical patients with coronavirus disease 2019: Risk factors and outcome nomogram.
    J Infect. 2020 Apr 6. pii: S0163-4453(20)30153.
    >> Share

  797. GE R, Qi Y, Yan Y, Tian M, et al
    The role of close contacts tracking management in COVID-19 prevention: A cluster investigation in Jiaxing, China.
    J Infect. 2020 Apr 5. pii: S0163-4453(20)30144.
    >> Share

  798. SUN S, Yu K, Xie Z, Pan X, et al
    China empowers Internet hospital to fight against COVID-19.
    J Infect. 2020 Apr 3. pii: S0163-4453(20)30183.
    >> Share

    March 2020
  799. WANG L, He W, Yu X, Hu D, et al
    Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up.
    J Infect. 2020 Mar 30. pii: S0163-4453(20)30146.
    >> Share

  800. KWOK KO, Lai F, Wei WI, Wong SYS, et al
    Herd immunity - estimating the level required to halt the COVID-19 epidemics in affected countries.
    J Infect. 2020 Mar 21. pii: S0163-4453(20)30154.
    >> Share

  801. XIAO DAT, Gao DC, Zhang DS
    Profile of Specific Antibodies to SARS-CoV-2: The First Report.
    J Infect. 2020 Mar 21. pii: S0163-4453(20)30138.
    >> Share

  802. ZHANG Z, Yao W, Wang Y, Long C, et al
    Wuhan and Hubei COVID-19 mortality analysis reveals the critical role of timely supply of medical resources.
    J Infect. 2020 Mar 21. pii: S0163-4453(20)30145.
    >> Share

  803. ZHOU B, She J, Wang Y, Ma X, et al
    The Clinical Characteristics of Myocardial injury 1 in Severe and Very Severe Patients with 2019 Novel Coronavirus Disease.
    J Infect. 2020 Mar 21. pii: S0163-4453(20)30149.
    >> Share

  804. FANG Z, Zhang Y, Hang C, Zhang W, et al
    Comparisons of nucleic acid conversion time of SARS-CoV-2 of different samples in ICU and non-ICU patients.
    J Infect. 2020 Mar 21. pii: S0163-4453(20)30139.
    >> Share

  805. LEI DP
    The Progression of Computed Tomographic (CT) Images in Patients with Coronavirus Disease (COVID-19) Pneumonia: The CT progression of COVID-19 pneumonia.
    J Infect. 2020 Mar 20. pii: S0163-4453(20)30151.
    >> Share

  806. HILL DKJ, Russell DCD, Clifford DS, Templeton DK, et al
    The index case of SARS-CoV-2 in Scotland: a case report.
    J Infect. 2020 Mar 20. pii: S0163-4453(20)30148.
    >> Share

  807. LEI P, Fan B, Mao J, Wang P, et al
    Comprehensive analysis for diagnosis of novel coronavirus disease (COVID-19) infection.
    J Infect. 2020 Mar 19. pii: S0163-4453(20)30142.
    >> Share

  808. LEI P, Fan B, Yuan Y
    The evolution of CT characteristics in the patients with COVID-19 pneumonia.
    J Infect. 2020 Mar 19. pii: S0163-4453(20)30143.
    >> Share

  809. CHEN J, Qi T, Liu L, Ling Y, et al
    Clinical progression of patients with COVID-19 in Shanghai, China.
    J Infect. 2020 Mar 11. pii: S0163-4453(20)30119.
    >> Share

  810. YE G, Pan Z, Pan Y, Deng Q, et al
    Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation.
    J Infect. 2020 Mar 11. pii: S0163-4453(20)30114.
    >> Share

  811. LIU H, Liu F, Li J, Zhang T, et al
    Clinical and CT Imaging Features of the COVID-19 Pneumonia: Focus on Pregnant Women and Children.
    J Infect. 2020 Mar 11. pii: S0163-4453(20)30118.
    >> Share

  812. LIU K, Chen Y, Lin R, Han K, et al
    Clinical feature of COVID-19 in elderly patients: a comparison with young and middle-aged patients.
    J Infect. 2020 Mar 11. pii: S0163-4453(20)30116.
    >> Share

  813. DENG L, Li C, Zeng Q, Liu X, et al
    Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019:a retrospective cohort study.
    J Infect. 2020 Mar 11. pii: S0163-4453(20)30113.
    >> Share

  814. IBRAHIM IM, Abdelmalek DH, Elshahat ME, Elfiky AA, et al
    COVID-19 spike-host cell receptor GRP78 binding site prediction.
    J Infect. 2020 Mar 10. pii: S0163-4453(20)30107.
    >> Share

  815. XIANG B, Chen L, Xie P, Lin Q, et al
    Wild Bird-Origin H5N6 Avian Influenza Virus is Transmissible in Guinea Pigs: H5N6 Avian Influenza Virus is Transmissible.
    J Infect. 2020 Mar 4. pii: S0163-4453(20)30112.
    >> Share

  816. HE Y, Wang Z, Li F, Shi Y, et al
    Public health might be endangered by possible prolonged discharge of SARS-CoV-2 in stool.
    J Infect. 2020 Mar 4. pii: S0163-4453(20)30111.
    >> Share

  817. BERMEJO-MARTIN JF, Almansa R, Menendez R, Mendez R, et al
    Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection: Lymphopenia in severe COVID-19 infection.
    J Infect. 2020 Mar 4. pii: S0163-4453(20)30110.
    >> Share

  818. WEN F, Yu H, Guo J, Li Y, et al
    Identification of the hyper-variable genomic hotspot for the novel coronavirus SARS-CoV-2.
    J Infect. 2020 Mar 4. pii: S0163-4453(20)30108.
    >> Share

  819. TANG JW, Tambyah PA, Hui DSC
    Emergence of a novel coronavirus causing respiratory illness from Wuhan, China.
    J Infect. 2020;80:350-371.
    >> Share

  820. WANG R, Zhang X, Irwin DM, Shen Y, et al
    Emergence of SARS-like coronavirus poses new challenge in China.
    J Infect. 2020;80:350-371.
    >> Share

    February 2020
  821. LILLIE PJ, Samson A, Li A, Adams K, et al
    Novel coronavirus disease (Covid-19): the first two patients in the UK with person to person transmission.
    J Infect. 2020 Feb 28. pii: S0163-4453(20)30102.
    >> Share

  822. LI Q, Feng W, Quan YH
    Trend and forecasting of the COVID-19 outbreak in China.
    J Infect. 2020 Feb 27. pii: S0163-4453(20)30095.
    >> Share

  823. TIAN S, Hu N, Lou J, Chen K, et al
    Characteristics of COVID-19 infection in Beijing.
    J Infect. 2020 Feb 27. pii: S0163-4453(20)30101.
    >> Share

  824. YANG W, Cao Q, Qin L, Wang X, et al
    Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China.
    J Infect. 2020 Feb 26. pii: S0163-4453(20)30099.
    >> Share

  825. FU X, Ying Q, Zeng T, Long T, et al
    Simulating and Forecasting the Cumulative Confirmed Cases of SARS-CoV-2 in China by Boltzmann Function-based Regression Analyses.
    J Infect. 2020 Feb 26. pii: S0163-4453(20)30098.
    >> Share

  826. HAN Q, Lin Q, Jin S, You L, et al
    Recent insights into 2019-nCoV: a brief but comprehensive review.
    J Infect. 2020 Feb 25. pii: S0163-4453(20)30087.
    >> Share

  827. XU YH, Dong JH, An WM, Lv XY, et al
    Clinical and computed tomographic imaging features of Novel Coronavirus Pneumonia caused by SARS-CoV-2.
    J Infect. 2020 Feb 25. pii: S0163-4453(20)30100.
    >> Share

  828. LI R, Qiao S, Zhang G
    Analysis of angiotensin-converting enzyme 2 (ACE2) from different species sheds some light on cross-species receptor usage of a novel coronavirus 2019-nCoV.
    J Infect. 2020 Feb 21. pii: S0163-4453(20)30090.
    >> Share

  829. FENG ZH, Cheng YR, Chen J, Ye L, et al
    Chinese medical personnel against the 2019-nCoV.
    J Infect. 2020 Feb 21. pii: S0163-4453(20)30082.
    >> Share

  830. KWOK KO, Wong V, Wei VWI, Wong SYS, et al
    Novel coronavirus (2019-nCoV) cases in Hong Kong and implications for further spread.
    J Infect. 2020 Feb 21. pii: S0163-4453(20)30084.
    >> Share

    January 2020
  831. HE W, Wang L, Zhao Y, Wang N, et al
    Adaption and Parallel Evolution of Human-Isolated H5 Avian Influenza Viruses.
    J Infect. 2020 Jan 30. pii: S0163-4453(20)30036.
    >> Share

  832. OU J, Chen R, Yan Z, Ou S, et al
    Codon usage bias of H3N8 equine influenza virus- an evolutionary perspective.
    J Infect. 2020 Jan 17. pii: S0163-4453(20)30021.
    >> Share

  833. CHEN J, Zhu H, Horby PW, Wang Q, et al
    Specificity, Kinetics and Longevity of Antibody Responses to Avian Influenza A(H7N9) Virus Infection in Humans.
    J Infect. 2020 Jan 16. pii: S0163-4453(20)30025.
    >> Share

  834. TOIVONEN L, Karppinen S, Schuez-Havupalo L, Teros-Jaakkola T, et al
    Respiratory syncytial virus infections in children 0-24 months of age in the community.
    J Infect. 2020;80:69-75.
    >> Share

    December 2019
  835. OU J, Huang M, Chen X, Wang Z, et al
    The potential threat of avian influenza virus to horses - Recalling the Chinese 1989-1990 equine influenza outbreaks.
    J Infect. 2019 Dec 28. pii: S0163-4453(19)30385.
    >> Share

  836. CHARLTON M, Dunn C, Dashey S, Lai FY, et al
    Severe influenza a cases requiring extra-corporeal membrane oxygenation (ECMO) therapy, 2018-2019.
    J Infect. 2019 Dec 25. pii: S0163-4453(19)30381.
    >> Share

    November 2019
  837. XU C, Shu Y
    The heterogeneity of influenza seasonality by subtype and lineage in China.
    J Infect. 2019 Nov 29. pii: S0163-4453(19)30368.
    >> Share

  838. HAIXU L, Haibin W, Lili R
    Detection of 20 Respiratory Viruses and Bacteria by Influenza-Like Illness Surveillance in Beijing, China, 2016-2018.
    J Infect. 2019 Nov 25. pii: S0163-4453(19)30352.
    >> Share

  839. CHEN X, Guo F, Pan J, Shen X, et al
    Rare homologous recombination in H3N2 avian influenza A viruses.
    J Infect. 2019 Nov 20. pii: S0163-4453(19)30348.
    >> Share

  840. WEN F, Huang S, Guo J
    Egg adaptive mutation patterns of H3N2 human influenza A viruses.
    J Infect. 2019 Nov 13. pii: S0163-4453(19)30343.
    >> Share

  841. TANG JW, Kennedy M, Lackenby A, Ellis J, et al
    Transmitted and acquired oseltamivir resistance during the 2018-2019 influenza season.
    J Infect. 2019 Nov 8. pii: S0163-4453(19)30334.
    >> Share

    October 2019
  842. GUO J, Huang S, Wen F
    Identification of coevolution sites and evolution history for neuraminidase of human influenza A viruses.
    J Infect. 2019 Oct 18. pii: S0163-4453(19)30322.
    >> Share

    September 2019
  843. CHONG KC, Lee TC, Bialasiewicz S, Chen J, et al
    Association between meteorological variations and activities of influenza A and B across different climate zones: a multi-region modelling analysis across the globe.
    J Infect. 2019 Sep 30. pii: S0163-4453(19)30284.
    >> Share

    February 2019
  844. PINANA JL, Gimenez E, Gomez MD, Perez A, et al
    Pulmonary Cytomegalovirus (CMV) DNA shedding in allogeneic hematopoietic stem cell transplant recipients: implications for the diagnosis of CMV pneumonia.
    J Infect. 2019 Feb 21. pii: S0163-4453(19)30058.
    >> Share

  845. GREEN CA, Sande CJ, Scarselli E, Capone S, et al
    Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults.
    J Infect. 2019 Feb 8. pii: S0163-4453(19)30038.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016